,datetime,title,source,link,sentiment_class,sentiment_score
0,9/29/2016 9:10:26 AM,BRIEF-U.S. FDA approves Orkambi for use in children with Cystic Fibrosis (VRTX),Reuters,/news/stocks/brief-u-s-fda-approves-orkambi-for-use-in-children-with-cystic-fibrosis-vrtx-1001425098,negative,0.6436923742294312
1,9/29/2016 12:00:22 PM,FDA approves expanded use of Vertex Pharma's cystic fibrosis drug (VRTX),Reuters,/news/stocks/fda-approves-expanded-use-of-vertex-pharmas-cystic-fibrosis-drug-vrtx-1001425165,negative,0.8283477425575256
2,10/14/2016 5:40:24 PM,BRIEF-Vertex Pharma: Amended and expanded agreement with Cystic Fibrosis Foundation Therapeutics (VRTX),Reuters,/news/stocks/brief-vertex-pharma-amended-and-expanded-agreement-with-cystic-fibrosis-foundation-therapeutics-vrtx-1001457135,negative,0.714630126953125
3,10/17/2016 6:10:23 PM,BRIEF-Vertex says entered into a credit agreement with BofA on Oct. 13 (VRTX),Reuters,/news/stocks/brief-vertex-says-entered-into-a-credit-agreement-with-bofa-on-oct-13-vrtx-1001460056,negative,0.8051654100418091
4,10/25/2016 10:22:30 PM,BRIEF-Vertex says data from study of VX-152 expected in second half of 2017 (VRTX),Reuters,http://www.businessinsider.com/r-brief-vertex-says-data-from-study-of-vx-152-expected-in-second-half-of-2017-2016-10,positive,0.8953334093093872
5,10/27/2016 10:20:20 PM,BRIEF-Bank of America declares quarterly dividend of $0.075/share (BAC),Reuters,http://www.businessinsider.com/r-brief-bank-of-america-declares-quarterly-dividend-of-0075/share-2016-10,positive,0.6821951866149902
6,12/2/2016 5:16:05 PM,BRIEF-Vertex Pharmaceuticals appoints Ian Smith COO and CFO (VRTX),Reuters,http://www.businessinsider.com/r-brief-vertex-pharmaceuticals-appoints-ian-smith-coo-and-cfo-2016-12,positive,0.9350383877754211
7,12/19/2016 11:08:03 AM,BRIEF-Vertex Pharmaceuticals reaches agreement with German Federal Association Of Statutory Health Insurances for ORKAMBI (VRTX),Reuters,http://www.businessinsider.com/r-brief-vertex-pharmaceuticals-reaches-agreement-with-german-federal-association-of-statutory-health-insurances-for-orkambi-2016-12,negative,0.9422505497932434
8,1/9/2017 2:36:05 AM,Vertex Pharmaceuticals revenue outlook for cystic fibrosis treatments (VRTX),Reuters,http://www.businessinsider.com/r-vertex-pharmaceuticals-revenue-outlook-for-cystic-fibrosis-treatments-2017-1,positive,0.8283962607383728
9,1/9/2017 3:32:05 AM,UPDATE 1-Vertex issues revenue outlook for cystic fibrosis treatments (VRTX),Reuters,http://www.businessinsider.com/r-update-1-vertex-issues-revenue-outlook-for-cystic-fibrosis-treatments-2017-1,positive,0.7550483345985413
10,1/11/2017 4:12:08 PM,"BRIEF-Merck KGaA, Darmstadt, Germany licenses four oncology research and development programs from Vertex (MRK, VRTX)",Reuters,http://www.businessinsider.com/r-brief-merck-kgaa-darmstadt-germany-licenses-four-oncology-research-and-development-programs-from-vertex-2017-1,negative,0.523679792881012
11,2/21/2017 5:30:11 PM,"UPDATE 1-Bristol-Myers adds 3 directors in agreement with JANA Partners (BMY, MRK, VRTX, SHP)",Reuters,http://www.businessinsider.com/r-update-1-bristol-myers-adds-3-directors-in-agreement-with-jana-partners-2017-2,negative,0.5899608731269836
12,3/6/2017 1:04:54 PM,Vertex To Buy CTP-656 From Concert Pharma For Treatment Of Cystic Fibrosis ,RTTNews,/news/stocks/vertex-to-buy-ctp-656-from-concert-pharma-for-treatment-of-cystic-fibrosis-1001806441,negative,0.7414966821670532
13,3/6/2017 1:30:21 PM,BRIEF-Vertex to acquire CTP-656 from Concert Pharmaceuticals (VRTX),Reuters,http://www.businessinsider.com/r-brief-vertex-to-acquire-ctp-656-from-concert-pharmaceuticals-2017-3,positive,0.8904675841331482
14,3/29/2017 12:14:50 AM,Vertex cystic fibrosis combination succeeds in late-stage trials,Reuters,http://www.businessinsider.com/r-vertex-cystic-fibrosis-combination-succeeds-in-late-stage-trials-2017-3,negative,0.9337233304977417
15,3/29/2017 4:56:55 AM,Vertex Seeks Approval For Cystic Fibrosis Drug; Stock Surges ,RTTNews,/news/stocks/vertex-seeks-approval-for-cystic-fibrosis-drug-stock-surges-1001875872,neutral,0.4797643721103668
16,3/29/2017 8:47:42 AM,"First Drug For 2 Forms Of MS Gets FDA Nod, RTTR Abuzz, VRTX Gains On Trial Data ",RTTNews,/news/stocks/first-drug-for-2-forms-of-ms-gets-fda-nod-rttr-abuzz-vrtx-gains-on-trial-data-1001876362,negative,0.9143662452697754
17,3/29/2017 1:40:53 PM,US STOCKS-Futures flat as investors await Fed speakers (VRTX),Reuters,http://www.businessinsider.com/r-us-stocks-futures-flat-as-investors-await-fed-speakers-2017-3,neutral,0.9497917294502258
18,3/29/2017 2:46:50 PM,US STOCKS-Wall Street set to open little changed (VRTX),Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-set-to-open-little-changed-2017-3,positive,0.7622279524803162
19,3/29/2017 3:58:38 PM,A cystic fibrosis drug succeeded in a late-stage trial — and the company's stock is soaring (VRTX),Reuters,http://www.businessinsider.com/r-update-1-vertex-cystic-fibrosis-combination-succeeds-in-late-stage-trials-2017-3,negative,0.8653026223182678
20,3/29/2017 4:20:52 PM,"US STOCKS-Wall Street flat; Fed officials in focus (BRK., GS, VRTX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-flat-fed-officials-in-focus-2017-3,neutral,0.7117619514465332
21,3/29/2017 6:04:47 PM,"US STOCKS-S&P, Nasdaq lifted by energy, discretionary stocks (XOM, AMZN, TGT, VRTX, UNH)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-nasdaq-lifted-by-energy-discretionary-stocks-2017-3,negative,0.9130859375
22,3/29/2017 7:34:49 PM,"US STOCKS-S&P, Dow weighed down by financial stocks; Nasdaq up (BRK., JPM, AMZN, VRTX, UNH)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-weighed-down-by-financial-stocks-nasdaq-up-2017-3,neutral,0.9617318511009216
23,3/29/2017 9:20:50 PM,"US STOCKS-S&P edges up as energy gains, Vertex soars (AMZN, VRTX, MYL)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-edges-up-as-energy-gains-vertex-soars-2017-3,negative,0.940481960773468
24,3/29/2017 10:38:49 PM,"US STOCKS-Energy, consumer shares lift S&P 500 to slight gain (JWN, KSS, AMZN, VRTX)",Reuters,http://www.businessinsider.com/r-us-stocks-energy-consumer-shares-lift-sp-500-to-slight-gain-2017-3,negative,0.9220321774482727
25,3/30/2017 4:46:05 AM,"Gainers & Losers Of Mar.29: ATHX, VRTX, ACHN, SSH, RTTR... ",RTTNews,/news/stocks/gainers-losers-of-mar-29-athx-vrtx-achn-ssh-rttr-1001879947,positive,0.9222623705863953
26,3/30/2017 12:18:52 PM,Corbus drug shows promise as add-on therapy for cystic fibrosis (VRTX),Reuters,http://www.businessinsider.com/r-corbus-drug-shows-promise-as-add-on-therapy-for-cystic-fibrosis-2017-3,negative,0.9425755143165588
27,3/31/2017 12:30:00 PM,"Biotech Stocks Under Scanner -- Rexahn Pharma, Northwest Biotherapeutics, Celldex Therapeutics, and Vertex Pharma",PR Newswire,/news/stocks/biotech-stocks-under-scanner-rexahn-pharma-northwest-biotherapeutics-celldex-therapeutics-and-vertex-pharma-1001885435,positive,0.8475744724273682
28,4/27/2017 10:06:09 PM,Vertex Pharmaceuticals Inc. Q1 Profit Advances 352%,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q1-profit-advances-352-1001958731,negative,0.7754904627799988
29,4/27/2017 10:15:09 PM,BRIEF-Vertex Q1 non-gaap earnings per share $0.41 (VRTX),Reuters,http://www.businessinsider.com/r-brief-vertex-q1-non-gaap-earnings-per-share-041-2017-4,positive,0.8250094056129456
30,5/15/2017 12:50:00 PM,"How These Biotech Stocks are Faring? -- Seattle Genetics, Sangamo Therapeutics, Vertex Pharma, and VIVUS",PR Newswire,/news/stocks/how-these-biotech-stocks-are-faring-seattle-genetics-sangamo-therapeutics-vertex-pharma-and-vivus-1002012198,positive,0.9222546815872192
31,5/16/2017 2:56:03 PM,BRIEF-X-Chem and Vertex enter into multi-target genetic disease collaboration (VRTX),Reuters,http://www.businessinsider.com/r-brief-x-chem-and-vertex-enter-into-multi-target-genetic-disease-collaboration-2017-5,positive,0.5149014592170715
32,5/18/2017 3:56:45 AM,FDA Expands Approved Use Of Kalydeco To Treat Addl Mutations Of Cystic Fibrosis ,RTTNews,/news/stocks/fda-expands-approved-use-of-kalydeco-to-treat-addl-mutations-of-cystic-fibrosis-1002022941,negative,0.9134599566459656
33,5/18/2017 8:22:28 AM,"SNDX Rises On Entinostat Data, Kalydeco Gets FDA Nod, Concert Fails To Enthrall ",RTTNews,/news/stocks/sndx-rises-on-entinostat-data-kalydeco-gets-fda-nod-concert-fails-to-enthrall-1002023439,negative,0.794793426990509
34,5/22/2017 1:18:35 PM,Concert Pharma Gets Second FTC Request For Pending CTP-656 Deal ,RTTNews,/news/stocks/concert-pharma-gets-second-ftc-request-for-pending-ctp-656-deal-1002032232,positive,0.5325347185134888
35,5/24/2017 6:18:03 PM,BRIEF-Concert pharmaceuticals announces shareholder approval of CTP-656 asset purchase agreement with Vertex Pharmaceuticals (VRTX),Reuters,http://www.businessinsider.com/r-brief-concert-pharmaceuticals-announces-shareholder-approval-of-ctp-656-asset-purchase-agreement-with-vertex-pharmaceuticals-2017-5,negative,0.7443318963050842
36,6/9/2017 10:46:19 AM,"Vertex Presents Data On ORKAMBI, KALYDECO At ECFS Conference - Quick Facts ",RTTNews,/news/stocks/vertex-presents-data-on-orkambi-kalydeco-at-ecfs-conference-quick-facts-1002081158,positive,0.9453852772712708
37,6/14/2017 1:28:06 PM,"BRIEF-J&J says Pimodivir alone or in combination with oseltamivir demonstrated a significant reduction in viral load in adults with Influenza A (JNJ, VRTX)",Reuters,http://www.businessinsider.com/r-brief-jj-says-pimodivir-alone-or-in-combination-with-oseltamivir-demonstrated-a-significant-reduction-in-viral-load-in-adults-with-influenza-a-2017-6,negative,0.9265514612197876
38,6/14/2017 1:48:06 PM,"UPDATE 1-Johnson & Johnson's flu drug succeeds in mid-stage trial (JNJ, VRTX)",Reuters,http://www.businessinsider.com/r-update-1-johnson--johnsons-flu-drug-succeeds-in-mid-stage-trial-2017-6,negative,0.9179571270942688
39,6/30/2017 12:35:00 PM,"Biotech Stock Performance Review -- Vertex Pharma, VIVUS, Xbiotech, and Axovant Sciences",PR Newswire,/news/stocks/biotech-stock-performance-review-vertex-pharma-vivus-xbiotech-and-axovant-sciences-1002138304,positive,0.9317299723625183
40,7/13/2017 11:36:04 AM,BRIEF-Vertex announces reimbursement agreement for ORKAMBI in Italy (VRTX),Reuters,http://www.businessinsider.com/r-brief-vertex-announces-reimbursement-agreement-for-orkambi-in-italy-2017-7,negative,0.5952702760696411
41,7/16/2017 11:16:08 PM,"Eaton Vance fund managers see major upside for healthcare stocks -Barron's (VRTX, SHP)",Reuters,http://www.businessinsider.com/r-eaton-vance-fund-managers-see-major-upside-for-healthcare-stocks--barrons-2017-7,negative,0.6421952843666077
42,7/18/2017 10:08:08 PM,Vertex reports positive results for cystic fibrosis triple combos (VRTX),Reuters,http://www.businessinsider.com/r-vertex-reports-positive-results-for-cystic-fibrosis-triple-combos-2017-7,negative,0.9458868503570557
43,7/18/2017 10:12:03 PM,BRIEF-Vertex issues positive results from three different triple drug combination cystic fibrosis trials (VRTX),Reuters,http://www.businessinsider.com/r-brief-vertex-issues-positive-results-from-three-different-triple-drug-combination-cystic-fibrosis-trials-2017-7,negative,0.6339719295501709
44,7/18/2017 11:02:17 PM,Vertex Reports Positive Data From Combination Regimens To Treat Cystic Fibrosis ,RTTNews,/news/stocks/vertex-reports-positive-data-from-combination-regimens-to-treat-cystic-fibrosis-1002184340,negative,0.9514500498771667
45,7/19/2017 8:20:42 AM,"FDA Nod For GILD, It's Take 2 For AEZS' Macrilen, VRTX Soars On CF Drug Trials ",RTTNews,/news/stocks/fda-nod-for-gild-it-s-take-2-for-aezs-macrilen-vrtx-soars-on-cf-drug-trials-1002185228,negative,0.752935528755188
46,7/19/2017 1:32:08 PM,"US STOCKS-Tech stocks lift Nasdaq futures; Dow, S&P flat (QCOM, AXP, IBM, UAL, MS, VRTX, DISCA)",Reuters,http://www.businessinsider.com/r-us-stocks-tech-stocks-lift-nasdaq-futures-dow-sp-flat-2017-7,negative,0.7337400913238525
47,7/19/2017 4:10:03 PM,"US STOCKS-Nasdaq, S&P hit record highs as tech, health stocks rise (IBM, NFLX, MSFT, VRTX, QCOM, AXP, UAL, MS, GS)",Reuters,http://www.businessinsider.com/r-us-stocks-nasdaq-sp-hit-record-highs-as-tech-health-stocks-rise-2017-7,negative,0.895133912563324
48,7/19/2017 5:18:05 PM,"US STOCKS-Tech lifts Nasdaq, S&P to new highs; IBM weighs on Dow (IBM, MSFT, VRTX, MS, GS)",Reuters,http://www.businessinsider.com/r-us-stocks-tech-lifts-nasdaq-sp-to-new-highs-ibm-weighs-on-dow-2017-7,negative,0.7943518161773682
49,7/19/2017 5:48:03 PM,"GLOBAL MARKETS-World stocks run win streak to 9 days as earnings heat up (MS, VRTX, IBM, ASML)",Reuters,http://www.businessinsider.com/r-global-markets-world-stocks-run-win-streak-to-9-days-as-earnings-heat-up-2017-7,negative,0.41683506965637207
50,7/19/2017 7:06:01 PM,Vertex Pulls Back Off Best Levels But Remains Firmly Positive ,RTTNews,/news/stocks/vertex-pulls-back-off-best-levels-but-remains-firmly-positive-1002187723,negative,0.8080015182495117
51,7/19/2017 7:12:05 PM,"US STOCKS-Tech lifts Nasdaq, S&P to record; IBM weighs on Dow (IBM, MSFT, NFLX, VRTX, MS, GS, UNP, KSU)",Reuters,http://www.businessinsider.com/r-us-stocks-tech-lifts-nasdaq-sp-to-record-ibm-weighs-on-dow-2017-7,negative,0.7095397710800171
52,7/19/2017 8:10:07 PM,"GLOBAL MARKETS-World stocks climb for 9th day as earnings kick in (MS, VRTX, IBM, ASML)",Reuters,http://www.businessinsider.com/r-global-markets-world-stocks-climb-for-9th-day-as-earnings-kick-in-2017-7,negative,0.9078717827796936
53,7/19/2017 9:42:03 PM,"US STOCKS-S&P, Nasdaq at records as Vertex rallies; IBM slips (VRTX, IBM, MS, GS, UNP, KSU, UAL)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-nasdaq-at-records-as-vertex-rallies-ibm-slips-2017-7,neutral,0.8569398522377014
54,7/19/2017 10:22:06 PM,"GLOBAL MARKETS-World stocks tally 9th day of gains as earnings pick up (MS, VRTX, IBM, ASML)",Reuters,http://www.businessinsider.com/r-global-markets-world-stocks-tally-9th-day-of-gains-as-earnings-pick-up-2017-7,negative,0.9316672682762146
55,7/19/2017 11:08:04 PM,"GLOBAL MARKETS-World stocks tally 9th day of gains as earnings pick up (MS, VRTX, IBM, ASML)",Reuters,http://www.businessinsider.com/r-global-markets-world-stocks-tally-9th-day-of-gains-as-earnings-pick-up-2017-7,negative,0.9316672682762146
56,7/19/2017 11:28:03 PM,"US STOCKS-Wall St at new highs as tech breaches dot-com era record (VRTX, IBM, MS, GS, UNP, KSU, UAL)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-at-new-highs-as-tech-breaches-dot-com-era-record-2017-7,negative,0.8816985487937927
57,7/20/2017 4:41:16 AM,"Gainers & Losers Of July 19: AEZS, VRTX, AGRX, PTI, INO... ",RTTNews,/news/stocks/gainers-losers-of-july-19-aezs-vrtx-agrx-pti-ino-1002188898,positive,0.8893235325813293
58,7/24/2017 2:02:06 PM,BRIEF-Concert Pharmaceuticals terminates Hart-Scott-Rodino act waiting period for CTP-656 asset purchase agreement (VRTX),Reuters,http://www.businessinsider.com/r-brief-concert-pharmaceuticals-terminates-hart-scott-rodino-act-waiting-period-for-ctp-656-asset-purchase-agreement-2017-7,positive,0.5708291530609131
59,7/25/2017 10:14:09 PM,BRIEF-Vertex and Concert Pharmaceuticals complete asset purchase agreement (VRTX),Reuters,http://www.businessinsider.com/r-brief-vertex-and-concert-pharmaceuticals-complete-asset-purchase-agreement-2017-7,positive,0.6053947806358337
60,7/26/2017 10:12:06 PM,Vertex Pharma reports quarterly profit (VRTX),Reuters,http://www.businessinsider.com/r-vertex-pharma-reports-quarterly-profit-2017-7,positive,0.8078863620758057
61,7/26/2017 10:20:09 PM,BRIEF-Vertex Q2 non-GAAP earnings per share $0.39 (VRTX),Reuters,http://www.businessinsider.com/r-brief-vertex-q2-non-gaap-earnings-per-share-039-2017-7,positive,0.8203870058059692
62,7/26/2017 10:32:06 PM,UPDATE 1-Vertex Pharma's quarterly profit beats estimates (VRTX),Reuters,http://www.businessinsider.com/r-update-1-vertex-pharmas-quarterly-profit-beats-estimates-2017-7,positive,0.8838210701942444
63,7/26/2017 10:55:15 PM,Vertex Pharmaceuticals Inc. Q2 Income Climbs 71%,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q2-income-climbs-71-1002207802,negative,0.9420250654220581
64,7/27/2017 12:08:05 AM,BRIEF-Vertex interested in early stage assets consistent with CF focus (VRTX),Reuters,http://www.businessinsider.com/r-brief-vertex-interested-in-early-stage-assets-consistent-with-cf-focus-2017-7,positive,0.8815053105354309
65,8/1/2017 2:52:22 PM,BRIEF-FDA approves Kalydeco(Ivacaftor) for more than 600 people ages 2 and older with Cystic Fibrosis who have certain residual function mutations (VRTX),Reuters,http://www.businessinsider.com/r-brief-fda-approves-kalydecoivacaftor-for-more-than-600-people-ages-2-and-older-with-cystic-fibrosis-who-have-certain-residual-function-mutations-2017-8,negative,0.8629152774810791
66,8/7/2017 12:10:00 PM,"Breakfast Technical Briefing on Biotech Stocks -- Sarepta Therapeutics, Trevena, Tesaro, and Vertex Pharma",PR Newswire,/news/stocks/breakfast-technical-briefing-on-biotech-stocks-sarepta-therapeutics-trevena-tesaro-and-vertex-pharma-1002236538,positive,0.9487186074256897
67,8/11/2017 5:43:00 PM,CD 2016-CD1 Mortgage Trust -- Moody's Affirms Eight Classes of CD 2016-CD1,Moodys,/news/bonds/cd-2016-cd1-mortgage-trust-moody-s-affirms-eight-classes-of-cd-2016-cd1-1002252551,positive,0.9113380312919617
68,8/24/2017 5:42:03 PM,"BRIEF-Vertex says FDA sets action date of Feb 28, 2018 for its Tezacaftor/Ivacaftor Combination Treatment (VRTX)",Reuters,http://www.businessinsider.com/r-brief-vertex-says-fda-sets-action-date-of-feb-28-2018-for-its-tezacaftor-ivacaftor-combination-treatment-2017-8,positive,0.9215235114097595
69,8/25/2017 8:37:17 AM,"ADMS Soars On FDA Nod, EARS Gets An Earful, Thumbs Up For BIIB's Humira Biosim ",RTTNews,/news/stocks/adms-soars-on-fda-nod-ears-gets-an-earful-thumbs-up-for-biib-s-humira-biosim-1002284421,negative,0.6734219789505005
70,10/25/2017 10:52:14 PM,"Vertex posts wider net loss, raises cystic fibrosis sales outlook (VRTX)",Reuters,http://www.businessinsider.com/r-vertex-posts-wider-net-loss-raises-cystic-fibrosis-sales-outlook-2017-10,neutral,0.8478714823722839
71,10/25/2017 11:14:41 PM,Vertex Pharmaceuticals Inc. Earnings Rise 216% In Q3,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-earnings-rise-216-in-q3-1005620815,negative,0.9355391263961792
72,11/10/2017 1:40:22 PM,Vertex Receives CHMP Positive Opinion For ORKAMBI - Quick Facts ,RTTNews,/news/stocks/vertex-receives-chmp-positive-opinion-for-orkambi-quick-facts-1007548910,negative,0.9383721947669983
73,11/10/2017 2:07:04 PM,BRIEF-Vertex receives CHMP positive opinion for Orkambi for the treatment of children with cystic fibrosis ages 6-11 (VRTX),Reuters,http://www.businessinsider.com/r-brief-vertex-receives-chmp-positive-opinion-for-orkambi-for-the-treatment-of-children-with-cystic-fibrosis-ages-6-11-2017-11,negative,0.9267311096191406
74,12/6/2017 9:52:03 PM,"FACBOX-Corporate alternative minimum tax threat hits pharma, tech (BA, VRTX, INCY, REGN, CDNS, CELG, ADSK)",Reuters,http://www.businessinsider.com/r-facbox-corporate-alternative-minimum-tax-threat-hits-pharma-tech-2017-12,neutral,0.796172022819519
75,12/7/2017 2:14:36 PM,Vertex Says Phase 3 Study Of KALYDECO Met Primary Endpoint ,RTTNews,/news/stocks/vertex-says-phase-3-study-of-kalydeco-met-primary-endpoint-1010489555,negative,0.7025578618049622
76,12/7/2017 2:22:03 PM,BRIEF-Vertex Announces Positive Results From Open-Label Phase 3 Study Of KALYDECO(ivacaftor) (VRTX),Reuters,http://www.businessinsider.com/r-brief-vertex-announces-positive-results-from-open-label-phase-3-study-of-kalydecoivacaftor-2017-12,negative,0.9426007270812988
77,12/8/2017 5:22:03 PM,"Wall St Week Ahead-Tax-loss selling to pressure 2017's losers in December (VRTX, RRC, SIG, GE)",Reuters,http://www.businessinsider.com/r-wall-st-week-ahead-tax-loss-selling-to-pressure-2017s-losers-in-december-2017-12,neutral,0.6468983292579651
78,12/12/2017 2:42:46 PM,"Vertex, CRISPR Therapeutics To Co-develop And Co-commercialize CTX001 ",RTTNews,/news/stocks/vertex-crispr-therapeutics-to-co-develop-and-co-commercialize-ctx001-1011083664,positive,0.778404176235199
79,12/22/2017 7:02:03 AM,"Wall St Week Ahead-This year's lumps of coal could be 2018's diamonds (GE, VRTX, ILMN, KR, AMZN, VZ, IBM, XOM, BA, CAT, CSCO, PFE, CVX, MRK, KO, PG, NKE, VRSN, EMR, ROK)",Reuters,http://www.businessinsider.com/r-wall-st-week-ahead-this-years-lumps-of-coal-could-be-2018s-diamonds-2017-12,positive,0.9232535362243652
80,12/22/2017 1:02:04 PM,"RPT-Wall St Week Ahead-This year's lumps of coal could be 2018's diamonds (GE, VRTX, ILMN, KR, AMZN, VZ, IBM, XOM, BA, CAT, CSCO, PFE, CVX, MRK, KO, PG, NKE, VRSN, EMR, ROK)",Reuters,http://www.businessinsider.com/r-rpt-wall-st-week-ahead-this-years-lumps-of-coal-could-be-2018s-diamonds-2017-12,positive,0.9183773994445801
81,1/10/2018 10:19:06 AM,Vertex Pharma Granted Extension Of Marketing Authorization For ORKAMBI In Europe ,RTTNews,/news/stocks/vertex-pharma-granted-extension-of-marketing-authorization-for-orkambi-in-europe-1012796142,negative,0.9134206771850586
82,1/22/2018 8:58:59 AM,Some Branded Drugs Going Generic In 2018 ,RTTNews,/news/stocks/some-branded-drugs-going-generic-in-2018-1013567302,positive,0.897983968257904
83,1/26/2018 4:33:36 AM,Biotech Stocks Facing FDA Decision In February ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-february-1014075310,positive,0.7358179092407227
84,1/31/2018 10:24:03 PM,Vertex Pharmaceuticals Inc. Reveals Advance In Q4 Profit,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-reveals-advance-in-q4-profit-1014721197,negative,0.9459631443023682
85,1/31/2018 11:24:17 PM,Vertex Pharma Board Authorizes $500 Mln Share Repurchase Program - Quick Facts ,RTTNews,/news/stocks/vertex-pharma-board-authorizes-500-mln-share-repurchase-program-quick-facts-1014726472,positive,0.6822106242179871
86,2/15/2018 7:17:49 AM,"AMAG Gets FDA Nod, ABMD Hits All-time High, GLMD's NAFLD Trial Flops, NKTR Abuzz ",RTTNews,/news/stocks/amag-gets-fda-nod-abmd-hits-all-time-high-glmd-s-nafld-trial-flops-nktr-abuzz-1015856809,negative,0.5203738212585449
87,3/1/2018 2:03:40 PM,Vertex Pharma Begins Phase 3 Study Of VX-659 - Quick Facts ,RTTNews,/news/stocks/vertex-pharma-begins-phase-3-study-of-vx-659-quick-facts-1017567356,positive,0.8099218010902405
88,3/5/2018 3:22:13 PM,New Drugs Approved In February ,RTTNews,/news/stocks/new-drugs-approved-in-february-1018015655,positive,0.6458381414413452
89,4/4/2018 2:11:27 PM,BRIEF-Q-State Biosciences Says Entered Strategic Collaboration With Vertex Pharmaceuticals,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/qYLVCQJDFX4/brief-q-state-biosciences-says-entered-strategic-collaboration-with-vertex-pharmaceuticals-idUSFWN1RH0EY,negative,0.891648530960083
90,4/6/2018 10:34:00 PM,BRIEF-Vertex Pharmaceuticals CEO Leiden's 2017 Compensation Was $17.2 Mln,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/fRJF9OtRn2E/brief-vertex-pharmaceuticals-ceo-leidens-2017-compensation-was-17-2-mln-idUSFWN1RJ0JP,positive,0.7832475304603577
91,4/26/2018 11:22:23 PM,Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q1-adjusted-earnings-beat-estimates-1022454946,negative,0.9086783528327942
92,5/31/2018 12:36:03 AM,"The FDA just put a pause on a cutting-edge gene editing trial that hadn't started yet — and the company's stock is dropping (CRSP, VRTX)",Business Insider,http://markets.businessinsider.com/news/stocks/crispr-therapeutics-and-vertex-fda-clinical-hold-on-gene-editing-trial-2018-5-1025903173,neutral,0.9632520079612732
93,6/7/2018 10:54:06 AM,Vertex Pharma Presents Data From KALYDECO Studies - Quick Facts ,RTTNews,/news/stocks/vertex-pharma-presents-data-from-kalydeco-studies-quick-facts-1026777953,positive,0.8869175314903259
94,6/18/2018 1:31:28 PM,Vertex Reaches Agreement In Sweden For Reimbursement Of ORKAMBI - Quick Facts ,RTTNews,/news/stocks/vertex-reaches-agreement-in-sweden-for-reimbursement-of-orkambi-quick-facts-1027166300,negative,0.946765661239624
95,7/23/2018 3:01:43 PM,Vertex Pharmaceuticals earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-q2-quarterly-earnings-preview-stock-1027389896,positive,0.9138038754463196
96,7/25/2018 10:05:48 PM,Vertex Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q2-adjusted-earnings-beat-estimates-1027400455,negative,0.9026922583580017
97,7/26/2018 9:39:05 AM,Biotech Stocks Facing FDA Decision In August ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-august-1027401882,positive,0.6419674754142761
98,7/30/2018 8:40:22 AM,"European Medicines Agency's CHMP Says Yes To 7 Drugs, No To 1 ",RTTNews,/news/stocks/european-medicines-agency-s-chmp-says-yes-to-7-drugs-no-to-1-1027410342,negative,0.664745032787323
99,8/4/2018 7:40:57 AM,"Week Ahead In Pharmaceuticals - 10 Stocks To Watch (ALNY, INSM, PRTK...) ",RTTNews,/news/stocks/week-ahead-in-pharmaceuticals-10-stocks-to-watch-alny-insm-prtk-1027430855,positive,0.8669117093086243
100,8/8/2018 7:26:38 AM,"BLPH's INOPulse Misses Rhythm, ONCE Bleeds, FDA Panel Nod For INSM ",RTTNews,/news/stocks/blph-s-inopulse-misses-rhythm-once-bleeds-fda-panel-nod-for-insm-1027440878,neutral,0.7393295764923096
101,8/11/2018 5:17:06 AM,"Week Ahead In Pharmaceuticals: 5 Stocks To Watch (REGN, PFE, ALT...) ",RTTNews,/news/stocks/week-ahead-in-pharmaceuticals-5-stocks-to-watch-regn-pfe-alt-1027451315,positive,0.8848251700401306
102,9/3/2018 9:17:54 AM,Vertex Pharma Announces Reimbursement Agreement In Australia For ORKAMBI ,RTTNews,/news/stocks/vertex-pharma-announces-reimbursement-agreement-in-australia-for-orkambi-1027502606,negative,0.8728190660476685
103,10/23/2018 3:02:10 PM,Here's what Wall Street expects from Vertex Pharmaceuticals's earnings,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-q3-quarterly-earnings-preview-1027644339,positive,0.9302723407745361
104,10/24/2018 10:16:08 PM,Vertex Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q3-adjusted-earnings-beat-estimates-1027651466,negative,0.9063999056816101
105,11/1/2018 9:36:04 AM,Vertex Pharma: EU Authorizes Cystic Fibrosis Medicine SYMKEVI ,RTTNews,/news/stocks/vertex-pharma-eu-authorizes-cystic-fibrosis-medicine-symkevi-1027679305,positive,0.7679480314254761
106,11/16/2018 2:08:12 PM,Vertex Pharma: CHMP Adopts Positive Opinion For ORKAMBI - Quick Facts ,RTTNews,/news/stocks/vertex-pharma-chmp-adopts-positive-opinion-for-orkambi-quick-facts-1027734518,negative,0.9274944067001343
107,11/27/2018 2:29:43 PM,Vertex: Two Phase 3 Studies Of VX-659 Triple Combination Met Primary Endpoint ,RTTNews,/news/stocks/vertex-two-phase-3-studies-of-vx-659-triple-combination-met-primary-endpoint-1027758917,negative,0.7720749378204346
108,11/29/2018 9:16:33 AM,Vertex Pharma Granted Label Extension For KALYDECO In EU - Quick Facts ,RTTNews,/news/stocks/vertex-pharma-granted-label-extension-for-kalydeco-in-eu-quick-facts-1027765816,negative,0.9226954579353333
109,12/13/2018 2:11:40 PM,Vertex: Health Canada Grants Market Authorization For ORKAMBI In Young Children ,RTTNews,/news/stocks/vertex-health-canada-grants-market-authorization-for-orkambi-in-young-children-1027806462,negative,0.6053126454353333
110,12/18/2018 2:49:22 PM,Vertex Pharma Reports Positive Phase 2 Data With VX-150 Proof-of-Concept Study ,RTTNews,/news/stocks/vertex-pharma-reports-positive-phase-2-data-with-vx-150-proof-of-concept-study-1027817692,negative,0.956041693687439
111,1/21/2019 10:33:44 AM,Vertex: EC Approves ORKAMBI To Treat Children With CF Aged 2 To 5 Years Old ,RTTNews,/news/stocks/vertex-ec-approves-orkambi-to-treat-children-with-cf-aged-2-to-5-years-old-1027882061,positive,0.5814116597175598
112,1/23/2019 11:26:59 PM,Vertex Pharmaceuticals Fires COO Ian Smith ,RTTNews,/news/stocks/vertex-pharmaceuticals-fires-coo-ian-smith-1027891298,positive,0.9381316304206848
113,1/24/2019 2:20:36 PM,Merck KGaA Grants License To Vertex For Two DNA Damage Response Inhibitors ,RTTNews,/news/stocks/merck-kgaa-grants-license-to-vertex-for-two-dna-damage-response-inhibitors-1027893174,negative,0.7917535305023193
114,2/3/2019 3:01:40 PM,Vertex Pharmaceuticals is about to announce its earnings — here's what to expect,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-q4-earnings-preview-stock-1027918612,positive,0.9413271546363831
115,2/5/2019 10:07:28 PM,Vertex Pharmaceuticals Inc. Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q4-adjusted-earnings-beat-estimates-1027927030,negative,0.9125694036483765
116,4/2/2019 3:08:11 PM,Vertex Appoints Charles Wagner As New CFO - Quick Facts ,RTTNews,/news/stocks/vertex-appoints-charles-wagner-as-new-cfo-quick-facts-1028078622,positive,0.9437404870986938
117,4/28/2019 3:02:09 PM,Here's what Wall Street expects from Vertex Pharmaceuticals's earnings,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-stock-price-q1-earnings-preview-1028145592,positive,0.9302723407745361
118,4/30/2019 2:49:01 PM,Vertex Pharma: FDA Approves Expanded Indication For KALYDECO - Quick Facts ,RTTNews,/news/stocks/vertex-pharma-fda-approves-expanded-indication-for-kalydeco-quick-facts-1028153599,negative,0.8697142004966736
119,4/30/2019 10:58:59 PM,Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q1-adjusted-earnings-beat-estimates-1028156020,negative,0.9086783528327942
120,5/8/2019 6:19:00 PM,Moody's assigns provisional ratings to five CMBS classes of KNDL 2019-KNSQ Mortgage Trust,Moodys,/news/bonds/moody-s-assigns-provisional-ratings-to-five-cmbs-classes-of-kndl-2019-knsq-mortgage-trust-1028183010,positive,0.9136515855789185
121,5/8/2019 6:23:00 PM,KNDL 2019-KNSQ Mortgage Trust -- Moody's assigns provisional ratings to five CMBS classes of KNDL 2019-KNSQ Mortgage Trust,Moodys,/news/bonds/kndl-2019-knsq-mortgage-trust-moody-s-assigns-provisional-ratings-to-five-cmbs-classes-of-kndl-2019-knsq-mortgage-trust-1028183018,positive,0.9105780124664307
122,5/30/2019 8:16:00 PM,KNDL 2019-KNSQ Mortgage Trust -- Moody's assigns definitive ratings to Five CMBS classes of KNDL 2019-KNSQ Mortgage Trust,Moodys,/news/bonds/kndl-2019-knsq-mortgage-trust-moody-s-assigns-definitive-ratings-to-five-cmbs-classes-of-kndl-2019-knsq-mortgage-trust-1028243060,positive,0.8742954730987549
123,6/7/2019 12:37:08 AM,Vertex Pharmaceuticals expands into Duchenne gene therapy with new deals,Reuters,http://feeds.reuters.com/~r/reuters/companyNews/~3/5E94R4jvxV0/vertex-pharmaceuticals-expands-into-duchenne-gene-therapy-with-new-deals-idUSL4N23D4CV,negative,0.6811807751655579
124,6/14/2019 11:22:36 AM,"3 Big Stock Charts for Friday: Symantec, Vertex Pharmaceuticals and Nektar Therapeutics",InvestorPlace,/news/stocks/3-big-stock-charts-for-friday-symantec-vertex-pharmaceuticals-and-nektar-therapeutics-1028281737,positive,0.8900999426841736
125,6/14/2019 6:59:58 PM,7 Top-Rated Biotech Stocks to Invest In Today,InvestorPlace,/news/stocks/7-healthy-biotech-stocks-to-invest-in-1028281710,positive,0.7840100526809692
126,7/12/2019 12:23:19 PM,"3 Big Stock Charts for Friday: HollyFrontier, Activision Blizzard and Vertex Pharmaceuticals",InvestorPlace,/news/stocks/3-big-stock-charts-for-friday-hollyfrontier-activision-blizzard-and-vertex-pharmaceuticals-1028350384,positive,0.914141833782196
127,7/26/2019 4:04:19 PM,4 Biotech Stocks Sliding Lower,InvestorPlace,/news/stocks/4-biotech-stocks-sliding-lower-1028389963,neutral,0.9591169953346252
128,7/29/2019 3:02:47 PM,Here's what to expect from Vertex Pharmaceuticals's earnings,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-quarter-earnings-preview-q2-1028393708,positive,0.9407998323440552
129,7/31/2019 10:20:18 PM,Vertex Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q2-adjusted-earnings-beat-estimates-1028405371,negative,0.9026922583580017
130,8/1/2019 10:04:07 AM,"AMRN'S Vascepa Hits Record Sales, ADMP Slumps On Stock Offering, SRDX On Watch… ",RTTNews,/news/stocks/amrn-s-vascepa-hits-record-sales-admp-slumps-on-stock-offering-srdx-on-watch-1028406896,neutral,0.8936618566513062
131,8/27/2019 12:44:47 PM,"3 Big Stock Charts for Tuesday: TechnipFMC PLC, Vertex Pharmaceuticals and Constellation Brands",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-technipfmc-plc-vertex-pharmaceuticals-and-constellation-brands-1028478935,positive,0.9322946071624756
132,9/27/2019 12:29:00 PM,"3 Big Stock Charts for Friday: Conagra Brands, HollyFrontier and Vertex Pharmaceuticals",InvestorPlace,/news/stocks/3-big-stock-charts-for-friday-conagra-brands-hollyfrontier-and-vertex-pharmaceuticals-1028560683,positive,0.9267409443855286
133,10/8/2019 5:55:32 PM,5 Large-Cap Stocks With Growth in the Tank,InvestorPlace,/news/stocks/5-large-cap-stocks-with-growth-in-the-tank-1028585547,negative,0.8544710278511047
134,10/22/2019 9:31:36 AM,"Odonate On The Move With CONTESSA, FDA Snubs CLSD, It's A Yes For AZN, VRTX ",RTTNews,/news/stocks/odonate-on-the-move-with-contessa-fda-snubs-clsd-it-s-a-yes-for-azn-vrtx-1028617555,positive,0.49870985746383667
135,10/22/2019 5:23:57 PM,5 Healthcare Stocks to Buy,InvestorPlace,/news/stocks/5-healthcare-stocks-to-buy-2-1028620498,positive,0.8994204998016357
136,10/24/2019 11:44:57 AM,Vertex In Deal With NHS England For Access To All Licensed CF Medicines ,RTTNews,/news/stocks/vertex-in-deal-with-nhs-england-for-access-to-all-licensed-cf-medicines-1028626516,positive,0.5742904543876648
137,10/30/2019 9:25:12 PM,Vertex Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q3-adjusted-earnings-beat-estimates-1028645617,negative,0.9063999056816101
138,11/20/2019 2:37:47 PM,Check Out These 5 Fast-Growing Stocks to Buy,InvestorPlace,/news/stocks/7-fast-growing-stocks-to-buy-today-1028296972,positive,0.8692518472671509
139,12/19/2019 10:16:39 AM,Why Longer-Term Investors Should Buy Amarin Stock on Weakness,InvestorPlace,/news/stocks/why-longer-term-investors-should-buy-amarin-stock-on-weakness-1028775027,positive,0.9243662357330322
140,1/29/2020 3:02:11 PM,Here's what Wall Street expects from Vertex Pharmaceuticals's earnings report,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-stock-price-quarter-earnings-preview-q4-1028855275,positive,0.9002076983451843
141,1/30/2020 10:10:38 PM,Vertex Pharmaceuticals Inc. Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q4-adjusted-earnings-beat-estimates-1028861455,negative,0.9125694036483765
142,1/31/2020 2:21:45 AM,"Vertex Pharma (VRTX) Q4 Results Trounce Estimates, Sees Stronger 2020 ",RTTNews,/news/stocks/vertex-pharma-vrtx-q4-results-trounce-estimates-sees-stronger-2020-1028861884,negative,0.9376460313796997
143,2/19/2020 12:13:45 PM,Stock Alert: VRTX Trading Close To 52-Week High ,RTTNews,/news/stocks/stock-alert-vrtx-trading-close-to-52-week-high-1028918026,negative,0.4156157076358795
144,3/9/2020 3:09:14 PM,Vertex Pharma Says No Coronavirus Impact On Supply Chain Or 2020 Outlook ,RTTNews,/news/stocks/vertex-pharma-says-no-coronavirus-impact-on-supply-chain-or-2020-outlook-1028976909,positive,0.7929734587669373
145,3/11/2020 10:10:04 AM,5 Biotech Stocks to Buy for a Strong Growth Prognosis,InvestorPlace,/news/stocks/5-biotech-stocks-to-buy-for-a-strong-growth-prognosis-1028378734,negative,0.5414467453956604
146,3/13/2020 12:36:02 PM,Healthcare stocks set for rally today,Seeking Alpha,https://seekingalpha.com/news/3551531-healthcare-stocks-set-for-rally-today?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6742608547210693
147,3/13/2020 3:08:38 PM,Key events next week - healthcare,Seeking Alpha,https://seekingalpha.com/news/3551612-key-events-next-week-healthcare?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9446426630020142
148,3/27/2020 12:21:37 PM,Vertex Pharma says supply chain OK,Seeking Alpha,https://seekingalpha.com/news/3555821-vertex-pharma-says-supply-chain-ok?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9317556023597717
149,3/27/2020 1:23:21 PM,"Vertex Pharma Confirms 2020 Business Outlook, Supply Chain Continuity ",RTTNews,/news/stocks/vertex-pharma-confirms-2020-business-outlook-supply-chain-continuity-1029039156,positive,0.6304736137390137
150,4/1/2020 11:50:43 AM,7 Biotech Stocks to Buy That Could Beat the Coronavirus,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-that-could-beat-the-coronavirus-1028882437,negative,0.6657755374908447
151,4/13/2020 5:12:58 PM,Barron's doubles down on 12 YTD winners,Seeking Alpha,https://seekingalpha.com/news/3560231-barrons-doubles-down-on-12-ytd-winners?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9546953439712524
152,4/23/2020 1:49:53 PM,BioSig up 10% on encouraging data on COVID-19 antiviral,Seeking Alpha,https://seekingalpha.com/news/3563670-biosig-up-10-on-encouraging-data-on-covidminus-19-antiviral?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.946386992931366
153,4/28/2020 11:32:55 AM,Wells softens view on Edwards Lifesciences in premarket analyst action,Seeking Alpha,https://seekingalpha.com/news/3565181-wells-softens-view-on-edwards-lifesciences-in-premarket-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.751943051815033
154,4/28/2020 3:02:13 PM,Vertex Pharmaceuticals earnings: here's what to expect,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-stock-price-quarter-earnings-preview-q1-1029138282,positive,0.9390793442726135
155,4/28/2020 9:35:59 PM,Vertex Pharmaceuticals Q1 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3565458-vertex-pharmaceuticals-q1-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8749633431434631
156,4/29/2020 8:08:12 PM,"Vertex Pharmaceuticals EPS beats by $0.72, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3566353-vertex-pharmaceuticals-eps-beats-0_72-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6330974698066711
157,4/29/2020 8:12:22 PM,Vertex Q1 sales up 77% on strong Trikafta ramp; shares up 3% after hours,Seeking Alpha,https://seekingalpha.com/news/3566372-vertex-q1-sales-up-77-on-strong-trikafta-ramp-shares-up-3-after-hours?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9512711763381958
158,4/29/2020 10:22:34 PM,Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q1-adjusted-earnings-beat-estimates-1029146922,negative,0.9086783528327942
159,5/1/2020 8:34:19 AM,Vertex gets CHMP positive opinion for CF treatment,Seeking Alpha,https://seekingalpha.com/news/3567470-vertex-gets-chmp-positive-opinion-for-cf-treatment?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8689292073249817
160,5/1/2020 9:46:11 AM,Vertex: KALYDECO Gets European CHMP Positive Opinion For CF In Children ,RTTNews,/news/stocks/vertex-kalydeco-gets-european-chmp-positive-opinion-for-cf-in-children-1029154488,negative,0.9423227310180664
161,5/8/2020 7:34:55 PM,"Time to buy these biopharma names is now, BofA says",Seeking Alpha,https://seekingalpha.com/news/3572315-time-to-buy-biopharma-names-is-now-bofa-says?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.901307225227356
162,5/21/2020 9:16:53 AM,The Virus Vaccine Race is Fueling Moderna Stock to New Highs,InvestorPlace,/news/stocks/the-virus-vaccine-race-is-fueling-moderna-stock-to-new-highs-1029222715,negative,0.700281023979187
163,5/22/2020 1:05:53 PM,7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine,InvestorPlace,/news/stocks/7-top-rated-biotech-stocks-to-buy-1029227095,positive,0.5756125450134277
164,6/2/2020 7:12:50 PM,Vertex Pharmaceuticals Is a Biotech Play With No Coronavirus Exposure,InvestorPlace,/news/stocks/vrtx-stock-is-a-biotech-play-with-no-coronavirus-exposure-1029274234,positive,0.9189702868461609
165,6/11/2020 2:55:31 PM,7 Great Biotech Stocks to Buy and Hold Now,InvestorPlace,/news/stocks/biotech-stocks-to-buy-for-long-term-1029301567,positive,0.8901899456977844
166,6/12/2020 11:07:44 AM,CRISPR/Cas9 candidates show encouraging action in blood disorders,Seeking Alpha,https://seekingalpha.com/news/3582549-crispr-cas9-candidates-show-encouraging-action-in-blood-disorders?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9473218321800232
167,6/22/2020 2:50:23 PM,CRISPR Therapeutics Is a Worthwhile Investment in Transformative Science,InvestorPlace,/news/stocks/crispr-stock-investment-transformative-science-1029330496,negative,0.7731188535690308
168,6/26/2020 12:20:05 PM,The Future Could Be Soon for Crispr Therapeutics,InvestorPlace,/news/stocks/future-is-coming-for-crispr-stock-1029346130,positive,0.8730226755142212
169,6/26/2020 2:29:31 PM,Vertex : CHMP Grants Positive Opinion For KAFTRIO - KALYDECO In People Ages 12 And Older With CF ,RTTNews,/news/stocks/vertex-chmp-grants-positive-opinion-for-kaftrio-kalydeco-in-people-ages-12-and-older-with-cf-1029345684,negative,0.8958407640457153
170,6/30/2020 3:00:05 PM,Vertex Pharma: NHS England To Expand Reimbursement Agreement To Include KAFTRIO ,RTTNews,/news/stocks/vertex-pharma-nhs-england-to-expand-reimbursement-agreement-to-include-kaftrio-1029354149,negative,0.9331039190292358
171,7/6/2020 10:40:08 AM,Royalty Pharma Stock Is Likely to Reach New Highs in the Coming Years,InvestorPlace,/news/stocks/rprx-stock-is-likely-to-reach-new-highs-coming-years-1029368649,negative,0.9159573912620544
172,7/29/2020 3:03:02 PM,Here's what Wall Street expects from Vertex Pharmaceuticals's earnings,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-q2-quarterly-earnings-preview-1029445422,positive,0.9302723407745361
173,7/30/2020 11:28:32 PM,Vertex Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q2-adjusted-earnings-beat-estimates-1029453278,negative,0.9026922583580017
174,7/31/2020 8:50:46 AM,"PRPO Up 400% As It Readies For Rollout Of COVID-19 Test, LXRX Realigns Business, VRTX Boosts Outlook ",RTTNews,/news/stocks/prpo-up-400-as-it-readies-for-rollout-of-covid-19-test-lxrx-realigns-business-vrtx-boosts-outlook-1029454130,negative,0.9493091106414795
175,8/13/2020 6:19:25 PM,5 Disruptive Biotech Stocks to Buy for the Future That Is Here,InvestorPlace,/news/stocks/5-disruptive-biotech-stocks-to-buy-for-the-future-that-is-here-1029502923,positive,0.8940719962120056
176,8/21/2020 3:31:13 PM,Vertex : EU Approves KAFTRIO-Ivacaftor To Treat Cystic Fibrosis In People Ages 12 Years And Older ,RTTNews,/news/stocks/vertex-eu-approves-kaftrio-ivacaftor-to-treat-cystic-fibrosis-in-people-ages-12-years-and-older-1029524078,negative,0.9058351516723633
177,8/21/2020 5:42:52 PM,7 Index Funds To Buy For A Firm Portfolio Foundation,InvestorPlace,/news/stocks/7-index-funds-to-buy-for-a-firm-portfolio-foundation-1029524805,positive,0.891994059085846
178,8/25/2020 1:46:20 PM,The 5 Best Tech ETFs to Buy for Safer Growth,InvestorPlace,/news/stocks/the-5-best-tech-etfs-to-buy-for-safer-growth-1029532192,positive,0.7524566650390625
179,9/2/2020 7:00:37 AM,"ATNX To Face FDA In Feb, ICPT Trims Workforce, JNCE Jumps On GILD Deal, SNY's Kevzara Flops Again ",RTTNews,/news/stocks/atnx-to-face-fda-in-feb-icpt-trims-workforce-jnce-jumps-on-gild-deal-sny-s-kevzara-flops-again-1029554661,negative,0.4803864359855652
180,9/2/2020 3:41:19 PM,Is CRISPR Therapeutics Worth It Without Drugs?,InvestorPlace,/news/stocks/crsp-stock-does-crispr-have-it-1029557226,positive,0.9077845215797424
181,9/14/2020 11:42:06 AM,Vertex Announces EMA Type II Variation Marketing Authorization Application Validation For KAFTRIO ,RTTNews,/news/stocks/vertex-announces-ema-type-ii-variation-marketing-authorization-application-validation-for-kaftrio-1029584987,positive,0.852958083152771
182,9/16/2020 8:33:54 PM,3 Nasdaq Stocks to Buy Off Their Corrective Bottoms,InvestorPlace,/news/stocks/3-nasdaq-stocks-to-buy-off-their-corrective-bottoms-1029596612,neutral,0.47537127137184143
183,9/18/2020 3:34:34 PM,4 Biotech Stocks to Buy for Big Gains in 2020,InvestorPlace,/news/stocks/4-biotech-stocks-to-buy-for-big-gains-in-2020-1029603327,negative,0.8859114646911621
184,10/6/2020 2:44:51 PM,The 7 Best New Stocks From 2020 to Buy Now,InvestorPlace,/news/stocks/the-7-best-new-stocks-from-2020-to-buy-now-1029653691,positive,0.8444294929504395
185,10/8/2020 11:22:13 PM,Oppenheimer sees divided sector in 'critical' months for biotech,Seeking Alpha,https://seekingalpha.com/news/3620981-oppenheimer-sees-divided-sector-in-critical-months-for-biotech?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5209524035453796
186,10/14/2020 8:47:00 PM,"Vertex Pharma -7.9% as it drops VX-814 study, development (updated)",Seeking Alpha,https://seekingalpha.com/news/3622270-vertex-pharmaminus-7_9-drops-vxminus-814-study-development-updated?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7883183360099792
187,10/14/2020 9:33:09 PM,"ARWR, SNBR, FSLY and NET among after-hours movers",Seeking Alpha,https://seekingalpha.com/news/3622292-arwr-snbr-fsly-and-net-among-after-hours-movers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9300556182861328
188,10/15/2020 8:06:24 AM,"FDA Approves 1st Ebola Drug, CYCN Drops Sickle Cell Disease Drug, VRTX Plunges In After-hours Trade ",RTTNews,/news/stocks/fda-approves-1st-ebola-drug-cycn-drops-sickle-cell-disease-drug-vrtx-plunges-in-after-hours-trade-1029682251,neutral,0.6357328295707703
189,10/15/2020 12:29:32 PM,"Vertex Pharmaceuticals, Infosys leads premarket losers' pack",Seeking Alpha,https://seekingalpha.com/news/3622421-vertex-pharmaceuticals-infosys-leads-premarket-losers-pack?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8943691849708557
190,10/15/2020 3:12:21 PM,"Organogenesis Holdings, Anavex Life Sciences leads healthcare gainers; Vertex Pharmaceuticals, Aphria among major losers",Seeking Alpha,https://seekingalpha.com/news/3622525-organogenesis-holdings-anavex-life-sciences-leads-healthcare-gainers-vertex-pharmaceuticals?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5738524794578552
191,10/15/2020 3:54:08 PM,Stock Alert: Vertex Pharma Tanks 15% On Stopping Development Of Protein-deficiency Drug ,RTTNews,/news/stocks/stock-alert-vertex-pharma-tanks-15-on-stopping-development-of-protein-deficiency-drug-1029684604,neutral,0.9389806389808655
192,10/15/2020 3:55:28 PM,Vertex Pharmaceuticals News: Why VRTX Stock Is Getting Slammed 20% Today,InvestorPlace,/news/stocks/vertex-pharmaceuticals-news-slamming-vrtx-stock-1029685440,negative,0.832390308380127
193,10/15/2020 4:47:20 PM,"PGEN, GME, APHA and FSLY among midday movers",Seeking Alpha,https://seekingalpha.com/news/3622550-pgen-gme-apha-and-fsly-among-midday-movers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9242899417877197
194,10/15/2020 8:31:35 PM,"4 Top Stock Trades for Friday: ZM, DKNG, VRTX, GME",InvestorPlace,/news/stocks/4-top-stock-trades-for-friday-zm-dkng-vrtx-gme-1029686559,positive,0.9373750686645508
195,10/28/2020 12:59:39 PM,7 Cutting-Edge Biotech Stocks for Tomorrow ,InvestorPlace,/news/stocks/7-cutting-edge-biotech-stocks-for-tomorrow-1029734117,positive,0.8713727593421936
196,10/28/2020 3:04:57 PM,Vertex Pharmaceuticals is about to announce earnings — here's what Wall Street expects,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-q3-quarterly-earnings-preview-1029734609,positive,0.9336851239204407
197,10/28/2020 9:35:42 PM,Vertex Pharmaceuticals Q3 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3627408-vertex-pharmaceuticals-q3-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8757296204566956
198,10/29/2020 10:17:02 PM,Vertex Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q3-adjusted-earnings-beat-estimates-1029744084,negative,0.9063999056816101
199,11/5/2020 6:11:01 AM,"BIIB Faces FDA Panel Tomorrow, CRSP Climbs On Hemoglobinopathies Trial Data, SAVA On Watch ",RTTNews,/news/stocks/biib-faces-fda-panel-tomorrow-crsp-climbs-on-hemoglobinopathies-trial-data-sava-on-watch-1029767914,positive,0.7399297952651978
200,11/5/2020 10:41:51 AM,Vertex: European Commission Approves KALYDECO To Treat Infants With Cystic Fibrosis ,RTTNews,/news/stocks/vertex-european-commission-approves-kalydeco-to-treat-infants-with-cystic-fibrosis-1029769084,negative,0.8012869954109192
201,11/5/2020 10:59:37 AM,EC OKs expanded use of Vertex Pharma's Kalydeco for infants with cystic fibrosis,Seeking Alpha,https://seekingalpha.com/news/3631858-ec-oks-expanded-use-of-vertex-pharmas-kalydeco-for-infants-cystic-fibrosis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8579690456390381
202,11/20/2020 4:23:06 PM,Vertex Pharmaceuticals Board approves $500M stock buyback program,Seeking Alpha,https://seekingalpha.com/news/3638381-vertex-pharmaceuticals-board-approves-500m-stock-buyback-program?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7470590472221375
203,11/27/2020 9:19:59 AM,Vertex: EU Approves SYMKEVI With KALYDECO For 6-11 Years Children With Cystic Fibrosis ,RTTNews,/news/stocks/vertex-eu-approves-symkevi-with-kalydeco-for-6-11-years-children-with-cystic-fibrosis-1029843774,negative,0.7394503951072693
204,11/27/2020 9:38:52 AM,EC OKs expanded use of Vertex's Symkevi with Kalydeco for children with cystic fibrosis,Seeking Alpha,https://seekingalpha.com/news/3639614-ec-oks-expanded-use-of-vertexs-symkevi-kalydeco-for-children-cystic-fibrosis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8543321490287781
205,11/30/2020 2:12:00 AM,Biotech Stocks Facing FDA Decision In December 2020 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-december-2020-1029847132,positive,0.7155784368515015
206,12/4/2020 8:30:00 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3641078-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
207,12/6/2020 4:43:54 PM,"CRISPR Therapeutics, Vertex CTX001 data show consistent, sustained response",Seeking Alpha,https://seekingalpha.com/news/3641959-crispr-therapeutics-vertex-ctx001-data-show-consistent-sustained-response?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9543519020080566
208,12/21/2020 8:14:47 PM,Vertex receives FDA approval for expanded use of cystic fibrosis therapy,Seeking Alpha,https://seekingalpha.com/news/3646333-vertex-receives-fda-approval-for-expanded-use-of-cystic-fibrosis-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9267839789390564
209,12/22/2020 2:32:58 PM,"Vertex Pharma, Skyhawk Therapeutic in licensing pact for RNA splicing modulating therapies",Seeking Alpha,https://seekingalpha.com/news/3646645-vertex-pharma-skyhawk-therapeutic-in-licensing-pact-for-rna-splicing-modulating-therapies?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6365411877632141
210,12/22/2020 2:55:33 PM,"Skyhawk, Vertex Enter Into Research Collaboration On Serious Diseases ",RTTNews,/news/stocks/skyhawk-vertex-enter-into-research-collaboration-on-serious-diseases-1029913913,negative,0.7143004536628723
211,12/26/2020 3:15:52 PM,"The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks",Benzinga,/news/stocks/the-week-ahead-in-biotech-dec-27-jan-2-data-releases-regulatory-filings-to-move-stocks-1029919761,positive,0.6830364465713501
212,12/28/2020 1:42:21 PM,Health Canada accepts Vertex Pharma's Trikafta application for priority review,Seeking Alpha,https://seekingalpha.com/news/3647499-health-canada-accepts-vertex-pharmas-trikafta-application-for-priority-review?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7202462553977966
213,12/28/2020 2:33:18 PM,Vertex's TRIKAFTA Accepted For Priority Review By Canada For Treatment Of Cystic Fibrosis ,RTTNews,/news/stocks/vertex-s-trikafta-accepted-for-priority-review-by-canada-for-treatment-of-cystic-fibrosis-1029921333,negative,0.8495820760726929
214,1/7/2021 12:36:09 PM,Imara declined yesterday as its sickle cell treatment appears to be not at par with its peers,Seeking Alpha,https://seekingalpha.com/news/3649541-imara-declined-yesterday-sickle-cell-treatment-appears-to-be-not-par-peers?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8335445523262024
215,1/11/2021 3:44:05 PM,Vertex Pharma projects a larger long-term opportunity in CF,Seeking Alpha,https://seekingalpha.com/news/3650345-vertex-pharma-projects-larger-long-term-opportunity-in-cf?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8086680173873901
216,1/11/2021 9:17:27 PM,Vertex expects over $6B revenue for 2020 at ~47% YoY growth,Seeking Alpha,https://seekingalpha.com/news/3650483-vertex-expects-over-6b-revenue-for-2020-47-yoy-growth?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5901787877082825
217,1/26/2021 4:10:26 PM,Vertex sNDA for cystic fibrosis drug Trikafta accepted by FDA,Seeking Alpha,https://seekingalpha.com/news/3654333-vertex-snda-for-cystic-fibrosis-drug-trikafta-accepted-by-fda?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7691842317581177
218,1/26/2021 10:50:08 PM,Biden's climate change steps lift renewables again,Seeking Alpha,https://seekingalpha.com/news/3654700-bidens-climate-change-steps-lift-renewables-again?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7520684599876404
219,1/29/2021 1:45:44 PM,"The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-novavax-vaccine-readout-clinical-hold-on-bellicum-study-lifted-lilly-earnings-nls-pharma-ipo-1030019600,positive,0.9045888781547546
220,1/30/2021 3:01:18 PM,Here's what Wall Street expects from Vertex Pharmaceuticals's earnings,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-stock-quarter-earnings-preview-q4-1030022126,positive,0.9302723407745361
221,1/30/2021 7:19:15 PM,"The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-merck-pfizer-in-earnings-mix-plus-adamas-mallinckrodt-fda-decisions-ipos-and-more-1030022250,positive,0.8783656358718872
222,1/31/2021 10:35:00 PM,Vertex Pharmaceuticals Q4 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3656324-vertex-pharmaceuticals-q4-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.882186770439148
223,1/31/2021 10:35:00 PM,Notable earnings after Monday's close,Seeking Alpha,https://seekingalpha.com/news/3656264-notable-earnings-after-mondays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8940557837486267
224,2/1/2021 9:03:41 PM,"Vertex Pharmaceuticals EPS misses by $0.06, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3656867-vertex-pharmaceuticals-eps-misses-0_06-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6193372011184692
225,2/1/2021 10:11:52 PM,Vertex Pharmaceuticals Inc. Q4 adjusted earnings Miss Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q4-adjusted-earnings-miss-estimates-1030029558,neutral,0.9561155438423157
226,2/1/2021 10:58:30 PM,8 Stocks Moving In Monday's After-Hours Session,Benzinga,/news/stocks/8-stocks-moving-in-monday-s-after-hours-session-1030029679,neutral,0.7672250270843506
227,2/2/2021 2:05:48 PM,"The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment",Benzinga,/news/stocks/the-daily-biotech-pulse-vertex-pfizer-earnings-tiziana-covid-19-vaccine-data-decision-day-for-mallinckrodt-s-burn-treatment-1030032611,positive,0.9199008345603943
228,2/2/2021 2:22:26 PM,10 Biggest Price Target Changes For Tuesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-tuesday-1030032753,positive,0.8152946829795837
229,2/2/2021 4:10:44 PM,Amicus shares rise on acquisition speculation from Vertex,Seeking Alpha,https://seekingalpha.com/news/3657252-amicus-files-for-shelf-registration-of-25m-warrants-for-share-purchases?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8455983400344849
230,2/17/2021 1:52:53 PM,CRISPR Therapeutics shares fall on fourth-quarter topline miss,Seeking Alpha,https://seekingalpha.com/news/3662811-crispr-therapeutics-shares-fall-on-fourth-quarter-topline-miss?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9650017619132996
231,2/23/2021 1:41:21 PM,10 Biggest Price Target Changes For Tuesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-tuesday-1030112313,positive,0.8152946829795837
232,2/23/2021 5:07:53 PM,"Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-february-23-2021-1030114226,neutral,0.6228817701339722
233,3/10/2021 1:07:31 PM,Vertex Pharma launches VX-880 study in diabetes; secures Fast Track tag,Seeking Alpha,https://seekingalpha.com/news/3671137-vertex-pharma-launches-vx-880-study-in-diabetes-secures-fast-track-tag?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.912488579750061
234,3/10/2021 2:07:51 PM,Vertex Reports FDA Fast Track Designation For VX-880 - Quick Facts ,RTTNews,/news/stocks/vertex-reports-fda-fast-track-designation-for-vx-880-quick-facts-1030168566,negative,0.5588917136192322
235,3/12/2021 6:04:49 PM,Merck and Pfizer among top picks to lead 2021 biopharma M&A activity: Goldman Sachs,Seeking Alpha,https://seekingalpha.com/news/3672343-merck-and-pfizer-among-top-picks-to-lead-2021-biopharma-ma-activity-goldman-sachs?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7542275786399841
236,3/19/2021 10:22:15 AM,7 Safe Stocks That Won’t Bleed Your Portfolio,InvestorPlace,/news/stocks/7-safe-stocks-that-wont-bleed-your-portfolio-1030227426,positive,0.9061007499694824
237,3/25/2021 12:58:24 PM,"The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut",Benzinga,/news/stocks/the-daily-biotech-pulse-bristol-myers-squibb-s-skin-cancer-readout-cellect-strikes-reverse-merger-deal-lava-therapeutics-makes-nasdaq-debut-1030245316,positive,0.8989565968513489
238,3/25/2021 1:00:10 PM,AstraZeneca’s updated data to address integrity issue; Vertex moves to focus list at Citi in today’s analyst action,Seeking Alpha,https://seekingalpha.com/news/3676238-astrazenecas-updated-data-and-biotech-slump-in-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9268554449081421
239,3/26/2021 6:00:46 AM,"Alibaba, Amazon, Palantir, Google, Takeda, Unity — What Cathie Wood's Ark Bought And Sold On Thursday",Benzinga,/news/stocks/alibaba-amazon-palantir-google-takeda-unity-—-what-cathie-wood-s-ark-bought-and-sold-on-thursday-1030248437,positive,0.937481701374054
240,3/26/2021 11:43:22 AM,Vertex's KAFTRIO combo gets EMA positive opinion for label extension,Seeking Alpha,https://seekingalpha.com/news/3676712-vertexs-kaftrio-combo-gets-ema-positive-opinion-for-label-extension?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9430730938911438
241,4/20/2021 11:44:03 AM,Vertex and CRISPR amend CTX001 development agreement,Seeking Alpha,https://seekingalpha.com/news/3683318-vertex-and-crispr-amend-ctx001-development-agreement?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8485673666000366
242,4/20/2021 3:18:50 PM,"Why Crispr, KalVista And Syndax Are Moving Today",Benzinga,/news/stocks/why-crispr-kalvista-and-syndax-are-moving-today-1030323268,positive,0.9385185241699219
243,4/20/2021 5:44:39 PM,Vertex bets on CRISPR for beta-thalassemia as Bluebird bio stumbles in Europe,Seeking Alpha,https://seekingalpha.com/news/3683569-crsp-stock-rises-as-vertex-bets-on-crispr-gene-editing-while-bluebird-bio-stumbles-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7970744967460632
244,4/21/2021 12:25:25 PM,"Intuitive Surgical upgraded after earnings beat; Oppenheimer sizes up new Vertex – CRISPR deal, and more in today’s analyst action",Seeking Alpha,https://seekingalpha.com/news/3683885-intuitive-surgical-upgraded-after-earnings-beat-oppenheimer-sizes-up-new-vertex-crispr-deal?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8570231795310974
245,4/22/2021 2:24:49 PM,"Vertex Pharma, Obsidian Announce Research Collaboration And Licensing Agreement ",RTTNews,/news/stocks/vertex-pharma-obsidian-announce-research-collaboration-and-licensing-agreement-1030333229,negative,0.5893293023109436
246,4/22/2021 3:42:30 PM,Vertex inks licensing agreement with Obsidian for gene-editing medicines,Seeking Alpha,https://seekingalpha.com/news/3684665-vertex-inks-licensing-agreement-with-obsidian-for-gene-editing-medicines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8656346201896667
247,4/24/2021 3:24:00 PM,"The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx",Benzinga,/news/stocks/the-week-ahead-in-biotech-april-25-may-1-fda-decisions-for-sol-gel-protalix-bio-ardelyx-1030340692,positive,0.9154146313667297
248,4/26/2021 11:34:22 AM,Vertex to advance VX-548 pain medication to mid-stage trials,Seeking Alpha,https://seekingalpha.com/news/3685379-vertex-to-advance-vx-548-pain-medication-to-mid-stage-trials?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7957815527915955
249,4/26/2021 12:47:00 PM,"Vertex, CRISPR's CTX001 gene-edited therapy gets EMA 'Priority Medicines' status",Seeking Alpha,https://seekingalpha.com/news/3685451-vertex-crisprs-ctx001-gene-edited-therapy-gets-ema-priority-medicines-status?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8880717158317566
250,4/27/2021 3:02:23 PM,Here's what to expect from Vertex Pharmaceuticals's earnings,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-q1-earnings-preview-1030351679,positive,0.9407998323440552
251,4/28/2021 9:35:21 PM,Vertex Pharmaceuticals Q1 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3687018-vertex-pharmaceuticals-q1-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8371734023094177
252,4/29/2021 1:52:24 PM,2 Must-Own Biotech Stocks to Buy in May,InvestorPlace,/news/stocks/2-must-own-biotech-stocks-to-buy-in-may-1030365481,positive,0.8939027786254883
253,4/29/2021 2:15:50 PM,"The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx",Benzinga,/news/stocks/the-daily-biotech-pulse-clinical-setback-for-adverum-galera-posts-data-readout-moderna-to-invest-in-vaccine-manufacturing-decision-day-for-ardelyx-1030364740,positive,0.7717582583427429
254,4/29/2021 6:10:51 PM,7 Health-Focused ETFs To Buy Now For the Post-Covid Future,InvestorPlace,/news/stocks/7-health-focused-etfs-to-buy-now-for-the-post-covid-future-1030366420,positive,0.847977340221405
255,4/29/2021 8:05:58 PM,"Vertex Pharmaceuticals EPS beats by $0.29, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3688141-vertex-pharmaceuticals-eps-beats-0_29-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6774068474769592
256,4/29/2021 9:00:50 PM,Vertex beats Q1 consensus as cystic fibrosis therapy drives revenue growth,Seeking Alpha,https://seekingalpha.com/news/3688353-vertex-beat-consensus-as-cystic-fibrosis-therapy-drives-revenue-growth?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9410801529884338
257,4/29/2021 10:47:43 PM,Vertex Pharmaceuticals Inc. Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q1-adjusted-earnings-beat-estimates-1030367045,negative,0.9086783528327942
258,5/14/2021 7:04:33 AM,Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day,Benzinga,/news/stocks/cathie-wood-sheds-33-6m-alibaba-shares-on-earnings-day-1030429592,neutral,0.6546709537506104
259,5/17/2021 5:33:43 AM,Cathie Wood Buys $26M Disney Shares And Sells $13M In Netflix: What You Need To Know,Benzinga,/news/stocks/cathie-wood-buys-26m-disney-shares-and-sells-13m-in-netflix-what-you-need-to-know-1030433399,positive,0.9386593699455261
260,5/17/2021 9:17:31 PM,Vertex pays $32 million for milestones linked to potential cystic fibrosis therapy,Seeking Alpha,https://seekingalpha.com/news/3697507-vertex-pharma-pays-32-million-for-milestones-linked-to-potential-cystic-fibrosis-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5842159390449524
261,5/18/2021 7:20:45 AM,Cathie Wood Cuts Apple Stake Almost Entirely — And Buys More Coinbase,Benzinga,/news/stocks/cathie-wood-cuts-apple-stake-almost-entirely-—-and-buys-more-coinbase-1030439382,positive,0.8073779344558716
262,6/1/2021 11:31:09 PM,Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-june-pdufa-dates-1030484849,positive,0.9476439952850342
263,6/4/2021 7:30:04 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3703423-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
264,6/7/2021 2:52:10 PM,"The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck",Benzinga,/news/stocks/the-week-ahead-in-biotech-biogen-alexion-and-vertex-fda-decisions-multiple-conference-presentations-on-the-deck-1030499585,positive,0.9329092502593994
265,6/8/2021 3:17:38 PM,"The Daily Biotech Pulse: Hookipa, PDS Biotech Report Positive Data, Ironwood CFO To Depart, Decision Day For Vertex",Benzinga,/news/stocks/the-daily-biotech-pulse-hookipa-pds-biotech-report-positive-data-ironwood-cfo-to-depart-decision-day-for-vertex-1030503836,positive,0.9079675674438477
266,6/9/2021 1:47:16 PM,FDA OKs expanded use of Vertex's Trikafta in children with cystic fibrosis,Seeking Alpha,https://seekingalpha.com/news/3704593-fda-oks-expanded-use-of-vertexs-trikafta-in-children-with-cystic-fibrosis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.737125813961029
267,6/9/2021 2:37:13 PM,FDA Oks Vertex's Trikafta In Children With CF Ages 6 Through 11 With Certain Mutations ,RTTNews,/news/stocks/fda-oks-vertex-s-trikafta-in-children-with-cf-ages-6-through-11-with-certain-mutations-1030507560,positive,0.7849569916725159
268,6/9/2021 2:41:50 PM,FDA Approves Expanded Use Of Vertex Pharma's Cystic Fibrosis Drug In Younger Patients ,RTTNews,/news/stocks/fda-approves-expanded-use-of-vertex-pharma-s-cystic-fibrosis-drug-in-younger-patients-1030507595,negative,0.8743162751197815
269,6/11/2021 9:57:20 AM,"Vertex, CRISPR Therapeutics present new CTX001 data in beta thalassemia and sickle cell disease",Seeking Alpha,https://seekingalpha.com/news/3705537-vertex-crispr-present-new-ctx001-data-in-beta-thalassemia-sickle-cell-disease?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8433926105499268
270,6/11/2021 11:22:38 AM,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-june-11-1030515521,positive,0.50490802526474
271,6/11/2021 12:27:14 PM,"Vertex Pharmaceuticals, Orange, CureVac among premarket losers' pack",Seeking Alpha,https://seekingalpha.com/news/3705597-vertex-pharmaceuticals-orange-curevac-among-premarket-losers-pack?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8847208619117737
272,6/11/2021 1:04:21 PM,28 Stocks Moving in Friday's Pre-Market Session,Benzinga,/news/stocks/28-stocks-moving-in-friday-s-pre-market-session-1030515295,positive,0.5442315936088562
273,6/11/2021 1:48:24 PM,10 Biggest Price Target Changes For Friday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-friday-1030515444,positive,0.7916322350502014
274,6/11/2021 2:05:19 PM,"The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts",Benzinga,/news/stocks/the-daily-biotech-pulse-vertex-shelves-mid-stage-study-precigen-novan-jump-on-data-hematology-conference-janux-debuts-1030515558,positive,0.8261427283287048
275,6/11/2021 2:21:11 PM,Vertex reaches 52-week low after abandoning phase 2 rare disease drug,Seeking Alpha,https://seekingalpha.com/news/3705657-vertex-reaches-52-week-low-after-abandoning-phase-2-rare-disease-drug?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4464084208011627
276,6/11/2021 3:35:25 PM,VRTX Stock: The Disappointing News Sending Vertex Pharma Shares Lower,InvestorPlace,/news/stocks/vrtx-stock-the-disappointing-news-sending-vertex-pharma-shares-lower-1030516408,neutral,0.9724560379981995
277,6/11/2021 4:02:59 PM,Stock Alert: Vertex Pharmaceuticals Down On Dropping Plans To Advance VX-864 Study Into Late Stage ,RTTNews,/news/stocks/stock-alert-vertex-pharmaceuticals-down-on-dropping-plans-to-advance-vx-864-study-into-late-stage-1030515979,neutral,0.958553671836853
278,6/11/2021 4:46:39 PM,AMST Stock: 15 Things to Know About Hot Penny Stock Amesite as Shares Rocket,InvestorPlace,/news/stocks/amst-stock-15-things-to-know-about-hot-penny-stock-amesite-as-shares-rocket-1030516687,positive,0.9464495778083801
279,6/11/2021 5:18:50 PM,What 11 Analyst Ratings Have To Say About Vertex Pharmaceuticals,Benzinga,/news/stocks/what-11-analyst-ratings-have-to-say-about-vertex-pharmaceuticals-1030516263,positive,0.9408686757087708
280,6/11/2021 7:10:12 PM,46 Stocks Moving In Friday's Mid-Day Session,Benzinga,/news/stocks/46-stocks-moving-in-friday-s-mid-day-session-1030516596,positive,0.6424785852432251
281,6/12/2021 3:26:11 PM,"Healthcare gainers for the week led by CLOV's meme-stock fever, CureVac falls on delay in regulatory approval for COVID vaccine",Seeking Alpha,https://seekingalpha.com/news/3705832-healthcare-gainers-for-the-week-led-by-clovs-meme-stock-fever-while-curevac-falls-on-delay-in-regulatory-approval-for-covid-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9691377282142639
282,6/13/2021 6:34:43 PM,"Cathie Wood, Bullish On SpaceX Partner Velo3D, Buys More SPFR Shares, Adds Vertex On Dip",Benzinga,/news/etf/cathie-wood-bullish-on-spacex-partner-velo3d-buys-more-spfr-shares-adds-vertex-on-dip-1030518164,positive,0.7786343097686768
283,6/13/2021 6:51:53 PM,"The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-takeda-blueprint-medicines-orphazyme-eton-on-the-radar-ahead-of-fda-decisions-ipos-1030518167,positive,0.921207845211029
284,6/14/2021 11:04:24 AM,64 Biggest Movers From Friday,Benzinga,/news/stocks/64-biggest-movers-from-friday-1030518909,positive,0.7875980138778687
285,6/14/2021 3:31:54 PM,10 Biggest Price Target Changes For Monday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-monday-1030520028,positive,0.7998325824737549
286,6/15/2021 2:07:38 PM,"The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda",Benzinga,/news/stocks/the-daily-biotech-pulse-astrazeneca-biogen-face-clinical-trial-disappointments-novavax-studies-coronavirus-flu-combo-vaccine-decision-day-for-takeda-1030523320,positive,0.9001525640487671
287,6/16/2021 2:02:10 PM,"Cramer Shares His Thoughts On Vertex Pharma, Snap And More",Benzinga,/news/stocks/cramer-shares-his-thoughts-on-vertex-pharma-snap-and-more-1030527592,positive,0.932751476764679
288,6/16/2021 2:20:39 PM,"The Daily Biotech Pulse: Regeneron COVID-19 Antibody Cocktail Data, FDA Nod For Mallinckrodt, Molecular Partners IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-regeneron-covid-19-antibody-cocktail-data-fda-nod-for-mallinckrodt-molecular-partners-ipo-1030527915,positive,0.9316365122795105
289,6/17/2021 2:31:50 PM,"The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme",Benzinga,/news/stocks/the-daily-biotech-pulse-biogen-faces-another-clinical-setback-curevac-s-covid-19-vaccine-study-fails-moment-of-reckoning-for-orphazyme-1030531978,neutral,0.90581876039505
290,6/18/2021 1:46:03 PM,"The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-orphazyme-falters-at-fda-athira-s-ceo-placed-on-temporary-leave-5-ipos-1030535179,neutral,0.951781153678894
291,6/18/2021 7:50:35 PM,Vertex's TRIKAFTA gets Health Canada nod to treat certain patients with cystic fibrosis,Seeking Alpha,https://seekingalpha.com/news/3707808-vertexs-trikafta-gets-health-canada-nod-to-treat-certain-patients-with-cystic-fibrosis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.831387460231781
292,6/18/2021 9:50:00 PM,Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in People Ages 12 and Older Who Have at Least One F508del Mutation,PR Newswire,/news/stocks/health-canada-grants-marketing-authorization-for-trikafta-elexacaftor-tezacaftor-ivacaftor-and-ivacaftor-in-people-ages-12-and-older-who-have-at-least-one-f508del-mutation-1030536449,positive,0.7899284958839417
293,6/18/2021 9:50:00 PM,Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in People Ages 12 and Older Who Have at Least One F508del Mutation,PR Newswire,/news/stocks/health-canada-grants-marketing-authorization-for-trikafta-elexacaftor-tezacaftor-ivacaftor-and-ivacaftor-in-people-ages-12-and-older-who-have-at-least-one-f508del-mutation-1030536450,positive,0.7899284958839417
294,6/23/2021 1:35:16 PM,"The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway",Benzinga,/news/stocks/the-daily-biotech-pulse-gemini-sinks-on-data-amgen-s-migraine-drug-approved-in-japan-liver-congress-gets-underway-1030546471,positive,0.8094765543937683
295,6/24/2021 12:02:49 PM,Vertex Pharma authorizes $1.5 billion share back program,Seeking Alpha,https://seekingalpha.com/news/3709487-vertex-pharma-authorizes-15-billion-share-back-program?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7281245589256287
296,7/1/2021 2:28:17 PM,"Vertex initiated at Raymond James, Altimmune price target lowered, and more in analyst action",Seeking Alpha,https://seekingalpha.com/news/3711844-vertex-initiated-at-raymond-james-altimmune-price-target-lowered-and-more-in-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6252794861793518
297,7/1/2021 4:11:05 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-1-2021-1030572035,positive,0.5107024908065796
298,7/1/2021 8:29:28 PM,Expert Ratings For Vertex Pharmaceuticals,Benzinga,/news/stocks/expert-ratings-for-vertex-pharmaceuticals-1030573066,positive,0.8546052575111389
299,7/11/2021 1:00:00 PM,"Biotech M&A may heat up with potential targets Horizon Therapeutics, Arrowhead Pharma, analyst says",Seeking Alpha,https://seekingalpha.com/news/3714139-biotech-ma-may-heat-up-with-potential-targets-horizon-therapeutics-arrowhead-pharma?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8715733885765076
300,7/20/2021 1:48:52 PM,10 Biggest Price Target Changes For Tuesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-tuesday-1030624601,positive,0.8152946829795837
301,7/20/2021 4:14:09 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-20-2021-1030625981,neutral,0.552625298500061
302,7/20/2021 5:42:05 PM,Where Vertex Pharmaceuticals Stands With Analysts,Benzinga,/news/stocks/where-vertex-pharmaceuticals-stands-with-analysts-1030626321,positive,0.8964000940322876
303,7/25/2021 3:26:31 PM,"The Week Ahead In Biotech: Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More",Benzinga,/news/stocks/the-week-ahead-in-biotech-july-25-31-big-pharma-earnings-iterum-fda-decision-alzheimer-s-conference-ipos-and-more-1030641744,positive,0.9177685976028442
304,7/27/2021 3:02:14 PM,Vertex Pharmaceuticals earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-stock-price-quarter-earnings-preview-q2-1030650333,positive,0.9138038754463196
305,7/28/2021 12:14:30 PM,Vertex to initiate Phase 3 program in H2 for new triple combination regimen in cystic fibrosis,Seeking Alpha,https://seekingalpha.com/news/3720402-vertex-to-initiate-phase-3-program-in-h2-for-new-triple-combination-regimen-in-cystic-fibrosis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.562577486038208
306,7/28/2021 2:48:25 PM,Vertex To Initiate Phase 3 Program For Once-Daily Triple Combination Regimen In Cystic Fibrosis ,RTTNews,/news/stocks/vertex-to-initiate-phase-3-program-for-once-daily-triple-combination-regimen-in-cystic-fibrosis-1030656478,negative,0.5672576427459717
307,7/28/2021 9:35:02 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3720530-notable-earnings-after-thursdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8900269269943237
308,7/29/2021 2:18:48 PM,"The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-s-disappointing-q2-atreca-falls-on-data-fda-nod-for-viatris-nuvalent-icosavax-ipos-1030662210,neutral,0.9680227041244507
309,7/29/2021 8:09:30 PM,"Vertex Pharmaceuticals EPS beats by $0.75, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3721833-vertex-pharmaceuticals-eps-beats-0_75-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6950471997261047
310,7/29/2021 8:41:07 PM,"Vertex posts Q2 earnings beat, raises FY product revenue forecast",Seeking Alpha,https://seekingalpha.com/news/3721964-vertex-posts-q2-earnings-beat-raises-fy-product-revenue-forecast?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9515929818153381
311,7/29/2021 10:11:32 PM,Vertex Pharmaceuticals Inc. Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q2-adjusted-earnings-beat-estimates-1030664289,negative,0.9026922583580017
312,7/30/2021 12:02:08 AM,Vertex Pharmaceuticals Lifts FY21 Revenue Outlook ,RTTNews,/news/stocks/vertex-pharmaceuticals-lifts-fy21-revenue-outlook-1030664884,negative,0.8998141288757324
313,7/30/2021 3:05:17 PM,CRISPR's Q2 earnings beat thanks to $900M upfront payment from Vertex,Seeking Alpha,https://seekingalpha.com/news/3722468-crispr-q2-earnings-beat-thanks-to-900m-upfront-payment-from-vertex?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9524682760238647
314,7/30/2021 3:35:46 PM,CRISPR anticipates filing of lead candidate CTX001 in 18 to 24 months,Seeking Alpha,https://seekingalpha.com/news/3722491-crispr-anticipates-filing-of-lead-candidate-ctx001-in-18-to-24-months?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9127045273780823
315,7/30/2021 6:14:49 PM,Expert Ratings for Vertex Pharmaceuticals,Benzinga,/news/stocks/expert-ratings-for-vertex-pharmaceuticals-1030668938,positive,0.8546052575111389
316,8/4/2021 12:49:49 PM,Vertex names Stuart Arbuckle as chief operating officer,Seeking Alpha,https://seekingalpha.com/news/3724890-vertex-names-stuart-arbuckle-as-chief-operating-officer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9422541856765747
317,8/12/2021 10:44:21 AM,7 Falling Knife Stocks To Sell Before Your Portfolio Bleeds Out,InvestorPlace,/news/stocks/7-falling-knife-stocks-to-sell-before-your-portfolio-bleeds-out-1030723480,positive,0.7991913557052612
318,8/24/2021 2:09:21 PM,"The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal",Benzinga,/news/stocks/the-daily-biotech-pulse-cara-s-korsuva-greenlighted-by-fda-clinical-trial-disappointments-for-novartis-theravance-vertex-inks-crispr-licensing-deal-1030754775,positive,0.5257502198219299
319,8/25/2021 4:08:19 PM,7 Best Biotech Stocks to Buy in 2021 with Huge Upside,InvestorPlace,/news/stocks/7-best-biotech-stocks-to-buy-in-2021-with-huge-upside-1030758448,negative,0.5626565217971802
320,8/30/2021 6:20:27 PM,7 Beaten-Down Stocks to Buy for September,InvestorPlace,/news/stocks/7-beaten-down-stocks-to-buy-for-september-1030767764,neutral,0.5748787522315979
321,9/2/2021 5:34:14 PM,7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In ,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-before-3-5-trillion-floods-in-1030777655,positive,0.8197962045669556
322,9/7/2021 4:02:32 PM,"Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-september-7-2021-1030784466,neutral,0.5165023803710938
323,9/7/2021 7:46:16 PM,Where Vertex Pharmaceuticals Stands With Analysts,Benzinga,/news/stocks/where-vertex-pharmaceuticals-stands-with-analysts-1030785092,positive,0.8964000940322876
324,9/9/2021 5:05:43 PM,"Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-september-9-2021-1030790697,neutral,0.5507400631904602
325,9/9/2021 7:19:30 PM,Expert Ratings For Vertex Pharmaceuticals,Benzinga,/news/stocks/expert-ratings-for-vertex-pharmaceuticals-1030790969,positive,0.8546052575111389
326,9/10/2021 1:51:06 PM,"Cramer Gives His Opinion On Service Corporation, Vertex And More",Benzinga,/news/stocks/cramer-gives-his-opinion-on-service-corporation-vertex-and-more-1030792444,positive,0.9501345753669739
327,9/15/2021 4:45:22 PM,7 Gene Editing Stocks Promising to Change our DNA,InvestorPlace,/news/stocks/7-gene-editing-stocks-promising-to-change-our-dna-1030802558,negative,0.49636170268058777
328,9/23/2021 1:56:57 PM,"The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data",Benzinga,/news/stocks/the-daily-biotech-pulse-restricted-authorization-for-pfizer-s-covid-19-booster-dose-abcellera-strikes-antibody-licensing-deal-solid-biosciences-issues-dmd-data-1030818618,positive,0.8776688575744629
329,9/28/2021 2:18:52 PM,"The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive",Benzinga,/news/stocks/the-daily-biotech-pulse-eisai-biogen-pursue-approval-of-second-alzheimer-s-treatment-sanofi-changes-mrna-strategy-gsk-subsidiary-to-develop-long-acting-hiv-preventive-1030827880,positive,0.5831677317619324
330,9/29/2021 2:13:41 PM,"The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug",Benzinga,/news/stocks/the-daily-biotech-pulse-abbvie-s-migraine-drug-ok-d-by-fda-amicus-spins-off-gene-therapy-business-geovax-in-licenses-cancer-drug-1030831016,positive,0.9129316210746765
331,10/5/2021 2:01:45 PM,"The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-files-for-booster-dose-authorization-gemini-restructures-strata-skin-cfo-departs-kaleido-reports-positive-readout-1030843466,positive,0.4234638512134552
332,10/6/2021 1:33:33 PM,"The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal",Benzinga,/news/stocks/the-daily-biotech-pulse-takeda-suspends-studies-on-safety-scare-acer-s-sleep-disorder-drug-filing-accepted-for-review-voyager-s-licensing-options-deal-1030846864,neutral,0.905750572681427
333,10/7/2021 2:23:53 PM,"The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-invests-in-africa-amgen-announces-neuroscience-r-d-collaboration-decision-day-for-chemocentryx-biophytis-to-restate-results-1030850125,positive,0.89493727684021
334,10/10/2021 5:10:13 AM,"This Robot-Run Large Cap ETF Has Shed Facebook Stake And Counts Tesla, Apple And These Stocks Among Top Holdings",Benzinga,/news/etf/this-robot-run-large-cap-etf-has-shed-facebook-stake-and-counts-tesla-apple-and-these-stocks-among-top-holdings-1030854111,neutral,0.6295973658561707
335,10/12/2021 4:17:17 PM,Inhibrx wins Street high target from Evercore after data for rare disease therapy,Seeking Alpha,https://seekingalpha.com/news/3752064-inhibrx-wins-street-high-target-from-evercore-after-data-for-rare-disease-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9382532238960266
336,10/12/2021 8:12:06 PM,Amgen hits new 52-week low as shares come close to falling below $200,Seeking Alpha,https://seekingalpha.com/news/3752134-amgen-hits-new-52-week-low-as-shares-come-close-to-falling-below-200?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9437329173088074
337,10/18/2021 2:02:42 PM,Vertex Announces Positive Data In Phase 1/2 Trial Dosed With VX-880 For Type 1 Diabetes Treatment ,RTTNews,/news/stocks/vertex-announces-positive-data-in-phase-1-2-trial-dosed-with-vx-880-for-type-1-diabetes-treatment-1030873405,negative,0.9501135945320129
338,10/31/2021 7:23:54 PM,"The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-31-nov-6-earnings-pick-up-pace-eton-awaits-seizure-drug-approval-kidney-conference-more-ipos-in-the-pipeline-1030917750,negative,0.939061164855957
339,11/1/2021 3:01:13 PM,Here's what Wall Street expects from Vertex Pharmaceuticals's earnings,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-stock-quarter-earnings-preview-q3-1030921784,positive,0.9302723407745361
340,11/1/2021 9:35:51 PM,Vertex Pharmaceuticals Q3 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3761596-vertex-pharmaceuticals-q3-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8449839949607849
341,11/1/2021 9:35:55 PM,Notable earnings after Tuesday's close,Seeking Alpha,https://seekingalpha.com/news/3761467-notable-earnings-after-tuesdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8953564763069153
342,11/2/2021 12:52:53 PM,"The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-reports-solid-q3-earnings-regulatory-setback-for-legend-lilly-to-supply-additional-covid-19-antibody-cocktails-to-us-1030925781,negative,0.9155561327934265
343,11/2/2021 8:05:35 PM,"Vertex Pharmaceuticals EPS beats by $0.51, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3763265-vertex-pharmaceuticals-eps-beats-0_51-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6551761627197266
344,11/2/2021 8:29:37 PM,Vertex Pharma sets guidance ahead of consensus as revenue growth picks up,Seeking Alpha,https://seekingalpha.com/news/3763362-vertex-pharma-sets-guidance-ahead-of-consensus-as-revenue-growth-picks-up?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5480718612670898
345,11/2/2021 9:08:21 PM,Vertex Pharmaceuticals Inc. Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q3-adjusted-earnings-beat-estimates-1030928072,negative,0.9063999056816101
346,11/8/2021 3:51:46 PM,Bluebird bio hurt by downgrades after oncology spinoff,Seeking Alpha,https://seekingalpha.com/news/3766847-bluebird-bio-hurt-by-downgrades-after-oncology-spinoff?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9730731844902039
347,11/12/2021 1:14:13 PM,Vertex gets positive EMA opinion for label extension of Kaftrio combo in cystic fibrosis,Seeking Alpha,https://seekingalpha.com/news/3770027-vertex-gets-positive-ema-opinion-for-label-extension-of-kaftrio-combo-in-cystic-fibrosis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9427961707115173
348,11/12/2021 1:39:05 PM,Vertex Pharma: CHMP Adopts Positive Opinion For Label Extension Of KAFTRIO To Include 6-11 Age Group ,RTTNews,/news/stocks/vertex-pharma-chmp-adopts-positive-opinion-for-label-extension-of-kaftrio-to-include-6-11-age-group-1030969814,negative,0.9135141968727112
349,11/15/2021 2:04:48 PM,Being First Is Not Enough For Crispr Therapeutics,InvestorPlace,/news/stocks/crsp-stock-being-first-is-not-enough-for-crispr-therapeutics-1030976668,positive,0.9086139798164368
350,11/19/2021 12:39:11 PM,Vertex Pharma: Spanish Government Approves Terms For Reimbursement Of KAFTRIO ,RTTNews,/news/stocks/vertex-pharma-spanish-government-approves-terms-for-reimbursement-of-kaftrio-1030991122,negative,0.7952516078948975
351,11/19/2021 3:35:59 PM,Piper Sandler downgrades Vertex to neutral on slowing cystic fibrosis growth,Seeking Alpha,https://seekingalpha.com/news/3772915-piper-sandler-downgrades-vertex-to-neutral-on-slowing-cystic-fibrosis-growth?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6592352986335754
352,11/19/2021 4:08:55 PM,"Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-november-19-2021-1030991825,neutral,0.6235842108726501
353,11/19/2021 6:01:05 PM,Expert Ratings For Vertex Pharmaceuticals,Benzinga,/news/stocks/expert-ratings-for-vertex-pharmaceuticals-1030992179,positive,0.8546052575111389
354,11/30/2021 7:29:27 PM,7 Drug Stocks to Buy Now While They’re Still on Sale,InvestorPlace,/news/stocks/7-drug-stocks-to-buy-now-while-theyre-still-on-sale-1031013701,positive,0.8935650587081909
355,12/1/2021 1:08:00 PM,Vertex gains 5% on positive VX-147 data in mid-stage focal glomerular sclerosis study,Seeking Alpha,https://seekingalpha.com/news/3775740-vertex-gains-6-on-positive-vx-147-data-in-mid-stage-focal-glomerular-sclerosis-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9326551556587219
356,12/1/2021 2:43:04 PM,Vertex Pharma Reports Positive Results From Phase 2 Study Of VX-147 - Quick Facts ,RTTNews,/news/stocks/vertex-pharma-reports-positive-results-from-phase-2-study-of-vx-147-quick-facts-1031016018,negative,0.9489124417304993
357,12/2/2021 5:10:25 PM,What 6 Analyst Ratings Have To Say About Vertex Pharmaceuticals,Benzinga,/news/stocks/what-6-analyst-ratings-have-to-say-about-vertex-pharmaceuticals-1031020597,positive,0.9424180388450623
358,12/5/2021 2:00:31 AM,"Adagio, Vir among weekly healthcare gainers; Novavax slips ahead of more data on Omicron",Seeking Alpha,https://seekingalpha.com/news/3777132-novavax-slips-ahead-of-more-data-on-omicron-adagio-vir-among-weekly-healthcare-gainers?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9490481615066528
359,12/9/2021 2:41:00 PM,Direxion Launches mRNA ETF (MSGR),PR Newswire,/news/stocks/direxion-launches-mrna-etf-msgr-1031035548,positive,0.8775545358657837
360,12/9/2021 4:27:21 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-9-2021-1031036161,neutral,0.5978407859802246
361,12/28/2021 6:30:25 PM,Why did Intellia soar in 2021 while other gene editing stocks faltered? CRISPR in humans,Seeking Alpha,https://seekingalpha.com/news/3783739-why-did-intellia-soar-in-2021-while-other-gene-editing-stocks-faltered-crispr-in-humans?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8541568517684937
362,1/5/2022 1:21:29 PM,"Cramer Gives His Opinion On Oppenheimer Holdings, Mosaic And More",Benzinga,/news/stocks/cramer-gives-his-opinion-on-oppenheimer-holdings-mosaic-and-more-1031078947,positive,0.9524210095405579
363,1/11/2022 9:53:56 AM,Vertex Pharma: EU Oks KAFTRIO In Combination With Ivacaftor To Treat Children With Cystic Fibrosis ,RTTNews,/news/stocks/vertex-pharma-eu-oks-kaftrio-in-combination-with-ivacaftor-to-treat-children-with-cystic-fibrosis-1031092963,positive,0.659111499786377
364,1/11/2022 10:07:40 AM,EC Approves Kaftrio In Combination With Ivacaftor To Treat Cystic Fibrosis In Children ,RTTNews,/news/stocks/ec-approves-kaftrio-in-combination-with-ivacaftor-to-treat-cystic-fibrosis-in-children-1031093012,negative,0.8268755674362183
365,1/11/2022 10:14:08 AM,EC approves Vertex's KAFTRIO + ivacaftor for cystic fibrosis in children aged 6 to 11 years,Seeking Alpha,https://seekingalpha.com/news/3786946-ec-approves-vertexs-kaftrio-ivacaftor-for-cystic-fibrosis-in-children-aged-6-to-11-years?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6091364622116089
366,1/14/2022 10:32:44 PM,Benzinga Asks: Which ARK Fund Would You Rather Buy And Hold For 5 Years?,Benzinga,/news/etf/benzinga-asks-which-ark-fund-would-you-rather-buy-and-hold-for-5-years-1031104221,positive,0.9421513080596924
367,1/20/2022 1:28:07 PM,10 Biggest Price Target Changes For Thursday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-thursday-1031115704,positive,0.7969076037406921
368,1/20/2022 4:41:22 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-20-2022-1031116726,neutral,0.513200044631958
369,1/20/2022 5:40:12 PM,Vertex upgraded to outperform at BMO on bullish outlook for rare kidney disease candidate,Seeking Alpha,https://seekingalpha.com/news/3789931-vertex-upgraded-to-outperform-at-bmo-on-bullish-outlook-for-rare-kidney-disease-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9038508534431458
370,1/20/2022 9:07:18 PM,Where Vertex Pharmaceuticals Stands With Analysts,Benzinga,/news/stocks/where-vertex-pharmaceuticals-stands-with-analysts-1031117424,positive,0.8964000940322876
371,1/25/2022 3:01:13 PM,Here's what Wall Street expects from Vertex Pharmaceuticals's earnings report,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-stock-quarter-earnings-preview-q4-1031126420,positive,0.9002076983451843
372,1/25/2022 10:35:04 PM,Vertex Pharmaceuticals Q4 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3791307-vertex-pharmaceuticals-q4-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8448514938354492
373,1/25/2022 10:35:19 PM,Notable earnings after Wednesday's close,Seeking Alpha,https://seekingalpha.com/news/3791276-notable-earnings-after-wednesdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8919203281402588
374,1/26/2022 2:29:25 PM,"The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data",Benzinga,/news/stocks/the-daily-biotech-pulse-gilead-s-blood-cancer-studies-placed-on-partial-clinical-hold-immunocore-gets-fda-nod-nrx-touts-positive-covid-19-data-1031130804,positive,0.8202436566352844
375,1/26/2022 9:02:38 PM,"Vertex Pharmaceuticals Non-GAAP EPS of $3.37 beats by $0.08, revenue of $2.07B beats by $60M",Seeking Alpha,https://seekingalpha.com/news/3792049-vertex-pharmaceuticals-non-gaap-eps-of-3_37-beats-0_08-revenue-of-2_07b-beats-60m?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6223317980766296
376,1/26/2022 10:13:40 PM,Vertex Q4 2021 beats on top and bottom lines as non-GAAP income soars 31%,Seeking Alpha,https://seekingalpha.com/news/3792173-vertex-q4-2021-beats-on-top-and-bottom-lines-as-non-gaap-income-soars-31?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9302991628646851
377,1/26/2022 10:21:44 PM,"Vertex Pharmaceuticals Inc. Q4 Profit Increases, beats estimates",RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q4-profit-increases-beats-estimates-1031132618,negative,0.9452891945838928
378,1/30/2022 2:06:35 AM,Goldman screens for best and worst stocks for tightening financial conditions,Seeking Alpha,https://seekingalpha.com/news/3793311-goldman-screens-for-stocks-for-tightening-financial-conditions?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.645543098449707
379,2/1/2022 11:00:28 AM,3 Biotech Stocks That Could Boom or Bust in Q1,InvestorPlace,/news/stocks/3-biotech-stocks-that-could-boom-or-bust-in-q1-1031148371,positive,0.7662330865859985
380,2/1/2022 6:57:20 PM,Will the poor performance of biotechs in January be a barometer for 2022? Look to 2016,Seeking Alpha,https://seekingalpha.com/news/3794328-will-the-poor-performance-of-biotechs-in-january-be-a-barometer-for-2022-look-to-2016?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5294581651687622
381,2/3/2022 4:04:23 PM,"Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-february-3-2022-1031159425,positive,0.48700419068336487
382,2/3/2022 7:58:59 PM,Vertex downgraded to sector perform at RBC due to valuation,Seeking Alpha,https://seekingalpha.com/news/3795664-vertex-downgraded-to-sector-perform-at-rbc-due-to-valuation?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7985761761665344
383,2/3/2022 8:42:12 PM,Can AbbVie take a bite out of Vertex's cystic fibrosis dominance? Not right now,Seeking Alpha,https://seekingalpha.com/news/3795702-can-abbvie-take-a-bite-out-of-vertex-cystic-fibrosis-dominance-not-right-now?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9003951549530029
384,2/9/2022 10:55:29 PM,Vertex Pharmaceuticals files for mixed shelf offering,Seeking Alpha,https://seekingalpha.com/news/3798310-vertex-pharmaceuticals-files-for-mixed-shelf-offering?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9529145956039429
385,2/23/2022 8:07:14 PM,Peloton Isn’t the ONLY Takeover Target. What Companies Could Be Bought Out in 2022?,InvestorPlace,/news/stocks/peloton-isnt-the-only-takeover-targets-what-companies-could-be-bought-out-in-2022-1031222900,positive,0.9349479079246521
386,2/28/2022 5:54:01 PM,AbbVie downgraded to neutral at UBS based on current valuation,Seeking Alpha,https://seekingalpha.com/news/3806985-abbvie-downgraded-to-neutral-at-ubs-based-on-current-valuation?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5508800745010376
387,3/10/2022 11:10:23 PM,7 Cathie Wood Stocks That Are Worth Buying in March,InvestorPlace,/news/stocks/7-cathie-wood-stocks-that-are-worth-buying-in-march-1031272050,positive,0.9181938767433167
388,3/22/2022 2:13:45 PM,Vertex to advance VX-147 for kidney disease into pivotal trial,Seeking Alpha,https://seekingalpha.com/news/3816019-vertex-to-advance-vx-147-for-kidney-disease-into-pivotal-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7701396942138672
389,3/22/2022 4:25:33 PM,Vertex called top large-cap biotech franchise pick by Jefferies,Seeking Alpha,https://seekingalpha.com/news/3816106-vertex-pharmaceuticals-called-top-large-cap-biotech-franchise-pick-by-jefferies?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7528319358825684
390,3/25/2022 12:50:01 PM,Vertex's Kalydeco for cystic fibrosis granted expanded use by Health Canada,Seeking Alpha,https://seekingalpha.com/news/3817443-vertexs-kalydeco-for-cystic-fibrosis-granted-expanded-use-by-health-canada?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8619623184204102
391,3/28/2022 7:43:18 AM,Vertex announces reimbursement pact in Australia for TRIKAFTA,Seeking Alpha,https://seekingalpha.com/news/3817815-vertex-announces-reimbursement-pact-in-australia-for-trikafta?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7905771136283875
392,3/31/2022 12:48:50 PM,Vertex pain therapy VX-548 high dose meets main goal in 2 mid-stage studies,Seeking Alpha,https://seekingalpha.com/news/3819288-vertex-pain-therapy-vx-48-high-dose-meets-main-goal-in-2-mid-stage-studies?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7888662219047546
393,4/5/2022 2:47:23 PM,10 Biggest Price Target Changes For Tuesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-tuesday-1031333236,positive,0.8152946829795837
394,4/5/2022 7:35:38 PM,Vertex Pharma gains as Truist reacts to new hire from Harvard,Seeking Alpha,https://seekingalpha.com/news/3820921-vrtx-stock-gains-as-truist-reacts-to-new-hire-from-harvard?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9435485601425171
395,4/6/2022 5:57:27 PM,Royalty Pharma upgraded at Morgan Stanley on valuation,Seeking Alpha,https://seekingalpha.com/news/3821323-rprx-stock-gains-on-morgan-stanley-upgrade?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9007900953292847
396,4/13/2022 2:44:38 PM,Vertex price target raised at UBS calling company top pick in large cap biotech,Seeking Alpha,https://seekingalpha.com/news/3823100-vertex-price-target-raised-at-ubs-calling-company-top-pick-in-large-cap-biotech?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8940551280975342
397,4/14/2022 8:52:44 PM,"4 Top Stock Trades for Monday: WMT, BAC, VRTX, COP",InvestorPlace,/news/stocks/4-top-stock-trades-for-monday-wmt-bac-vrtx-cop-1031358118,positive,0.9356047511100769
398,4/20/2022 10:02:20 PM,Canada approves expanded use of Vertex's cystic fibrosis treatment Trikafta for kids aged 6-11,Seeking Alpha,https://seekingalpha.com/news/3825062-canada-approves-expanded-use-of-vertexs-cystic-fibrosis-treatment-trikafta-for-kids-aged-6-11?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8154597878456116
399,4/21/2022 12:10:33 PM,7 Potential Biotech Stocks Buyout Targets in 2022,InvestorPlace,/news/stocks/7-potential-biotech-stocks-targets-in-2022-1031371733,positive,0.8115262389183044
400,4/21/2022 4:15:08 PM,"The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data",Benzinga,/news/stocks/the-daily-biotech-pulse-ampio-falls-on-knee-osteoarthritis-trial-update-astrazeneca-s-covid-19-antibody-data-curevac-gsk-s-bivalent-covid-19-vaccine-data-1031372424,neutral,0.5761231184005737
401,4/27/2022 3:02:06 PM,Goldman Sachs issues Buy rating on Royalty Pharma citing outlook for deals,Seeking Alpha,https://seekingalpha.com/news/3827659-rprx-stock-gains-as-goldman-sachs-issues-buy-rating?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8247159123420715
402,5/2/2022 1:53:07 PM,FDA puts Vertex's phase 1/2 trial of VX-880 for the treatment of diabetes on clinical hold,Seeking Alpha,https://seekingalpha.com/news/3830017-fda-puts-vertexs-phase-12-trial-of-vx-880-for-the-treatment-of-diabetes-on-clinical-hold?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8516967296600342
403,5/2/2022 2:26:53 PM,"The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-may-1-7-phathom-fda-decision-pfizer-vertex-pharma-lead-earnings-news-ophthalmology-conference-presentations-and-more-1031408449,positive,0.9381586909294128
404,5/2/2022 3:22:34 PM,Vertex Pharma Issues Updates On Phase 1/2 Trial Of VX-880; FDA Places Clinical Hold ,RTTNews,/news/stocks/vertex-pharma-issues-updates-on-phase-1-2-trial-of-vx-880-fda-places-clinical-hold-1031409070,positive,0.7352814078330994
405,5/2/2022 7:21:29 PM,Vertex slips after FDA clinical hold even as analysts defend the stock,Seeking Alpha,https://seekingalpha.com/news/3830392-vrtx-stock-slips-after-fda-clinical-hold-as-analysts-defends-stock?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8634573221206665
406,5/3/2022 4:04:16 PM,"Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-may-3-2022-1031414516,positive,0.5485699772834778
407,5/3/2022 4:45:54 PM,Vertex upgraded at Morgan Stanley as AbbVie fails in cystic fibrosis study,Seeking Alpha,https://seekingalpha.com/news/3831225-vrtx-stock-rebounds-as-morgan-stanley-upgrades-on-abbvie-setback?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5455621480941772
408,5/3/2022 6:09:52 PM,Analyst Ratings for Vertex Pharmaceuticals,Benzinga,/news/stocks/analyst-ratings-for-vertex-pharmaceuticals-1031414882,positive,0.91236412525177
409,5/4/2022 3:01:13 PM,Here's what to expect from Vertex Pharmaceuticals's earnings,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-stock-q1-earnings-preview-1031419799,positive,0.9407998323440552
410,5/4/2022 9:35:46 PM,Vertex Pharmaceuticals Q1 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3832191-vertex-pharmaceuticals-q1-2022-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9091177582740784
411,5/4/2022 9:35:55 PM,Notable earnings after Thursday's close,Seeking Alpha,https://seekingalpha.com/news/3832050-notable-earnings-after-thursdays-close?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8900269269943237
412,5/5/2022 8:05:05 PM,"Vertex Pharmaceuticals Non-GAAP EPS of $3.52 misses by $0.02, revenue of $2.1B beats by $30M",Seeking Alpha,https://seekingalpha.com/news/3833627-vertex-pharmaceuticals-non-gaap-eps-of-3_52-misses-0_02-revenue-of-2_1b-beats-30m?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6531075239181519
413,5/5/2022 9:52:56 PM,Vertex Pharmaceuticals Q1 net income rises 17% on strong increase in Trikafta sales,Seeking Alpha,https://seekingalpha.com/news/3834013-vertex-pharmaceuticals-q1-net-income-rises-17-on-strong-increase-in-trikafta-sales?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9532383680343628
414,5/5/2022 10:08:55 PM,"Vertex Pharmaceuticals Inc. Q1 Profit Increases, beats estimates",RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q1-profit-increases-beats-estimates-1031427466,negative,0.9449380040168762
415,5/6/2022 1:02:20 PM,Vertex cut to neutral at Baird as stock fairly valued and no further upside,Seeking Alpha,https://seekingalpha.com/news/3834275-vertex-cut-to-neutral-at-baird-as-stock-fairly-valued-and-no-further-upside?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7460118532180786
416,5/10/2022 8:24:26 PM,Why This Analyst Has 'Little Conviction' On CRISPR's Upcoming Trial Data,Benzinga,/news/stocks/why-this-analyst-has-little-conviction-on-crispr-s-upcoming-trial-data-1031443477,positive,0.6299815773963928
417,5/18/2022 8:49:48 AM,Vertex to expand in Boston with new cell/gene therapy facility,Seeking Alpha,https://seekingalpha.com/news/3840295-vertex-to-expand-in-boston-with-new-cellgene-therapy-facility?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7365241646766663
418,5/23/2022 12:58:26 PM,Vertex agrees to buy protease drugs from Catalyst Bio,Seeking Alpha,https://seekingalpha.com/news/3841691-cbio-stock-climbs-on-asset-sales-to-vertex?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5233374834060669
419,5/23/2022 2:22:33 PM,"Vertex initiated with a market perform at Leerink on validating pipeline, need for M&A",Seeking Alpha,https://seekingalpha.com/news/3841743-vertex-initiated-with-a-market-perform-at-leerink-on-validating-pipeline-need-for-ma?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.77024245262146
420,5/23/2022 2:36:13 PM,Why Is Catalyst Biosciences (CBIO) Stock Soaring 170% Today?,InvestorPlace,/news/stocks/why-is-catalyst-biosciences-cbio-stock-soaring-170-today-1031482370,positive,0.7731574177742004
421,5/23/2022 4:33:42 PM,"Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-may-23-2022-1031482320,positive,0.527824878692627
422,5/23/2022 5:40:00 PM,What 5 Analyst Ratings Have To Say About Vertex Pharmaceuticals,Benzinga,/news/stocks/what-5-analyst-ratings-have-to-say-about-vertex-pharmaceuticals-1031482475,positive,0.9396241307258606
423,5/26/2022 11:16:53 PM,7 Growth Stocks to Buy Before They Make a Big Comeback,InvestorPlace,/news/stocks/7-growth-stocks-to-buy-before-they-make-a-big-comeback-1031492163,positive,0.8763882517814636
424,5/30/2022 8:03:18 PM,"The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-may-30-june-4-fda-decision-for-eton-s-partnered-epilepsy-drug-asco-conference-gets-underway-and-more-1031496572,positive,0.689422607421875
425,6/1/2022 4:08:32 PM,"Benzinga's Top Ratings Upgrades, Downgrades For June 1, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-june-1-2022-1031502286,positive,0.5502418875694275
426,6/8/2022 11:00:07 AM,7 Oversold Stocks to Buy Right Now,InvestorPlace,/news/stocks/7-oversold-stocks-to-buy-right-now-2-cmcsa-itt-gs-swks-gild-crox-crsp-1031515832,neutral,0.6448518633842468
427,6/8/2022 12:26:32 PM,Vertex wins key FDA and EU designations for kidney disease drug,Seeking Alpha,https://seekingalpha.com/news/3846657-vrtx-stock-gains-on-fda-and-eu-designations-for-kidney-disease-drug?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8814297914505005
428,6/8/2022 2:37:06 PM,Vertex Pharma: FDA Grants Inaxaplin Breakthrough Therapy Designation ,RTTNews,/news/stocks/vertex-pharma-fda-grants-inaxaplin-breakthrough-therapy-designation-1031516281,positive,0.6744389533996582
429,6/9/2022 10:15:05 AM,7 of the Hottest ETFs to Buy Right Now,InvestorPlace,/news/stocks/7-of-the-hottest-etfs-to-buy-right-now-1031518693,positive,0.8981585502624512
430,6/11/2022 12:51:35 PM,"Vertex, CRISPR update long-term data for gene edited therapy in blood disorders",Seeking Alpha,https://seekingalpha.com/news/3847852-vertex-crispr-update-long-term-data-for-gene-edited-therapy-in-blood-disorders?utm_source=businessinsider&utm_medium=referral,positive,0.9185105562210083
431,6/13/2022 5:08:26 PM,Expert Ratings for Vertex Pharmaceuticals,Benzinga,/news/stocks/expert-ratings-for-vertex-pharmaceuticals-1031525567,positive,0.8546052575111389
432,6/13/2022 5:44:08 PM,Crispr falls 12% most since 2020 as rival wins FDA backing for beta thalassemia drug,Seeking Alpha,https://seekingalpha.com/news/3848147-crispr-falls-12-most-since-2020-as-rival-wins-fda-backing-for-beta-thalassemia-drug?utm_source=businessinsider&utm_medium=referral,neutral,0.9622511267662048
433,6/13/2022 7:27:08 PM,"Analysts Consider CRISPR Therapeutics' Blood Disorder Trial Data Encouraging, Impressive",Benzinga,/news/stocks/analysts-consider-crispr-therapeutics-blood-disorder-trial-data-encouraging-impressive-1031525915,negative,0.9518249034881592
434,6/22/2022 12:15:20 PM,Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money,InvestorPlace,/news/stocks/economic-hurricane-ahead-7-profitable-places-to-hide-your-money-1031543188,positive,0.8941921591758728
435,6/23/2022 2:36:58 PM,Why Jim Cramer Prefers Devon Energy Over EOG Resources,Benzinga,/news/stocks/why-jim-cramer-prefers-devon-energy-over-eog-resources-1031546005,positive,0.9294520020484924
436,7/1/2022 1:28:20 PM,Teva names new medical chief,Seeking Alpha,https://seekingalpha.com/news/3853597-teva-stock-in-focus-on-appointment-of-new-medical-chief?utm_source=businessinsider&utm_medium=referral,positive,0.9154450297355652
437,7/5/2022 12:16:09 PM,Vertex says FDA lifted clinical hold on trial for stem cell-based diabetes therapy,Seeking Alpha,https://seekingalpha.com/news/3854103-vrtx-stock-in-focus-as-fda-lifts-clinical-hold-on-diabetes-trial?utm_source=businessinsider&utm_medium=referral,neutral,0.643815279006958
438,7/5/2022 2:10:22 PM,Vertex Pharma Says FDA Lifts Clinical Hold On Phase 1/2 Trial Of VX-880 To Treat Type 1 Diabetes ,RTTNews,/news/stocks/vertex-pharma-says-fda-lifts-clinical-hold-on-phase-1-2-trial-of-vx-880-to-treat-type-1-diabetes-1031567383,neutral,0.6822489500045776
439,7/5/2022 3:07:43 PM,"The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study",Benzinga,/news/stocks/the-daily-biotech-pulse-astrazeneca-goes-shopping-tyme-technologies-syros-pharma-merger-fda-clears-vertex-pharma-s-stem-cell-based-diabetes-therapy-study-1031567656,positive,0.8135465383529663
440,7/7/2022 8:14:45 PM,Vertex adds to public reimbursement agreement for Trikafta in Canada,Seeking Alpha,https://seekingalpha.com/news/3855162-vertex-adds-to-public-reimbursement-agreement-for-trikafta-cystic-fibrosis-in-canada?utm_source=businessinsider&utm_medium=referral,positive,0.6400579214096069
441,7/8/2022 7:53:05 PM,7 Moonshot Investments Upending a $10 Trillion Industry,InvestorPlace,/news/stocks/7-moonshot-investments-upending-a-10-trillion-industry-1031576272,negative,0.5756996273994446
442,7/8/2022 8:12:42 PM,The 3 Leaders of the Gene Editing Revolution,InvestorPlace,/news/stocks/the-3-leaders-of-the-gene-editing-revolution-1031576321,positive,0.9342885613441467
443,7/11/2022 1:14:06 PM,Vertex announces ViaCyte acquisition to expand diabetes pipeline,Seeking Alpha,https://seekingalpha.com/news/3855667-vertex-to-acquire-viacyte-stock-to-expand-diabetes-pipeline?utm_source=businessinsider&utm_medium=referral,negative,0.4977070689201355
444,7/11/2022 2:25:59 PM,Vertex Pharma To Acquire ViaCyte For $320 Mln In Cash ,RTTNews,/news/stocks/vertex-pharma-to-acquire-viacyte-for-320-mln-in-cash-1031578248,positive,0.9258871674537659
445,7/13/2022 4:07:16 PM,"Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-july-13-2022-1031584866,positive,0.5326911807060242
446,7/13/2022 5:04:23 PM,What 8 Analyst Ratings Have To Say About Vertex Pharmaceuticals,Benzinga,/news/stocks/what-8-analyst-ratings-have-to-say-about-vertex-pharmaceuticals-1031585117,positive,0.9419438242912292
447,7/20/2022 8:35:37 PM,"Vertex, Verve in gene editing partnership for liver disease worth up to $466M",Seeking Alpha,https://seekingalpha.com/news/3858805-vertex-verve-in-gene-editing-partnership-for-liver-disease-worth-up-to-466m?utm_source=businessinsider&utm_medium=referral,positive,0.7110428214073181
448,7/21/2022 1:54:21 PM,"Verve Therapeutics, Vertex Join Forces For Liver Disease-Focused Gene Program",Benzinga,/news/stocks/verve-therapeutics-vertex-join-forces-for-liver-disease-focused-gene-program-1031604424,positive,0.5354414582252502
449,7/21/2022 4:14:27 PM,"Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners",Benzinga,/news/stocks/daily-biotech-pulse-liver-disease-focused-gene-therapy-pact-assembly-bio-stops-hbv-infection-trial-x4-pharma-looks-for-partners-1031605137,positive,0.845745325088501
450,7/22/2022 1:12:45 PM,Vertex to run late-stage studies for pain therapy in 4Q 2022,Seeking Alpha,https://seekingalpha.com/news/3859614-vrtx-stock-on-watch-after-plans-for-late-stage-studies-for-pain-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.9032889008522034
451,7/22/2022 2:53:44 PM,"Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset",Benzinga,/news/stocks/daily-biotech-pulse-vistagen-s-anxiety-study-fails-silverback-to-merge-with-firm-developing-epipen-alternative-setback-for-liminal-s-lead-asset-1031607760,neutral,0.877272367477417
452,7/23/2022 6:55:04 PM,UBS lists top conviction stock ideas for its favorite sectors,Seeking Alpha,https://seekingalpha.com/news/3859827-ubs-lists-top-conviction-stock-ideas-for-its-favorite-sectors?utm_source=businessinsider&utm_medium=referral,positive,0.9275354146957397
453,7/31/2022 6:57:28 PM,UBS reveals its highest conviction stock picks for the rest of 2022,Seeking Alpha,https://seekingalpha.com/news/3863507-ubs-reveals-its-highest-conviction-stock-picks-for-the-rest-of-2022?utm_source=businessinsider&utm_medium=referral,negative,0.8287612795829773
454,8/3/2022 3:01:13 PM,What Wall Street expects from Vertex Pharmaceuticals's earnings,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-q2-earnings-preview-stock-1031645308,positive,0.9222412705421448
455,8/3/2022 3:15:33 PM,Will Vertex Pharmaceuticals Q2 results bring positive surprise?,Seeking Alpha,https://seekingalpha.com/news/3865817-will-vertex-pharmaceuticals-q2-results-bring-positive-surprise?utm_source=businessinsider&utm_medium=referral,positive,0.6090751886367798
456,8/4/2022 3:06:29 PM,"Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate",Benzinga,/news/stocks/biotech-daily-amgen-gilead-go-shopping-nod-for-astrazeneca-s-lynparza-in-early-stage-breast-cancer-decision-day-for-alzheimer-s-associated-hallucinations-candidate-1031651306,positive,0.8657047748565674
457,8/4/2022 8:05:57 PM,"Vertex Pharmaceuticals Non-GAAP EPS of $3.60 beats by $0.10, revenue of $2.2B beats by $70M",Seeking Alpha,https://seekingalpha.com/news/3867494-vertex-pharmaceuticals-non-gaap-eps-of-3_60-beats-0_10-revenue-of-2_2b-beats-70m?utm_source=businessinsider&utm_medium=referral,positive,0.6781058311462402
458,8/4/2022 8:48:04 PM,Vertex raises 2022 revenue guidance on back of Q2 top and bottom line beats,Seeking Alpha,https://seekingalpha.com/news/3867687-vertex-raises-2022-revenue-guidance-on-back-of-q2-top-and-bottom-line-beats?utm_source=businessinsider&utm_medium=referral,negative,0.7156618237495422
459,8/4/2022 10:41:47 PM,Vertex Pharmaceuticals Lifts FY22 Product Revenue Outlook ,RTTNews,/news/stocks/vertex-pharmaceuticals-lifts-fy22-product-revenue-outlook-1031652786,negative,0.9359826445579529
460,8/4/2022 10:42:31 PM,Vertex Pharmaceuticals Inc. Reveals Rise In Q2 Bottom Line,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-reveals-rise-in-q2-bottom-line-1031652785,negative,0.9421972036361694
461,8/5/2022 8:15:04 PM,Where Vertex Pharmaceuticals Stands With Analysts,Benzinga,/news/stocks/where-vertex-pharmaceuticals-stands-with-analysts-1031656443,positive,0.8964000940322876
462,8/6/2022 8:00:00 PM,"Biotech poised for H2 recovery as stocks rise amid quarterly results, M&A activity",Seeking Alpha,https://seekingalpha.com/news/3868377-biotech-poised-for-h2-recovery-as-stocks-rise-amid-quarterly-results-ma-activity?utm_source=businessinsider&utm_medium=referral,negative,0.7241557836532593
463,8/11/2022 8:44:15 PM,3 Best Funds for Aggressive Investors,InvestorPlace,/news/stocks/best-funds-for-aggressive-investors-1031677463,positive,0.8665502071380615
464,8/17/2022 2:27:48 PM,"This Analyst Boosts Price Target On Home Depot Following Strong Earnings, Plus Citigroup Slashes PT On This Stock By Over 60%",Benzinga,/news/stocks/this-analyst-boosts-price-target-on-home-depot-following-strong-earnings-plus-citigroup-slashes-pt-on-this-stock-by-over-60-1031689943,negative,0.6911306977272034
465,8/22/2022 6:00:58 PM,7 Cathie Wood Stocks to Buy on the Dip,InvestorPlace,/news/stocks/cathie-wood-stocks-to-buy-on-the-dip-1031588252,positive,0.829841673374176
466,8/26/2022 8:53:05 PM,5 Top Stocks Cathie Wood Is Selling This Week,InvestorPlace,/news/stocks/5-top-stocks-cathie-wood-is-selling-this-week-1031708967,positive,0.9074086546897888
467,8/31/2022 8:52:36 PM,"Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know",Benzinga,/news/stocks/bluebird-bio-seeks-back-to-back-nods-go-or-no-go-for-revance-s-botox-rival-amylyx-twin-hurdles-and-more-september-s-key-pdufa-catalysts-biotech-investors-must-know-1031717312,positive,0.7547863721847534
468,9/2/2022 6:09:04 PM,Vertex wins FDA label expansion for cystic fibrosis drug to add younger children,Seeking Alpha,https://seekingalpha.com/news/3880061-vertex-wins-fda-label-expansion-for-cystic-fibrosis-drug?utm_source=businessinsider&utm_medium=referral,negative,0.922271192073822
469,9/12/2022 8:49:32 PM,Biotech Stocks Stand to Benefit as Biden Announces Support for Industry,InvestorPlace,/news/stocks/biotech-stocks-stand-to-benefit-as-biden-announces-support-for-industry-1031738367,negative,0.9459112882614136
470,9/20/2022 5:45:25 PM,The 7 Best Biotech Stocks to Buy,InvestorPlace,/news/stocks/best-biotech-stocks-1031575358,positive,0.6688135266304016
471,9/23/2022 2:54:16 PM,7 Growth Stocks to Buy During a Stock Market Crash,InvestorPlace,/news/stocks/7-growth-stocks-to-buy-during-a-stock-market-crash-1031762133,positive,0.8986569046974182
472,9/27/2022 11:15:11 AM,The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market,InvestorPlace,/news/stocks/the-7-best-stocks-to-buy-to-tap-into-a-hidden-bull-market-1031766644,positive,0.8398815989494324
473,9/27/2022 12:07:04 PM,"Vertex, CRISPR to begin rolling review in US for gene-edited therapy in Nov; get FDA, EMA designations",Seeking Alpha,https://seekingalpha.com/news/3886283-vertex-crispr-to-begin-rolling-review-in-us-for-gene-edited-therapy-in-nov-get-fda-ema-designations?utm_source=businessinsider&utm_medium=referral,positive,0.7465906739234924
474,9/27/2022 2:53:25 PM,Why Is Crispr Therapeutics (CRSP) Stock Up Today?,InvestorPlace,/news/stocks/why-is-crispr-therapeutics-crsp-stock-up-today-1031767568,positive,0.7071463465690613
475,9/28/2022 2:28:08 PM,Vertex in licensing agreement with MaxCyte to use platform for gene editing candidate,Seeking Alpha,https://seekingalpha.com/news/3886763-vertex-in-licensing-agreement-with-maxcyte-to-use-platform-for-gene-editing-candidate?utm_source=businessinsider&utm_medium=referral,negative,0.7381312251091003
476,9/28/2022 6:39:11 PM,MaxCyte Inks Platform License With Vertex For Gene-Editing Program For Rare Blood Disorders,Benzinga,/news/stocks/maxcyte-inks-platform-license-with-vertex-for-gene-editing-program-for-rare-blood-disorders-1031770888,positive,0.5335276126861572
477,9/30/2022 8:32:48 PM,VRTX vs. SRPT: Which Biotech Stock is Better?,TipRanks,/news/stocks/vrtx-vs-srpt-which-biotech-stock-is-better-1031776841,positive,0.8467076420783997
478,10/3/2022 9:20:19 PM,"Bluebird Bio Offers World's Most Expensive Drugs, But Uncertainty Looms Over Its Financial Future",Benzinga,/news/stocks/bluebird-bio-offers-world-s-most-expensive-drugs-but-uncertainty-looms-over-its-financial-future-1031779843,neutral,0.7174401879310608
479,10/5/2022 12:15:30 PM,"Use short-term rallies to boost high-momentum stock exposure, Wells Fargo says",Seeking Alpha,https://seekingalpha.com/news/3888434-use-short-term-rallies-to-bost-high-momentum-stock-exposure?utm_source=businessinsider&utm_medium=referral,negative,0.7352736592292786
480,10/10/2022 10:15:48 AM,These 7 Biotech Stocks Are Set to Boom in 2023,InvestorPlace,/news/stocks/7-biotech-stocks-set-to-boom-2023-1031792647,negative,0.8603333234786987
481,10/11/2022 1:05:12 PM,"Vertex to advance two AAT correctors to potentially treat rare, genetic disease",Seeking Alpha,https://seekingalpha.com/news/3890315-vertex-to-advance-two-aat-correctors-to-potentially-treat-rare-genetic-disease?utm_source=businessinsider&utm_medium=referral,negative,0.8502581119537354
482,10/17/2022 2:34:50 PM,Morgan Stanley says large cap healthcare remains attractive amid macro concerns,Seeking Alpha,https://seekingalpha.com/news/3891861-morgan-stanely-says-large-cap-healthcare-remains-attractive-amid-macro-concerns?utm_source=businessinsider&utm_medium=referral,negative,0.9349676966667175
483,10/21/2022 9:10:40 PM,The Top 5 Stocks Cathie Wood Bought and Sold This Week,InvestorPlace,/news/stocks/the-top-5-stocks-cathie-wood-bought-and-sold-this-week-1031825391,positive,0.9377351999282837
484,10/24/2022 6:33:59 PM,Analyst Ratings for Vertex Pharmaceuticals,Benzinga,/news/stocks/analyst-ratings-for-vertex-pharmaceuticals-1031829377,positive,0.91236412525177
485,10/24/2022 7:08:57 PM,Expert Ratings for Vertex Pharmaceuticals,Benzinga,/news/stocks/expert-ratings-for-vertex-pharmaceuticals-1031829417,positive,0.8546052575111389
486,10/26/2022 3:01:13 PM,What Wall Street expects from Vertex Pharmaceuticals's earnings,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-stock-q3-earnings-preview-1031838120,positive,0.9222412705421448
487,10/26/2022 9:44:52 PM,Vertex Pharmaceuticals Q3 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3896055-vertex-pharmaceuticals-q3-2022-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.9031574130058289
488,10/27/2022 6:47:54 PM,Vertex falls on rising volume ahead of Q3 earnings,Seeking Alpha,https://seekingalpha.com/news/3896726-vrtx-stock-falls-on-rising-volume-ahead-of-q3-earnings?utm_source=businessinsider&utm_medium=referral,neutral,0.9214723706245422
489,10/27/2022 8:07:49 PM,"Vertex Pharmaceuticals Non-GAAP EPS of $4.01 beats by $0.37, revenue of $2.33B beats by $100M",Seeking Alpha,https://seekingalpha.com/news/3896779-vertex-pharmaceuticals-non-gaap-eps-of-4_01-beats-0_37-revenue-of-2_33b-beats-100m?utm_source=businessinsider&utm_medium=referral,positive,0.701277494430542
490,10/27/2022 9:16:54 PM,Vertex Q3 net income rises 14% as it raises full-year revenue guidance,Seeking Alpha,https://seekingalpha.com/news/3896959-vertex-q3-net-income-rises-14-as-it-raises-full-year-revenue-guidance?utm_source=businessinsider&utm_medium=referral,negative,0.9517611861228943
491,10/27/2022 10:25:35 PM,Vertex Pharmaceuticals Inc. Q3 Profit Advances,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q3-profit-advances-1031845212,negative,0.6604777574539185
492,10/28/2022 10:30:44 AM,Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Vaccitech Plc (VACC),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-vaccitech-plc-vacc-1031847812,positive,0.9022901058197021
493,10/28/2022 10:35:11 AM,Needham Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/needham-sticks-to-their-hold-rating-for-vertex-pharmaceuticals-vrtx-1031847884,positive,0.8682271242141724
494,10/28/2022 12:36:12 PM,Vertex Pharmaceuticals (VRTX) Receives a Buy from Wells Fargo,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-buy-from-wells-fargo-1031848319,negative,0.721979022026062
495,10/28/2022 1:03:49 PM,"Analysts’ Top Healthcare Picks: Edwards Lifesciences (EW), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-top-healthcare-picks-edwards-lifesciences-ew-vertex-pharmaceuticals-vrtx-1031848550,negative,0.761616587638855
496,10/28/2022 2:06:33 PM,"Cramer Says Stay With This Stock As It Is 'Really, Really Well-Run Company'",Benzinga,/news/stocks/cramer-says-stay-with-this-stock-as-it-is-really-really-well-run-company-1031848196,negative,0.6010406613349915
497,10/28/2022 4:35:48 PM,Morgan Stanley Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/morgan-stanley-reaffirms-their-hold-rating-on-vertex-pharmaceuticals-vrtx-1031849127,positive,0.8259227871894836
498,10/28/2022 4:43:28 PM,"Analysts Offer Insights on Healthcare Companies: Teleflex (TFX), Vertex Pharmaceuticals (VRTX) and Argenx Se (ARGX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-teleflex-tfx-vertex-pharmaceuticals-vrtx-and-argenx-se-argx-1031849177,positive,0.89225172996521
499,10/29/2022 11:25:16 AM,Vertex Pharmaceuticals (VRTX) Receives a Buy from Maxim Group,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-buy-from-maxim-group-1031849749,positive,0.5928342342376709
500,10/31/2022 4:15:52 AM,Vertex Pharmaceuticals (VRTX) Gets a Hold from Robert W. Baird,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-hold-from-robert-w-baird-1031850855,positive,0.8822978138923645
501,10/31/2022 4:25:36 AM,Vertex Pharmaceuticals (VRTX) Receives a Hold from SVB Securities,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-hold-from-svb-securities-1031850972,positive,0.9284045100212097
502,11/1/2022 7:01:11 AM,Stifel Nicolaus Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/stifel-nicolaus-reaffirms-their-hold-rating-on-vertex-pharmaceuticals-vrtx-1031857107,positive,0.8062240481376648
503,11/17/2022 1:45:39 AM,RBC Capital Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/rbc-capital-sticks-to-their-hold-rating-for-vertex-pharmaceuticals-vrtx-1031920444,positive,0.7001856565475464
504,11/17/2022 3:40:19 PM,Tesla Fame's Robot-Run ETF Is Now Betting Big On These Oil Stocks,Benzinga,/news/etf/tesla-fame-s-robot-run-etf-is-now-betting-big-on-these-oil-stocks-1031922620,positive,0.8526854515075684
505,11/17/2022 5:07:47 PM,What 6 Analyst Ratings Have To Say About Vertex Pharmaceuticals,Benzinga,/news/stocks/what-6-analyst-ratings-have-to-say-about-vertex-pharmaceuticals-1031922936,positive,0.9424180388450623
506,11/17/2022 6:02:47 PM,6 Analysts Have This to Say About Vertex Pharmaceuticals,Benzinga,/news/stocks/6-analysts-have-this-to-say-about-vertex-pharmaceuticals-1031923079,positive,0.921196699142456
507,11/23/2022 11:47:47 PM,7 Stocks on the Perfect 10 List,InvestorPlace,/news/stocks/7-stocks-on-the-perfect-10-list-1031935181,positive,0.5972025394439697
508,12/2/2022 12:47:46 PM,"BioNTech, Vertex Pharmaceuticals And Other Big Biotechnology Stocks From Benzinga's Most Accurate Analysts",Benzinga,/news/stocks/biontech-vertex-pharmaceuticals-and-other-big-biotechnology-stocks-from-benzinga-s-most-accurate-analysts-1031950025,positive,0.8538835048675537
509,12/8/2022 12:34:44 PM,Vertex and Entrada ink four-year partnership targeting muscle disorder,Seeking Alpha,https://seekingalpha.com/news/3915232-trda-stock-gains-on-four-year-partnership-vertex-muscle-disorder?utm_source=businessinsider&utm_medium=referral,positive,0.5041037201881409
510,12/8/2022 1:46:14 PM,"Vertex, Entrada To Develop Endosomal Escape Vehicle Therapeutics For Myotonic Dystrophy Type 1 ",RTTNews,/news/stocks/vertex-entrada-to-develop-endosomal-escape-vehicle-therapeutics-for-myotonic-dystrophy-type-1-1031960227,positive,0.645256519317627
511,12/8/2022 4:58:17 PM,Entrada Therapeutics Stock Gains On Licensing Pact With Vertex For Form Of Neuromuscular Disorder,Benzinga,/news/stocks/entrada-therapeutics-stock-gains-on-licensing-pact-with-vertex-for-form-of-neuromuscular-disorder-1031960943,negative,0.9418794512748718
512,12/9/2022 6:10:46 AM,"Analysts Conflicted on These Healthcare Names: HCA Healthcare (HCA), Vertex Pharmaceuticals (VRTX) and Design Therapeutics (DSGN)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-hca-healthcare-hca-vertex-pharmaceuticals-vrtx-and-design-therapeutics-dsgn-1031962058,neutral,0.7286378741264343
513,12/9/2022 10:42:48 PM,Our 7 Top Biotech Stock Picks for 2023,InvestorPlace,/news/stocks/our-7-top-biotech-stock-picks-for-2023-1031963677,positive,0.8780429363250732
514,12/12/2022 3:54:47 PM,Vertex receives IND clearance for mRNA cystic fibrosis therapy,Seeking Alpha,https://seekingalpha.com/news/3916164-vertex-receives-ind-clearance-for-mrna-cystic-fibrosis-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.7248433828353882
515,12/19/2022 4:00:50 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 19, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-19-2022-1031980293,positive,0.4876725673675537
516,12/19/2022 9:04:02 PM,"Vertex Pharmaceuticals downgraded to hold at Jefferies on valuation, stock outperformance",Seeking Alpha,https://seekingalpha.com/news/3918705-vertex-pharmaceuticals-downgraded-to-hold-at-jefferies-on-valuation-stock-outperformance?utm_source=businessinsider&utm_medium=referral,neutral,0.9356610178947449
517,12/29/2022 4:30:22 PM,7 Undervalued Biotech Stocks to Buy Before They Boom,InvestorPlace,/news/stocks/undervalued-biotech-stocks-1031612013,positive,0.7585014700889587
518,1/1/2023 7:00:00 PM,"Cashing out in biotech in 2022: On-target predictions for AbbVie, Vertex and Genmab",Seeking Alpha,https://seekingalpha.com/news/3920793-abbvie-vertex-genmab-among-accurate-stock-picks-at-sa-for-2022?utm_source=businessinsider&utm_medium=referral,negative,0.6699269413948059
519,1/2/2023 11:33:02 AM,7 Stocks for Beginners to Buy Now,InvestorPlace,/news/stocks/best-stocks-for-beginners-1031607349,positive,0.9169201254844666
520,1/6/2023 11:50:42 PM,3 Biotech Companies to Watch in 2023,InvestorPlace,/news/stocks/3-biotech-companies-to-watch-in-2023-1032005189,positive,0.9001237750053406
521,1/10/2023 12:29:26 PM,7 Long-Term Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/long-term-stocks-to-buy-and-hold-1031656398,positive,0.9400481581687927
522,1/11/2023 6:04:07 PM,"Vertex, Arbor Biotechnologies extend agreement on precision gene editing technology",Seeking Alpha,https://seekingalpha.com/news/3923840-vertex-arbor-biotechnologies-extend-agreement-on-precision-gene-editing-technology?utm_source=businessinsider&utm_medium=referral,negative,0.7275238037109375
523,1/17/2023 12:31:23 PM,"Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH), Vertex Pharmaceuticals (VRTX) and Ascendis Pharma (ASND)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-unitedhealth-unh-vertex-pharmaceuticals-vrtx-and-ascendis-pharma-asnd-1032022505,positive,0.904448926448822
524,1/17/2023 4:01:25 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-17-2023-1032022889,neutral,0.5494208931922913
525,1/18/2023 4:01:00 PM,"Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-january-18-2023-1032025872,neutral,0.5707111954689026
526,1/18/2023 8:44:49 PM,7 Biotech Stocks That Will Make You Rich in 10 Years,InvestorPlace,/news/stocks/7-biotech-stocks-that-will-make-you-rich-in-10-years-1032026652,positive,0.8400203585624695
527,1/19/2023 8:01:12 PM,The Latest Analyst Ratings for Vertex Pharmaceuticals,Benzinga,/news/stocks/the-latest-analyst-ratings-for-vertex-pharmaceuticals-1032029362,positive,0.9388018846511841
528,1/22/2023 5:00:19 PM,Global drug spending to reach $1.9T by 2027 – IQVIA,Seeking Alpha,https://seekingalpha.com/news/3926554-global-drug-spending-reach-usd-two-trillion-2027-iqvia?utm_source=businessinsider&utm_medium=referral,negative,0.8150349855422974
529,1/24/2023 4:25:31 PM,Morgan Stanley Remains a Hold on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/morgan-stanley-remains-a-hold-on-vertex-pharmaceuticals-vrtx-1032037489,positive,0.8461959362030029
530,1/25/2023 10:00:18 PM,7 Cream-of-the-Crop Stocks to Buy Today,InvestorPlace,/news/stocks/7-cream-of-the-crop-stocks-to-buy-today-1032041865,positive,0.8321917653083801
531,1/25/2023 10:20:18 PM,3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later,InvestorPlace,/news/stocks/3-gene-editing-stocks-to-buy-now-or-youll-be-kicking-yourself-later-1032041864,positive,0.8379383683204651
532,2/6/2023 3:01:13 PM,Vertex Pharmaceuticals earnings preview: what to expect,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-stock-price-quarter-earnings-preview-q4-1032070402,positive,0.9229901432991028
533,2/6/2023 10:35:07 PM,Notable earnings after Tuesday's close,Seeking Alpha,https://seekingalpha.com/news/3932340-notable-earnings-after-tuesdays-close?utm_source=businessinsider&utm_medium=referral,negative,0.8953564763069153
534,2/6/2023 10:35:16 PM,Vertex Pharmaceuticals Q4 2022 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3932439-vertex-pharmaceuticals-q4-2022-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.9118933081626892
535,2/7/2023 6:35:10 PM,Vertex under fire as activists demand generics for best-selling drug,Seeking Alpha,https://seekingalpha.com/news/3933058-vertex-under-fire-as-activists-demand-generics-for-best-selling-drug?utm_source=businessinsider&utm_medium=referral,neutral,0.842839777469635
536,2/7/2023 6:51:59 PM,The 7 Best Biotech Stocks to Buy for February 2023,InvestorPlace,/news/stocks/the-7-best-biotech-stocks-to-buy-for-february-2023-1032075170,positive,0.8734033107757568
537,2/7/2023 9:03:00 PM,"Vertex Pharmaceuticals Non-GAAP EPS of $3.76 beats by $0.25, revenue of $2.3B in-line",Seeking Alpha,https://seekingalpha.com/news/3933161-vertex-pharmaceuticals-non-gaap-eps-of-3_76-beats-0_25-revenue-of-2_3b-in-line?utm_source=businessinsider&utm_medium=referral,positive,0.734394907951355
538,2/7/2023 9:36:18 PM,Vertex indicates slowdown in growth; announces share buybacks,Seeking Alpha,https://seekingalpha.com/news/3933244-vrtx-stock-slips-after-q4-2022-earnings?utm_source=businessinsider&utm_medium=referral,neutral,0.9481570720672607
539,2/7/2023 10:07:57 PM,Vertex Pharmaceuticals Inc. Reports Rise In Q4 Profit,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-reports-rise-in-q4-profit-1032075409,negative,0.9464005827903748
540,2/8/2023 12:02:06 PM,Analysts Have Conflicting Sentiments on These Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Rocket Pharmaceuticals (RCKT),TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-vertex-pharmaceuticals-vrtx-and-rocket-pharmaceuticals-rckt-1032078195,neutral,0.9385315179824829
541,2/8/2023 12:30:26 PM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Cigna (CI), Illumina (ILMN) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-cigna-ci-illumina-ilmn-and-vertex-pharmaceuticals-vrtx-1032078305,neutral,0.8528494238853455
542,2/8/2023 4:25:24 PM,Piper Sandler Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/piper-sandler-sticks-to-its-hold-rating-for-vertex-pharmaceuticals-vrtx-1032079417,positive,0.8204450607299805
543,2/8/2023 4:26:23 PM,Bank of America Securities Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/bank-of-america-securities-reaffirms-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1032079376,positive,0.7993835806846619
544,2/8/2023 4:31:05 PM,"Analysts Offer Insights on Healthcare Companies: Illumina (ILMN), Vertex Pharmaceuticals (VRTX) and Inspire Medical Systems (INSP)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-illumina-ilmn-vertex-pharmaceuticals-vrtx-and-inspire-medical-systems-insp-1032079484,positive,0.8978617191314697
545,2/8/2023 4:45:06 PM,Vertex Pharmaceuticals (VRTX) Gets a Buy from BMO Capital,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-buy-from-bmo-capital-1032079538,positive,0.71013343334198
546,2/9/2023 1:50:47 AM,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Siegfried Holding AG (OtherSGFEF) and Demant (OtherWILLF)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-siegfried-holding-ag-othersgfef-and-demant-otherwillf-1032080509,positive,0.8996784090995789
547,2/9/2023 12:25:27 PM,"Entrada, Vertex licensing deal on muscle disorder program closes after US antitrust clearance",Seeking Alpha,https://seekingalpha.com/news/3934149-entrada-vertex-licensing-deal-on-muscle-disorder-program-closes-after-us-antitrust-clearance?utm_source=businessinsider&utm_medium=referral,positive,0.9038575291633606
548,2/9/2023 12:30:52 PM,"Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Vertex Pharmaceuticals (VRTX) and AbbVie (ABBV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-teva-pharmaceutical-teva-vertex-pharmaceuticals-vrtx-and-abbvie-abbv-1032082776,positive,0.9071211218833923
549,2/13/2023 7:49:54 PM,ARK Invest: The 7 Words That Explain Why Wall Street Can’t Stand Cathie Wood,InvestorPlace,/news/stocks/ark-invest-the-7-words-that-explain-why-wall-street-cant-stand-cathie-wood-1032092169,positive,0.8888998031616211
550,2/22/2023 6:29:06 PM,CRISPR surges 14% most in over two years after Q4 earnings,Seeking Alpha,https://seekingalpha.com/news/3939308-crsp-stock-surges-after-q4-earnings?utm_source=businessinsider&utm_medium=referral,negative,0.9326397776603699
551,2/22/2023 7:21:40 PM,AbbVie sued in Netherlands for breaching human rights over Humira pricing,Seeking Alpha,https://seekingalpha.com/news/3939351-abbvie-sued-in-netherlands-for-breaching-human-rights-over-humira-pricing?utm_source=businessinsider&utm_medium=referral,neutral,0.8990124464035034
552,2/23/2023 1:25:08 PM,Oppenheimer Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/oppenheimer-reaffirms-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1032119758,positive,0.8358345031738281
553,3/1/2023 11:56:04 AM,Vertex in pact with ImmunoGen to expand gene editing reach,Seeking Alpha,https://seekingalpha.com/news/3942447-vertex-in-pact-with-immunogen-to-expand-gene-editing-reach?utm_source=businessinsider&utm_medium=referral,negative,0.7588565349578857
554,3/1/2023 5:27:03 PM,ImmunoGen Allows Vertex Pharma Use Its Technology For Conditioning Agents For Use With Gene Editing,Benzinga,/news/stocks/immunogen-allows-vertex-pharma-use-its-technology-for-conditioning-agents-for-use-with-gene-editing-1032137134,positive,0.7470396161079407
555,3/6/2023 5:13:26 PM,3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing,InvestorPlace,/news/stocks/crsp-beam-vrtx-3-crispr-gene-editing-stocks-to-consider-for-ground-floor-investing-1032148100,positive,0.8794715404510498
556,3/7/2023 7:48:57 PM,7 Cathie Wood Stocks for Your March Buy List,InvestorPlace,/news/stocks/7-cathie-wood-stocks-for-your-march-buy-list-1032151503,positive,0.9288001656532288
557,3/9/2023 1:47:00 PM,Vertex gets FDA nod to start trial of cell therapy VX-264 for type 1 diabetes,Seeking Alpha,https://seekingalpha.com/news/3945939-vertex-gets-fda-nod-to-start-trial-of-cell-therapy-vx-264-for-type-1-diabetes?utm_source=businessinsider&utm_medium=referral,negative,0.6750104427337646
558,3/9/2023 2:17:17 PM,Vertex Pharma: FDA Clears IND Application For VX-264; Plans To Begin Phase 1/2 Trial In H1 ,RTTNews,/news/stocks/vertex-pharma-fda-clears-ind-application-for-vx-264-plans-to-begin-phase-1-2-trial-in-h1-1032156827,negative,0.662259578704834
559,3/15/2023 3:31:39 PM,The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector,InvestorPlace,/news/stocks/the-7-best-biotech-etfs-to-buy-for-exposure-to-the-healthcare-sector-1032170074,positive,0.6613713502883911
560,3/17/2023 5:01:40 PM,3 Pharma Stocks That Could Benefit from Global Healthcare Trends,InvestorPlace,/news/stocks/gsk-vtvt-vrtx-3-pharma-stocks-that-could-benefit-from-global-healthcare-trends-1032176476,negative,0.5566078424453735
561,3/21/2023 4:00:33 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-21-2023-1032182336,neutral,0.511221706867218
562,3/21/2023 6:00:26 PM,10 Analysts Have This to Say About Vertex Pharmaceuticals,Benzinga,/news/stocks/10-analysts-have-this-to-say-about-vertex-pharmaceuticals-1032182765,positive,0.9162748456001282
563,3/25/2023 1:17:25 PM,The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket,InvestorPlace,/news/stocks/the-3-best-crispr-stocks-to-buy-now-before-they-skyrocket-1032192146,positive,0.8489053845405579
564,3/27/2023 12:24:11 PM,"Vertex, CRISPR Therapeutics ink licensing deal for diabetes therapies",Seeking Alpha,https://seekingalpha.com/news/3951414-vertex-crispr-therapeutics-ink-licensing-deal-for-diabetes-therapies?utm_source=businessinsider&utm_medium=referral,negative,0.8166893124580383
565,3/27/2023 2:37:27 PM,Vertex Pharma Inks Licensing Agreement To Use CRISPR Therapeutics' Gene Editing Technology ,RTTNews,/news/stocks/vertex-pharma-inks-licensing-agreement-to-use-crispr-therapeutics-gene-editing-technology-1032193967,negative,0.7907249331474304
566,3/28/2023 5:21:30 AM,"VRTX, BIIB, or IQV: Which Biotech Stock Could Deliver the Highest Return?",TipRanks,/news/stocks/vrtx-biib-or-iqv-which-biotech-stock-could-deliver-the-highest-return-1032195771,positive,0.9018274545669556
567,3/29/2023 5:39:21 PM,Why Bluebird Bio Shares Are Plunging Today,Benzinga,/news/stocks/why-bluebird-bio-shares-are-plunging-today-1032201018,neutral,0.9264169335365295
568,3/30/2023 2:23:48 AM,The 3 Best Growth Stocks to Buy in the Biotech Sector,InvestorPlace,/news/stocks/the-3-best-biotech-growth-stocks-to-buy-1032201815,positive,0.5816062688827515
569,4/3/2023 12:39:07 PM,"Vertex, CRISPR finish rolling submission of application for sickle cell candidate",Seeking Alpha,https://seekingalpha.com/news/3953578-vertex-crispr-finish-rolling-submission-application-sickle-cell-candidate?utm_source=businessinsider&utm_medium=referral,positive,0.9269534349441528
570,4/4/2023 2:35:07 PM,Maxim Group Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/maxim-group-reaffirms-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1032214173,positive,0.768547773361206
571,4/6/2023 6:15:47 AM,Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global,Benzinga,/news/etf/cathie-wood-loads-up-on-biotech-stocks-—-continues-to-raise-stake-in-coinbase-global-1032218156,negative,0.6108030080795288
572,4/8/2023 1:45:21 AM,Vertex Pharmaceuticals (VRTX) Gets a Hold from RBC Capital,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-hold-from-rbc-capital-1032220981,positive,0.9371644854545593
573,4/10/2023 4:44:22 PM,Vertex : Canada Approves PrORKAMBI For Treatment Of Cystic Fibrosis In Children Ages 1 To <2 Year ,RTTNews,/news/stocks/vertex-canada-approves-prorkambi-for-treatment-of-cystic-fibrosis-in-children-ages-1-to-2-year-1032222252,negative,0.7869567275047302
574,4/13/2023 1:50:09 AM,Wall Street Analysts Are Neutral on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-neutral-on-top-healthcare-picks-1032228580,neutral,0.700346827507019
575,4/13/2023 2:11:17 PM,ICER suggests $1.9M price tag for pending sick cell disease drugs,Seeking Alpha,https://seekingalpha.com/news/3956311-icer-suggests-19m-price-tag-pending-sick-cell-disease-drugs?utm_source=businessinsider&utm_medium=referral,positive,0.5874433517456055
576,4/13/2023 2:40:48 PM,CRISPR jumps 15% as Cantor issues bullish view citing exa-cel approval,Seeking Alpha,https://seekingalpha.com/news/3956326-crispr-stock-jumps-cantor-issues-bullish-view?utm_source=businessinsider&utm_medium=referral,negative,0.9169675707817078
577,4/13/2023 2:50:19 PM,ICER suggests $1.9M price tag for pending sickle cell disease drugs,Seeking Alpha,https://seekingalpha.com/news/3956311-icer-suggests-19m-price-tag-pending-sickle-cell-disease-drugs?utm_source=businessinsider&utm_medium=referral,positive,0.5939010977745056
578,4/13/2023 6:24:02 PM,"$2M Price Tag for Sickle Cell Gene Therapies Could Be Cost-Effective Under Certain Scenarios, Finds ICER Analysis",Benzinga,/news/stocks/2m-price-tag-for-sickle-cell-gene-therapies-could-be-cost-effective-under-certain-scenarios-finds-icer-analysis-1032230859,negative,0.8571076989173889
579,4/13/2023 6:25:28 PM,"Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today?",InvestorPlace,/news/stocks/why-are-gene-editing-stocks-crsp-edit-ntla-stock-up-today-1032231097,positive,0.9001046419143677
580,4/18/2023 10:40:45 AM,3 High-Growth Biotech Stocks Poised for Success in 2023,InvestorPlace,/news/stocks/3-high-growth-biotech-stocks-poised-for-success-in-2023-1032239203,negative,0.7813158631324768
581,4/19/2023 1:20:23 AM,"Analysts’ Top Healthcare Picks: Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-top-healthcare-picks-johnson-johnson-jnj-vertex-pharmaceuticals-vrtx-1032241274,negative,0.8078631162643433
582,4/24/2023 11:55:25 AM,Bluebird bio seeks FDA priority review for sickle cell disease therapy lovo-cel,Seeking Alpha,https://seekingalpha.com/news/3959004-bluebird-bio-stock-gains-bla-filing-sickle-cell-disease-drug-lovo-cel?utm_source=businessinsider&utm_medium=referral,negative,0.7841680645942688
583,4/24/2023 7:49:55 PM,"With FDA Submission For Sickle Cell Gene Therapy, Bluebird Bio Can Potentially Have 3 Approved Products By 2023",Benzinga,/news/stocks/with-fda-submission-for-sickle-cell-gene-therapy-bluebird-bio-can-potentially-have-3-approved-products-by-2023-1032255203,negative,0.6831178665161133
584,4/25/2023 1:51:15 PM,3 Cash-Rich Biotech Stocks to Bet on for the Long Haul,InvestorPlace,/news/stocks/3-cash-rich-biotech-stocks-to-bet-on-for-the-long-haul-1032258809,positive,0.8360501527786255
585,4/26/2023 6:08:00 PM,Vertex wins FDA label expansion for cystic fibrosis therapy Trikafta,Seeking Alpha,https://seekingalpha.com/news/3960696-vertex-stock-wins-fda-label-expansion-cystic-fibrosis-drug?utm_source=businessinsider&utm_medium=referral,negative,0.9274864792823792
586,4/27/2023 3:09:09 PM,Vertex gains as AbbVie ends cystic fibrosis development program,Seeking Alpha,https://seekingalpha.com/news/3961447-vertex-gains-as-abbvie-ends-cystic-fibrosis-development-program?utm_source=businessinsider&utm_medium=referral,negative,0.7121264338493347
587,4/28/2023 4:12:21 PM,ImmunoGen Boosts Annual Guidance On Upbeat Uptake Of Newly Approved Ovarian Cancer Drug,Benzinga,/news/stocks/immunogen-boosts-annual-guidance-on-upbeat-uptake-of-newly-approved-ovarian-cancer-drug-1032274159,negative,0.9465528726577759
588,4/30/2023 3:01:13 PM,Here's what to expect from Vertex Pharmaceuticals's earnings report,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-stock-price-quarter-earnings-preview-q1-1032275873,positive,0.9273366928100586
589,4/30/2023 9:35:00 PM,Vertex Pharmaceuticals Q1 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3962235-vertex-pharmaceuticals-q1-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.9040619134902954
590,4/30/2023 9:35:40 PM,Notable earnings after Monday's close,Seeking Alpha,https://seekingalpha.com/news/3962390-notable-earnings-after-mondays-close?utm_source=businessinsider&utm_medium=referral,negative,0.8940557837486267
591,5/1/2023 8:02:54 PM,"Vertex Pharmaceuticals Non-GAAP EPS of $3.05 beats by $0.05, revenue of $2.37B beats by $30M",Seeking Alpha,https://seekingalpha.com/news/3962912-vertex-pharmaceuticals-non-gaap-eps-of-3_05-beats-0_05-revenue-of-2_37b-beats-30m?utm_source=businessinsider&utm_medium=referral,positive,0.5247800946235657
592,5/1/2023 9:23:56 PM,Vertex Q1 beats thanks to strong Trikafta year-over-year sales increase,Seeking Alpha,https://seekingalpha.com/news/3963039-vertex-q1-beats-thanks-strong-trikafta-year-over-year-sales-increase?utm_source=businessinsider&utm_medium=referral,negative,0.9559791684150696
593,5/1/2023 10:11:03 PM,"Vertex Pharmaceuticals Inc. Q1 Profit Decreases, but beats estimates",RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q1-profit-decreases-but-beats-estimates-1032279285,neutral,0.966012716293335
594,5/2/2023 10:30:13 AM,Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Urogen Pharma (URGN),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-urogen-pharma-urgn-1032281560,positive,0.8875101208686829
595,5/2/2023 11:05:26 AM,BMO Capital Gives a Buy Rating to Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/bmo-capital-gives-a-buy-rating-to-vertex-pharmaceuticals-vrtx-1032281712,positive,0.835803210735321
596,5/2/2023 11:10:46 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hologic (HOLX), Vertex Pharmaceuticals (VRTX) and Travere Therapeutics (TVTX)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-hologic-holx-vertex-pharmaceuticals-vrtx-and-travere-therapeutics-tvtx-1032281703,neutral,0.7989246249198914
597,5/2/2023 12:10:38 PM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032282035,negative,0.5521676540374756
598,5/2/2023 12:25:24 PM,Oppenheimer Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/oppenheimer-sticks-to-their-buy-rating-for-vertex-pharmaceuticals-vrtx-1032282105,positive,0.8647192120552063
599,5/2/2023 4:31:41 PM,"Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Vertex Pharmaceuticals (VRTX) and Axonics Modulation Technologies (AXNX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-stryker-syk-vertex-pharmaceuticals-vrtx-and-axonics-modulation-technologies-axnx-1032283481,positive,0.8974195718765259
600,5/2/2023 4:35:10 PM,Morgan Stanley Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/morgan-stanley-sticks-to-its-hold-rating-for-vertex-pharmaceuticals-vrtx-1032283479,positive,0.8064924478530884
601,5/2/2023 7:00:45 PM,Baird Maintains Neutral Rating for Vertex Pharmaceuticals: Here's What You Need To Know,Benzinga,/news/stocks/baird-maintains-neutral-rating-for-vertex-pharmaceuticals-here-s-what-you-need-to-know-1032283561,positive,0.9262174367904663
602,5/2/2023 11:01:35 PM,Analyst Expectations for Vertex Pharmaceuticals's Future,Benzinga,/news/stocks/analyst-expectations-for-vertex-pharmaceuticals-s-future-1032284138,negative,0.8458836078643799
603,5/4/2023 8:30:41 AM,Analysts Conflicted on These Healthcare Names: Vertex Pharmaceuticals (VRTX) and IVERIC bio (ISEE),TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-vertex-pharmaceuticals-vrtx-and-iveric-bio-isee-1032291369,neutral,0.6082888841629028
604,5/4/2023 7:36:19 PM,Vertex assumed Overweight at Piper Sandler despite recent rally,Seeking Alpha,https://seekingalpha.com/news/3965917-vertex-stock-draws-bullish-view-piper-sandler?utm_source=businessinsider&utm_medium=referral,positive,0.5357123017311096
605,5/5/2023 3:25:16 PM,SVB Securities Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/svb-securities-sticks-to-their-buy-rating-for-vertex-pharmaceuticals-vrtx-1032298000,positive,0.7656950354576111
606,5/6/2023 8:00:00 PM,"Eli Lilly, Humana among best health care names in defensive environment - BofA",Seeking Alpha,https://seekingalpha.com/news/3966792-eli-lilly-humana-among-best-health-care-names-defensive-environment?utm_source=businessinsider&utm_medium=referral,negative,0.6749860644340515
607,5/9/2023 6:02:02 PM,CRISPR adds 13% to reach seven-month high after Q1 update,Seeking Alpha,https://seekingalpha.com/news/3968329-crispr-stock-hits-seven-month-high-after-q1-update?utm_source=businessinsider&utm_medium=referral,negative,0.9390389919281006
608,5/12/2023 5:11:43 PM,AI-Run ETF Dumps Apple In Favor Of This Chip Stock And Hints At New Opportunity Brewing In Market,Benzinga,/news/etf/ai-run-etf-dumps-apple-in-favor-of-this-chip-stock-and-hints-at-new-opportunity-brewing-in-market-1032323317,neutral,0.5373362302780151
609,5/19/2023 2:00:52 PM,3 Biotech Stocks That Are Revolutionizing Healthcare in 2023,InvestorPlace,/news/stocks/best-biotech-stocks-to-buy-on-the-cusp-of-breakthroughs-1032340011,positive,0.8015285134315491
610,5/30/2023 12:40:12 PM,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ) and COMPASS Pathways (CMPS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-jazz-pharmaceuticals-jazz-and-compass-pathways-cmps-1032358216,positive,0.9073694348335266
611,5/30/2023 2:23:37 PM,Vertex initiated at outperform at William Blair on cystic fibrosis growth,Seeking Alpha,https://seekingalpha.com/news/3975829-vertex-initiated-outperform-william-blair-cystic-fibrosis-growth?utm_source=businessinsider&utm_medium=referral,negative,0.452208012342453
612,5/30/2023 5:00:39 PM,"Benzinga's Top Ratings Upgrades, Downgrades For May 30, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-may-30-2023-1032358705,positive,0.5174804329872131
613,5/30/2023 5:58:02 PM,CRISPR Therapeutics an outperform at William Blair on diversified pipeline,Seeking Alpha,https://seekingalpha.com/news/3975902-crispr-therapeutics-outperform-william-blair-diversified-pipeline?utm_source=businessinsider&utm_medium=referral,neutral,0.7326182126998901
614,5/30/2023 7:01:32 PM,Expert Ratings for Vertex Pharmaceuticals,Benzinga,/news/stocks/expert-ratings-for-vertex-pharmaceuticals-1032358989,positive,0.8546052575111389
615,6/1/2023 5:41:12 PM,"Barclays ups bluebird rating to overweight, citing sickle cell opportunity",Seeking Alpha,https://seekingalpha.com/news/3976773-barclays-ups-bluebird-rating-to-overweight-citing-sickle-cell-opportunity?utm_source=businessinsider&utm_medium=referral,neutral,0.5613271594047546
616,6/7/2023 11:00:00 AM,Stocks with top pricing power across all sectors,Seeking Alpha,https://seekingalpha.com/news/3977995-morgan-stanley-identifies-high-potential-stocks-with-strong-pricing-power-across-key-sectors?utm_source=businessinsider&utm_medium=referral,negative,0.5818864703178406
617,6/9/2023 10:40:04 AM,"CRISPR, Vertex gain as FDA starts review for gene edited therapy",Seeking Alpha,https://seekingalpha.com/news/3978882-crispr-stock-vertex-stock-gain-fda-review-exa-cel?utm_source=businessinsider&utm_medium=referral,negative,0.8928051590919495
618,6/9/2023 2:35:05 PM,Why Is CRISPR Therapeutics (CRSP) Stock Moving Today?,InvestorPlace,/news/stocks/why-is-crispr-therapeutics-crsp-stock-moving-today-1032381055,positive,0.8206328749656677
619,6/9/2023 8:08:34 PM,Breakthrough in CRISPR-Based Therapy: FDA Accepts Vertex and CRISPR Therapeutics' Exa-cel Application,Benzinga,/news/stocks/breakthrough-in-crispr-based-therapy-fda-accepts-vertex-and-crispr-therapeutics-exa-cel-application-1032381458,negative,0.9204865097999573
620,6/12/2023 3:51:15 PM,5 Stocks to Buy With Explosive 500% Potential,InvestorPlace,/news/stocks/5-stocks-to-buy-with-explosive-500-potential-1032384018,positive,0.8883646726608276
621,6/12/2023 6:20:53 PM,Editas upgraded to overweight at Raymond James on sickle cell candidate,Seeking Alpha,https://seekingalpha.com/news/3979300-editas-upgraded-overweight-raymond-james-sickle-cell-candidate?utm_source=businessinsider&utm_medium=referral,negative,0.6325879096984863
622,6/18/2023 8:56:10 PM,How to Retire Rich: Biotech Stocks Edition,InvestorPlace,/news/stocks/how-to-retire-rich-biotech-stocks-edition-1032395848,positive,0.9189780354499817
623,6/20/2023 12:25:13 PM,3 Millionaire-Maker Biotech Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/3-long-term-biotech-stock-investments-that-may-make-millionaire-1032398780,positive,0.8955403566360474
624,6/21/2023 11:24:47 AM,bluebird bio gains on FDA priority review for new gene therapy,Seeking Alpha,https://seekingalpha.com/news/3981328-bluebird-bio-wins-fda-priority-review-gene-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.7236284017562866
625,6/22/2023 9:33:41 AM,"Analysts Offer Insights on Healthcare Companies: Patterson Companies (PDCO), PTC Therapeutics (PTCT) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-patterson-companies-pdco-ptc-therapeutics-ptct-and-vertex-pharmaceuticals-vrtx-1032403851,positive,0.917859673500061
626,6/22/2023 4:30:31 PM,"Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), Vertex Pharmaceuticals (VRTX) and Pfizer (PFE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-axsome-therapeutics-axsm-vertex-pharmaceuticals-vrtx-and-pfizer-pfe-1032405301,positive,0.9012991786003113
627,6/22/2023 10:00:54 PM,Analyst Ratings for Vertex Pharmaceuticals,Benzinga,/news/stocks/analyst-ratings-for-vertex-pharmaceuticals-1032405689,positive,0.91236412525177
628,6/23/2023 4:25:58 PM,Cantor Fitzgerald Remains a Buy on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/cantor-fitzgerald-remains-a-buy-on-vertex-pharmaceuticals-vrtx-1032407428,positive,0.9443042874336243
629,6/26/2023 10:10:19 AM,Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Esperion (ESPR),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-esperion-espr-1032409193,positive,0.8878582119941711
630,6/26/2023 10:30:40 AM,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Dexcom (DXCM) and Genmab (GMAB)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-dexcom-dxcm-and-genmab-gmab-1032409256,positive,0.9066442251205444
631,6/26/2023 12:55:16 PM,Vertex Pharmaceuticals (VRTX) Initiated with a Buy at BMO Capital,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-initiated-with-a-buy-at-bmo-capital-1032409649,positive,0.8447351455688477
632,6/26/2023 1:18:50 PM,Vertex in deal with Lonza for facility to produce cell-based diabetes therapies,Seeking Alpha,https://seekingalpha.com/news/3982725-vertex-deal-lonza-facility-produce-cell-based-diabetes-therapies?utm_source=businessinsider&utm_medium=referral,negative,0.7880769371986389
633,6/26/2023 3:13:56 PM,"Vertex Pharma, Lonza Collaborate To Build Manufacturing Facility For Type 1 Diabetes Cell Therapies ",RTTNews,/news/stocks/vertex-pharma-lonza-collaborate-to-build-manufacturing-facility-for-type-1-diabetes-cell-therapies-1032409784,negative,0.6948633193969727
634,6/27/2023 2:35:05 PM,Maxim Group Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/maxim-group-sticks-to-its-buy-rating-for-vertex-pharmaceuticals-vrtx-1032412800,positive,0.7736368179321289
635,6/28/2023 11:05:18 AM,BMO Capital Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/bmo-capital-keeps-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1032414642,positive,0.9081143140792847
636,6/28/2023 1:45:21 PM,SVB Securities Gives a Buy Rating to Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/svb-securities-gives-a-buy-rating-to-vertex-pharmaceuticals-vrtx-1032415343,positive,0.8595984578132629
637,7/1/2023 4:15:10 AM,Morgan Stanley Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/morgan-stanley-sticks-to-their-hold-rating-for-vertex-pharmaceuticals-vrtx-1032421806,positive,0.849822998046875
638,7/1/2023 8:00:00 PM,"Lilly, Vertex top pharma performers in H1; Moderna, Pfizer the worst",Seeking Alpha,https://seekingalpha.com/news/3984694-lilly-vertex-top-pharma-performers-h1-moderna-pfizer-worst?utm_source=businessinsider&utm_medium=referral,negative,0.6028405427932739
639,7/5/2023 5:05:57 PM,The 3 Best Biotech Stocks to Buy In July,InvestorPlace,/news/stocks/biotech-stocks-to-buy-2-1032428210,positive,0.7658016681671143
640,7/6/2023 12:24:53 AM,3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025,InvestorPlace,/news/stocks/triple-digit-return-biotech-stocks-3-ai-picks-2025-1032428652,negative,0.8742924928665161
641,7/12/2023 11:51:55 AM,3 Biotech Stocks That AI is Loving in July,InvestorPlace,/news/stocks/3-biotech-stocks-that-ai-is-loving-in-july-1032440899,positive,0.9186151623725891
642,7/14/2023 1:24:24 AM,3 Pharma Stocks That AI is Loving in July,InvestorPlace,/news/stocks/3-pharma-stocks-that-ai-is-loving-in-july-1032445958,positive,0.9090803265571594
643,7/19/2023 1:03:12 PM,bluebird bio gains as BofA upgrades citing FDA nod for new gene therapy,Seeking Alpha,https://seekingalpha.com/news/3988695-bluebird-bio-stock-gains-bofa-upgrades?utm_source=businessinsider&utm_medium=referral,negative,0.9023428559303284
644,7/19/2023 8:14:45 PM,3 Tech Stocks to Watch for Groundbreaking Innovations in 2030,InvestorPlace,/news/stocks/groundbreaking-innovations-and-3-tech-stocks-that-will-profit-1032460294,negative,0.6130121946334839
645,7/21/2023 7:00:11 PM,B of A Securities Maintains Buy Rating for Vertex Pharmaceuticals: Here's What You Need To Know,Benzinga,/news/stocks/b-of-a-securities-maintains-buy-rating-for-vertex-pharmaceuticals-here-s-what-you-need-to-know-1032466654,positive,0.9273717403411865
646,7/24/2023 9:55:38 PM,The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-biotech-stocks-to-buy-now-july-2023-2-1032471656,positive,0.9041306376457214
647,7/26/2023 5:23:00 PM,"If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names",InvestorPlace,/news/stocks/if-you-can-only-buy-one-biotech-stock-it-better-be-one-of-these-3-names-1032481009,positive,0.9435527920722961
648,7/27/2023 11:00:14 AM,3 Biotech Stocks You Better Be Buying on Each and Every Dip,InvestorPlace,/news/stocks/3-biotech-stocks-you-better-be-buying-on-each-and-every-dip-1032483984,positive,0.9300490617752075
649,7/28/2023 6:45:14 AM,Bernstein Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/bernstein-sticks-to-its-buy-rating-for-vertex-pharmaceuticals-vrtx-1032488559,positive,0.7886233329772949
650,7/28/2023 9:14:36 PM,3 Biotech Stocks to Buy Before the Breakout,InvestorPlace,/news/stocks/3-biotech-stocks-to-buy-before-the-breakout-1032491365,positive,0.8637402057647705
651,7/31/2023 3:01:13 PM,Here's what to expect from Vertex Pharmaceuticals's earnings,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-stock-price-q2-earnings-preview-1032495442,positive,0.9407998323440552
652,7/31/2023 5:03:19 PM,"Rising Stars, Falling Trends: July's Industry ETF Winners And Losers",Benzinga,/news/etf/rising-stars-falling-trends-july-s-industry-etf-winners-and-losers-1032496121,neutral,0.9192143082618713
653,7/31/2023 9:35:10 PM,Notable earnings after Tuesday's close,Seeking Alpha,https://seekingalpha.com/news/3993436-notable-earnings-after-tuesdays-close?utm_source=businessinsider&utm_medium=referral,negative,0.8953564763069153
654,7/31/2023 9:35:24 PM,Vertex Pharmaceuticals Q2 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3993489-vertex-pharmaceuticals-q2-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.9039023518562317
655,8/1/2023 8:45:13 AM,Bank of America Securities Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/bank-of-america-securities-reaffirms-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1032499648,positive,0.7993835806846619
656,8/1/2023 8:02:08 PM,"Vertex Pharmaceuticals Non-GAAP EPS of $3.89 beats by $0.01, revenue of $2.49B beats by $70M",Seeking Alpha,https://seekingalpha.com/news/3994603-vertex-pharmaceuticals-non-gaap-eps-of-3_89-beats-0_01-revenue-of-2_49b-beats-70m?utm_source=businessinsider&utm_medium=referral,positive,0.6330430507659912
657,8/1/2023 10:10:06 PM,"Vertex Pharmaceuticals Inc. Q2 Profit Increases, beats estimates",RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q2-profit-increases-beats-estimates-1032502421,negative,0.9455630779266357
658,8/2/2023 6:45:49 AM,Bernstein Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/bernstein-keeps-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1032505159,positive,0.9173125624656677
659,8/2/2023 9:32:46 AM,"Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Vertex Pharmaceuticals (VRTX) and IQVIA Holdings (IQV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-idexx-laboratories-idxx-vertex-pharmaceuticals-vrtx-and-iqvia-holdings-iqv-1032505747,positive,0.9153348207473755
660,8/2/2023 10:20:41 AM,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Entrada Therapeutics Inc (TRDA) and Minerva Neurosciences (NERV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-entrada-therapeutics-inc-trda-and-minerva-neurosciences-nerv-1032505925,positive,0.9056695103645325
661,8/2/2023 11:30:21 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032506292,negative,0.5521676540374756
662,8/2/2023 8:10:50 PM,"Vertex Pharma Raises Annual Forecast On Strong Uptake For Cystic Fibrosis Drug, Analysts Says Investors' Focus On Non-CF Pipeline",Benzinga,/news/stocks/vertex-pharma-raises-annual-forecast-on-strong-uptake-for-cystic-fibrosis-drug-analysts-says-investors-focus-on-non-cf-pipeline-1032508232,negative,0.9359769225120544
663,8/3/2023 2:30:40 AM,"Analysts’ Top Healthcare Picks: Tenet Healthcare (THC), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-top-healthcare-picks-tenet-healthcare-thc-vertex-pharmaceuticals-vrtx-1032509298,negative,0.7912315726280212
664,8/3/2023 11:45:10 AM,Maxim Group Remains a Buy on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/maxim-group-remains-a-buy-on-vertex-pharmaceuticals-vrtx-1032512330,positive,0.946113646030426
665,8/3/2023 12:20:25 PM,"Analysts Are Bullish on Top Healthcare Stocks: Oculis Holding (OCS), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-oculis-holding-ocs-vertex-pharmaceuticals-vrtx-1032512487,negative,0.5946857333183289
666,8/4/2023 7:25:33 AM,Vertex Pharmaceuticals (VRTX) Gets a Hold from Robert W. Baird,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-hold-from-robert-w-baird-1032516591,positive,0.8822978138923645
667,8/7/2023 6:00:44 PM,Analyst Expectations for Vertex Pharmaceuticals's Future,Benzinga,/news/stocks/analyst-expectations-for-vertex-pharmaceuticals-s-future-1032524961,negative,0.8458836078643799
668,8/8/2023 7:46:11 PM,Why did CRISPR Therapeutics stock soar today? Q2 results,Seeking Alpha,https://seekingalpha.com/news/3999390-why-did-crispr-therapeutics-stock-soar-today-q2-results?utm_source=businessinsider&utm_medium=referral,positive,0.8074092268943787
669,8/17/2023 9:12:48 AM,The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-biotech-stocks-to-buy-now-august-2023-1032562527,positive,0.901785671710968
670,8/17/2023 7:16:43 PM,CRISPR Therapeutics upgraded to buy at Citi on near-term approvals,Seeking Alpha,https://seekingalpha.com/news/4004113-crispr-therapeutics-upgraded-buy-citi-near-term-approvals?utm_source=businessinsider&utm_medium=referral,negative,0.918283224105835
671,8/21/2023 3:56:10 PM,"Vertex/CRISPR, bluebird sickle cell therapies could be cost-effective - ICER",Seeking Alpha,https://seekingalpha.com/news/4004801-vertexcrispr-bluebird-sickle-cell-therapies-cost-effective-icer?utm_source=businessinsider&utm_medium=referral,positive,0.5616505146026611
672,8/21/2023 7:58:31 PM,"Lilly's market cap soared 36% in Q2, eclipsing J&J, Merck, Novo Nordisk",Seeking Alpha,https://seekingalpha.com/news/4004913-lillys-market-cap-soared-in-q2-eclipsing-jnj-merck-novo-nordisk?utm_source=businessinsider&utm_medium=referral,negative,0.9460121989250183
673,8/24/2023 7:42:35 PM,Bluebird bio favored at Baird as sickle cell disease space gets busy,Seeking Alpha,https://seekingalpha.com/news/4006147-bluebird-bio-stock-favored-baird-sickle-cell-disease?utm_source=businessinsider&utm_medium=referral,positive,0.6810605525970459
674,8/24/2023 8:17:49 PM,Got $600? Here are 3 No-Brainer Stocks You Absolutely Must Buy,InvestorPlace,/news/stocks/got-600-here-are-3-no-brainer-stocks-you-absolutely-must-buy-1032581174,positive,0.9344510436058044
675,8/29/2023 1:22:48 PM,Vertex appoints Atkinson EVP Chief Technical Operations Officer,Seeking Alpha,https://seekingalpha.com/news/4007022-vertex-appoints-atkinson-evp-chief-technical-operations-officer?utm_source=businessinsider&utm_medium=referral,positive,0.9172014594078064
676,8/30/2023 12:15:33 PM,Vertex Pharmaceuticals (VRTX) Receives a Hold from Jefferies,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-hold-from-jefferies-1032592612,positive,0.8082994222640991
677,8/31/2023 9:42:17 AM,The 3 Most Promising Biotech Stocks to Own Now,InvestorPlace,/news/stocks/the-3-most-promising-biotech-stocks-to-own-now-1032595542,positive,0.7112976908683777
678,9/4/2023 7:43:41 PM,The 3 Best Biotech Stocks to Buy Now: September 2023,InvestorPlace,/news/stocks/the-3-best-biotech-stocks-to-buy-now-september-2023-1032603521,positive,0.9307847023010254
679,9/5/2023 10:35:53 PM,"3 Biotech Stocks to Invest In for Big-Time, Long-Term Gains",InvestorPlace,/news/stocks/3-biotech-stocks-to-invest-in-for-big-time-long-term-gains-1032606984,positive,0.7922794222831726
680,9/7/2023 5:52:34 PM,CRSP Stock Alert: What to Know as CRISPR Therapeutics Co-Founder Steps Down,InvestorPlace,/news/stocks/crsp-stock-alert-what-to-know-as-crispr-therapeutics-co-founder-steps-down-1032614115,positive,0.8829095363616943
681,9/7/2023 7:00:42 PM,Expert Ratings for Vertex Pharmaceuticals,Benzinga,/news/stocks/expert-ratings-for-vertex-pharmaceuticals-1032614030,positive,0.8546052575111389
682,9/8/2023 12:15:08 AM,Cantor Fitzgerald Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/cantor-fitzgerald-keeps-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1032614562,positive,0.9179483652114868
683,9/8/2023 10:00:48 AM,September Rally? 3 Stocks to Buy Before Liftoff,InvestorPlace,/news/stocks/september-rally-3-stocks-to-buy-before-liftoff-1032615596,positive,0.5501723885536194
684,9/26/2023 5:00:53 PM,Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher,InvestorPlace,/news/stocks/dont-miss-the-boom-3-biotech-stocks-set-to-explode-higher-1032657128,positive,0.913301944732666
685,9/27/2023 6:56:14 PM,Don’t Miss the Boom: 3 Pharma Stocks Set to Explode Higher,InvestorPlace,/news/stocks/dont-miss-the-boom-3-pharma-stocks-set-to-explode-higher-1032660795,positive,0.8992198705673218
686,9/29/2023 5:00:43 PM,Analyst Ratings for Vertex Pharmaceuticals,Benzinga,/news/stocks/analyst-ratings-for-vertex-pharmaceuticals-1032667066,positive,0.91236412525177
687,9/30/2023 7:00:05 PM,Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs,InvestorPlace,/news/stocks/moonshot-medicine-3-stocks-to-buy-to-bet-on-long-shot-drugs-1032668021,positive,0.9284905791282654
688,10/3/2023 9:00:53 PM,Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich,InvestorPlace,/news/stocks/biotechnology-breakthroughs-3-biotech-stocks-that-could-make-early-investors-rich-1032675994,positive,0.8753173351287842
689,10/4/2023 8:35:43 AM,Positive Trial Results and Promising Cell Therapy Approach Bolster Buy Rating for Vertex Pharmaceuticals: An Analyst’s Perspective,TipRanks,/news/stocks/positive-trial-results-and-promising-cell-therapy-approach-bolster-buy-rating-for-vertex-pharmaceuticals-an-analyst-s-perspective-1032677010,negative,0.8942853808403015
690,10/6/2023 1:45:39 AM,RBC Capital Remains a Hold on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/rbc-capital-remains-a-hold-on-vertex-pharmaceuticals-vrtx-1032683177,positive,0.8767268061637878
691,10/6/2023 3:08:03 PM,Jim Cramer: This Company Is 'Arranging Deck Chairs On The Titanic... Not A Believer',Benzinga,/news/stocks/jim-cramer-this-company-is-arranging-deck-chairs-on-the-titanic-not-a-believer-1032684609,positive,0.9247823357582092
692,10/7/2023 1:00:48 PM,3 Biotech Stocks Ready to Break Out in 2024,InvestorPlace,/news/stocks/3-biotech-stocks-ready-to-break-out-in-2024-1032685969,positive,0.8537952303886414
693,10/11/2023 6:21:18 AM,"Analysts’ Top Healthcare Picks: Cytokinetics (CYTK), Axsome Therapeutics (AXSM)",TipRanks,/news/stocks/analysts-top-healthcare-picks-cytokinetics-cytk-axsome-therapeutics-axsm-1032695057,negative,0.6098278760910034
694,10/16/2023 7:00:24 PM,The Latest Analyst Ratings for Vertex Pharmaceuticals,Benzinga,/news/stocks/the-latest-analyst-ratings-for-vertex-pharmaceuticals-1032709569,positive,0.9388018846511841
695,10/17/2023 8:25:14 AM,Cantor Fitzgerald Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/cantor-fitzgerald-reaffirms-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1032711504,positive,0.8290557265281677
696,10/17/2023 9:17:55 AM,Wells Fargo Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/wells-fargo-sticks-to-their-buy-rating-for-vertex-pharmaceuticals-vrtx-1032711632,positive,0.7921885848045349
697,10/17/2023 8:33:08 PM,"Mixed Signals For CRISPR Therapeutics, Analyst Weighs Barriers, Potential Sales For Sickle Cell Therapy",Benzinga,/news/stocks/mixed-signals-for-crispr-therapeutics-analyst-weighs-barriers-potential-sales-for-sickle-cell-therapy-1032713900,negative,0.6138683557510376
698,10/18/2023 3:05:28 PM,3 Gene Editing Stocks to Generate Super-Charged Gains,InvestorPlace,/news/stocks/3-gene-editing-stocks-to-generate-super-charged-gains-1032717792,positive,0.8095833659172058
699,10/25/2023 6:11:42 AM,Buy Rating for Vertex Pharmaceuticals: Assessing Upcoming Trials and Management’s Disclosure Strategy,TipRanks,/news/stocks/buy-rating-for-vertex-pharmaceuticals-assessing-upcoming-trials-and-management-s-disclosure-strategy-1032740101,positive,0.9031996726989746
700,10/26/2023 8:35:46 PM,Hold Rating on Vertex Pharmaceuticals: Anticipated Outcomes from Phase 2/3 Studies of VX-548,TipRanks,/news/stocks/hold-rating-on-vertex-pharmaceuticals-anticipated-outcomes-from-phase-2-3-studies-of-vx-548-1032748018,positive,0.713217556476593
701,10/27/2023 7:10:25 PM,CRSP Stock: FDA Considers Additional Review of CRISPR Therapeutics Gene Therapy,InvestorPlace,/news/stocks/crsp-stock-fda-considers-additional-review-crispr-therapeutics-gene-therapy-1032749721,positive,0.9248803853988647
702,10/30/2023 10:30:56 AM,"Analysts Offer Insights on Healthcare Companies: Chemed (CHE), Teladoc (TDOC) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-chemed-che-teladoc-tdoc-and-vertex-pharmaceuticals-vrtx-1032755940,positive,0.9016191959381104
703,11/1/2023 9:40:40 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Argenx Se (ARGX)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-ge-healthcare-technologies-inc-gehc-vertex-pharmaceuticals-vrtx-and-argenx-se-argx-1032767451,neutral,0.935084342956543
704,11/1/2023 10:32:38 AM,Vertex Pharmaceuticals (VRTX) Gets a Buy from Piper Sandler,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-buy-from-piper-sandler-1032767567,negative,0.6648930311203003
705,11/1/2023 10:40:09 AM,"Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Biogen (BIIB) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-amgen-amgn-biogen-biib-and-vertex-pharmaceuticals-vrtx-1032767548,positive,0.9025466442108154
706,11/2/2023 5:31:07 PM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Repligen (RGEN), Vertex Pharmaceuticals (VRTX) and Lemaitre Vascular (LMAT)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-repligen-rgen-vertex-pharmaceuticals-vrtx-and-lemaitre-vascular-lmat-1032774792,neutral,0.9398921728134155
707,11/2/2023 8:00:31 PM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032775193,negative,0.5521676540374756
708,11/5/2023 3:01:13 PM,Here's what Wall Street expects from Vertex Pharmaceuticals's earnings,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-q3-earnings-preview-stock-1032779024,positive,0.9302723407745361
709,11/6/2023 2:01:14 AM,7 Tech Stocks to Buy and Hold for the Next 25 Years,InvestorPlace,/news/stocks/7-tech-stocks-to-buy-and-hold-for-the-next-25-years-1032779221,positive,0.9006269574165344
710,11/6/2023 2:01:33 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Cardinal Health (CAH), Vertex Pharmaceuticals (VRTX) and Privia Health Group (PRVA)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-cardinal-health-cah-vertex-pharmaceuticals-vrtx-and-privia-health-group-prva-1032782336,neutral,0.9411460757255554
711,11/6/2023 7:35:14 PM,"Stocks Fight To Extend Winning Streak, Treasury Yields Rise: What's Driving Markets Monday?",Benzinga,/news/etf/stocks-fight-to-extend-winning-streak-treasury-yields-rise-what-s-driving-markets-monday-1032783413,neutral,0.6440357565879822
712,11/6/2023 10:08:14 PM,"Vertex Pharmaceuticals Inc. Q3 Profit Increases, beats estimates",RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q3-profit-increases-beats-estimates-1032783750,negative,0.9452749490737915
713,11/7/2023 2:31:49 AM,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), BioMarin Pharmaceutical (BMRN) and Bausch Health Companies (BHC)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-biomarin-pharmaceutical-bmrn-and-bausch-health-companies-bhc-1032788302,positive,0.9002223014831543
714,11/7/2023 10:22:01 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Shockwave Medical (SWAV), Icon (ICLR) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-shockwave-medical-swav-icon-iclr-and-vertex-pharmaceuticals-vrtx-1032789925,neutral,0.853208601474762
715,11/7/2023 12:20:24 PM,"Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), SI-Bone (SIBN) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-voyager-therapeutics-vygr-si-bone-sibn-and-vertex-pharmaceuticals-vrtx-1032790099,positive,0.890443742275238
716,11/7/2023 12:30:54 PM,"Analysts’ Top Healthcare Picks: Shockwave Medical (SWAV), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-top-healthcare-picks-shockwave-medical-swav-vertex-pharmaceuticals-vrtx-1032790140,negative,0.7831539511680603
717,11/7/2023 12:55:35 PM,"Positive Outlook for Vertex Pharmaceuticals: Revenue Growth, Upward Revision of CF Product Revenue Guidance, and Ongoing Research Efforts",TipRanks,/news/stocks/positive-outlook-for-vertex-pharmaceuticals-revenue-growth-upward-revision-of-cf-product-revenue-guidance-and-ongoing-research-efforts-1032790143,negative,0.9471406936645508
718,11/7/2023 7:00:31 PM,What 10 Analyst Ratings Have To Say About Vertex Pharmaceuticals,Benzinga,/news/stocks/what-10-analyst-ratings-have-to-say-about-vertex-pharmaceuticals-1032789307,positive,0.940902829170227
719,11/7/2023 7:36:49 PM,These Analysts Revise Their Forecasts On Vertex Pharmaceuticals After Q3 Results,Benzinga,/news/stocks/these-analysts-revise-their-forecasts-on-vertex-pharmaceuticals-after-q3-results-1032789408,positive,0.9190300703048706
720,11/7/2023 8:48:45 PM,"US Stocks Eye Longest Winning Streak In 2 Years, Oil Tumbles: What's Driving Markets Tuesday?",Benzinga,/news/etf/us-stocks-eye-longest-winning-streak-in-2-years-oil-tumbles-what-s-driving-markets-tuesday-1032789501,neutral,0.6659721732139587
721,11/8/2023 5:27:54 AM,Promising Pipeline and Earnings Beat Spur Buy Rating for Vertex Pharmaceuticals,TipRanks,/news/stocks/promising-pipeline-and-earnings-beat-spur-buy-rating-for-vertex-pharmaceuticals-1032795918,negative,0.9524374604225159
722,11/8/2023 5:43:43 AM,Hold Rating for Vertex Pharmaceuticals: Balancing Solid CF Franchise Performance and Uncertainties around VX-548,TipRanks,/news/stocks/hold-rating-for-vertex-pharmaceuticals-balancing-solid-cf-franchise-performance-and-uncertainties-around-vx-548-1032795965,negative,0.9513609409332275
723,11/8/2023 7:45:36 AM,Promising Revenue Growth and Robust Pipeline Bolster Buy Rating for Vertex Pharmaceuticals,TipRanks,/news/stocks/promising-revenue-growth-and-robust-pipeline-bolster-buy-rating-for-vertex-pharmaceuticals-1032796280,negative,0.9562863707542419
724,11/8/2023 12:38:31 PM,Balancing Trikafta Success and Upcoming Challenges: An Analysis of Whitney Ijem’s Hold Rating on Vertex Pharmaceuticals,TipRanks,/news/stocks/balancing-trikafta-success-and-upcoming-challenges-an-analysis-of-whitney-ijem-s-hold-rating-on-vertex-pharmaceuticals-1032797009,positive,0.8422828912734985
725,11/8/2023 1:01:38 PM,"Analysts Conflicted on These Healthcare Names: Ascend Wellness Holdings LLC (OtherAAWH), Vertex Pharmaceuticals (VRTX) and Outset Medical (OM)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-ascend-wellness-holdings-llc-otheraawh-vertex-pharmaceuticals-vrtx-and-outset-medical-om-1032797130,neutral,0.8036580681800842
726,11/9/2023 3:00:22 AM,"Analysts Offer Insights on Healthcare Companies: Paycor HCM (PYCR), Stryker (SYK) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-paycor-hcm-pycr-stryker-syk-and-vertex-pharmaceuticals-vrtx-1032801629,positive,0.9074308276176453
727,11/9/2023 8:37:06 PM,3 Biotech Stocks That Are Betting on the Future of Gene Editing ,InvestorPlace,/news/stocks/3-gene-editing-stocks-that-may-define-the-future-of-biotech-1032802453,positive,0.8985041379928589
728,11/15/2023 2:00:56 AM,Analysts Conflicted on These Healthcare Names: Vertex Pharmaceuticals (VRTX) and Cormedix (CRMD),TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-vertex-pharmaceuticals-vrtx-and-cormedix-crmd-1032823194,neutral,0.7369842529296875
729,11/15/2023 12:21:04 PM,"Analysts Offer Insights on Healthcare Companies: Atreca (BCEL), Lucid Diagnostics (LUCD) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-atreca-bcel-lucid-diagnostics-lucd-and-vertex-pharmaceuticals-vrtx-1032824906,positive,0.8970478773117065
730,11/16/2023 1:21:03 AM,Analysts Offer Insights on Healthcare Companies: Seelos Therapeutics (SEEL) and Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-seelos-therapeutics-seel-and-vertex-pharmaceuticals-vrtx-1032827504,positive,0.9039371609687805
731,11/16/2023 8:51:34 AM,First Regulatory Authorization For A CRISPR-based Gene-editing Therapy ,RTTNews,/news/stocks/first-regulatory-authorization-for-a-crispr-based-gene-editing-therapy-1032826363,positive,0.8071998953819275
732,11/16/2023 12:28:52 PM,Risinger’s Buy Rating for Vertex Pharmaceuticals: Confidence in VX-548 Despite Lack of Placebo Arm in Trial,TipRanks,/news/stocks/risinger-s-buy-rating-for-vertex-pharmaceuticals-confidence-in-vx-548-despite-lack-of-placebo-arm-in-trial-1032829577,negative,0.953196108341217
733,11/16/2023 1:46:56 PM,CRISPR Therapeutics (CRSP) Stock Jumps as U.K. Authorizes Gene Therapy,InvestorPlace,/news/stocks/crispr-therapeutics-crsp-stock-jumps-as-u-k-authorizes-gene-therapy-1032827621,negative,0.7206107974052429
734,11/17/2023 8:25:17 AM,Cantor Fitzgerald Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-its-buy-rating-for-vertex-pharmaceuticals-vrtx-1032832626,positive,0.8075454831123352
735,11/22/2023 12:35:37 PM,Stifel Nicolaus Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/stifel-nicolaus-sticks-to-its-hold-rating-for-vertex-pharmaceuticals-vrtx-1032844355,positive,0.7680284380912781
736,11/28/2023 1:48:29 PM,3 Top-Rated Biotech Stocks That Analysts Are Loving Now,InvestorPlace,/news/stocks/3-top-rated-biotech-stocks-that-analysts-are-loving-now-1032854794,positive,0.8388064503669739
737,11/30/2023 8:53:23 AM,Biotech Stocks Facing FDA Decision In December 2023 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-december-2023-1032861195,positive,0.8986747860908508
738,12/1/2023 2:37:11 AM,3 Biotech Stocks That Could Be Multibaggers in the Making,InvestorPlace,/news/stocks/3-biotech-stocks-that-could-be-multibaggers-in-the-making-1032864780,positive,0.8610324859619141
739,12/2/2023 5:55:47 AM,Vertex Pharmaceuticals (VRTX) Gets a Hold from DBS,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-hold-from-dbs-1032868103,positive,0.9274942874908447
740,12/4/2023 11:55:49 AM,Hold Rating on Vertex Pharmaceuticals Pending Clinical Trial Outcomes,TipRanks,/news/stocks/hold-rating-on-vertex-pharmaceuticals-pending-clinical-trial-outcomes-1032872186,positive,0.9216926693916321
741,12/4/2023 12:31:23 PM,Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA) and Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-centessa-pharmaceuticals-cnta-and-vertex-pharmaceuticals-vrtx-1032872244,positive,0.8985573649406433
742,12/6/2023 12:25:25 AM,Cantor Fitzgerald Remains a Buy on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/cantor-fitzgerald-remains-a-buy-on-vertex-pharmaceuticals-vrtx-1032877774,positive,0.9443042874336243
743,12/6/2023 12:41:32 PM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), CVS Health (CVS) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-cvs-health-cvs-and-vertex-pharmaceuticals-vrtx-1032880041,positive,0.905311107635498
744,12/7/2023 10:15:00 AM,Next-Gen Biotech: 3 Companies Leading the Charge in Gene Therapy,InvestorPlace,/news/stocks/next-gen-biotech-3-companies-leading-the-charge-in-gene-therapy-1032881188,positive,0.8742164969444275
745,12/7/2023 11:50:26 AM,"Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Rhythm Pharmaceuticals (RYTM) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-veeva-systems-veev-rhythm-pharmaceuticals-rytm-and-vertex-pharmaceuticals-vrtx-1032883825,positive,0.8996580839157104
746,12/7/2023 11:00:08 PM,Healthcare Gems: 3 Essential Long-Term Stock Picks,InvestorPlace,/news/stocks/healthcare-gems-3-essential-long-term-stock-picks-1032883779,positive,0.9290483593940735
747,12/8/2023 7:35:29 PM,"FDA Approves First Gene-Editing Cell Therapy For Sickle Cell Disease, An Inherited Blood Disorder",Benzinga,/news/stocks/fda-approves-first-gene-editing-cell-therapy-for-sickle-cell-disease-an-inherited-blood-disorder-1032886628,negative,0.7189579606056213
748,12/11/2023 1:25:36 AM,Barclays Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/barclays-sticks-to-their-buy-rating-for-vertex-pharmaceuticals-vrtx-1032889447,positive,0.8371436595916748
749,12/11/2023 2:40:26 AM,Analysts Offer Insights on Healthcare Companies: TScan Therapeutics (TCRX) and Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-tscan-therapeutics-tcrx-and-vertex-pharmaceuticals-vrtx-1032889765,positive,0.8974418640136719
750,12/11/2023 2:47:38 AM,Buy Rating for Vertex Pharmaceuticals Amidst CRISPR Breakthrough and Competitive Advantages,TipRanks,/news/stocks/buy-rating-for-vertex-pharmaceuticals-amidst-crispr-breakthrough-and-competitive-advantages-1032890191,negative,0.9015650153160095
751,12/11/2023 11:00:28 AM,Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-autolus-therapeutics-autl-and-vertex-pharmaceuticals-vrtx-1032891161,positive,0.8899018168449402
752,12/11/2023 3:00:41 PM,The Latest Analyst Ratings for Vertex Pharmaceuticals,Benzinga,/news/stocks/the-latest-analyst-ratings-for-vertex-pharmaceuticals-1032889611,positive,0.9388018846511841
753,12/13/2023 10:20:00 AM,3 Gene-Editing Stocks With the Potential to Mint Millionaires,InvestorPlace,/news/stocks/3-gene-editing-stocks-with-the-potential-to-mint-millionaires-1032896336,positive,0.8445789217948914
754,12/13/2023 12:32:20 PM,"Analysts Offer Insights on Healthcare Companies: Krystal Biotech (KRYS), Vertex Pharmaceuticals (VRTX) and Align Tech (ALGN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-krystal-biotech-krys-vertex-pharmaceuticals-vrtx-and-align-tech-algn-1032899035,positive,0.8780322074890137
755,12/13/2023 12:46:51 PM,Vertex Announces Positive Results From Phase 2 Study Of VX-548 In Diabetic Peripheral Neuropathy ,RTTNews,/news/stocks/vertex-announces-positive-results-from-phase-2-study-of-vx-548-in-diabetic-peripheral-neuropathy-1032896565,negative,0.9413508176803589
756,12/13/2023 3:20:40 PM,Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX) and Centene (CNC),TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-vertex-pharmaceuticals-vrtx-and-centene-cnc-1032899179,neutral,0.8249804377555847
757,12/13/2023 5:04:25 PM,Next Wave Biotech: 3 Stocks Poised for Breakthrough Success,InvestorPlace,/news/stocks/next-wave-biotech-3-stocks-poised-for-breakthrough-success-1032898189,negative,0.6624009609222412
758,12/13/2023 6:45:09 PM,"Stocks Hold Steady, Yields Decline As Fed Meeting Looms: What's Driving Markets Wednesday?",Benzinga,/news/etf/stocks-hold-steady-yields-decline-as-fed-meeting-looms-what-s-driving-markets-wednesday-1032898290,neutral,0.9202335476875305
759,12/13/2023 7:40:34 PM,Why Despegar.com Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session,Benzinga,/news/stocks/why-despegar-com-shares-are-trading-higher-by-over-16-here-are-other-stocks-moving-in-wednesday-s-mid-day-session-1032898412,positive,0.8775336146354675
760,12/14/2023 1:50:35 AM,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alnylam Pharma (ALNY) and Integra Lifesciences (IART)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alnylam-pharma-alny-and-integra-lifesciences-iart-1032901063,positive,0.905171275138855
761,12/14/2023 3:39:18 AM,3 Biotech Stocks With Promising Pipelines and Big Growth Potential in 2024,InvestorPlace,/news/stocks/3-biotech-stocks-with-promising-pipelines-and-big-growth-potential-in-2024-1032899182,negative,0.8417342901229858
762,12/14/2023 10:22:04 AM,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Avidity Biosciences (RNA) and Alnylam Pharma (ALNY)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-avidity-biosciences-rna-and-alnylam-pharma-alny-1032902893,positive,0.9071972370147705
763,12/14/2023 10:25:38 AM,Vertex Pharmaceuticals’ Growth Potential Bolstered by Promising Pain Treatment Pipeline and Revenue Projections,TipRanks,/news/stocks/vertex-pharmaceuticals-growth-potential-bolstered-by-promising-pain-treatment-pipeline-and-revenue-projections-1032902891,negative,0.9513925313949585
764,12/14/2023 12:14:58 PM,"Analysts Conflicted on These Healthcare Names: Alector (ALEC), Argenx Se (ARGX) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-alector-alec-argenx-se-argx-and-vertex-pharmaceuticals-vrtx-1032903058,neutral,0.69612717628479
765,12/14/2023 12:41:41 PM,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alnylam Pharma (ALNY) and Pfizer (PFE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alnylam-pharma-alny-and-pfizer-pfe-1032903070,positive,0.9099569320678711
766,12/14/2023 1:03:32 PM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032903125,negative,0.5521676540374756
767,12/14/2023 1:51:32 PM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Rain Therapeutics (RAIN), Vertex Pharmaceuticals (VRTX) and Exelixis (EXEL)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-rain-therapeutics-rain-vertex-pharmaceuticals-vrtx-and-exelixis-exel-1032903161,neutral,0.7266936898231506
768,12/14/2023 5:21:03 PM,"Analysts Are Bullish on Top Healthcare Stocks: Gritstone Oncology (GRTS), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-gritstone-oncology-grts-vertex-pharmaceuticals-vrtx-1032903364,negative,0.5965275764465332
769,12/14/2023 11:25:30 PM,3 Small-Cap Stocks That Could Skyrocket 1000% by 2030,InvestorPlace,/news/stocks/3-small-cap-stocks-that-could-skyrocket-1000-by-2030-1032902984,positive,0.8052541613578796
770,12/15/2023 8:03:05 AM,"Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Catalent (CTLT) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-catalent-ctlt-and-vertex-pharmaceuticals-vrtx-1032905951,positive,0.8905031085014343
771,12/15/2023 8:41:34 AM,Vertex Pharmaceuticals Rated ‘Buy’ on Promising VX-548 Trial Results and Safety Profile,TipRanks,/news/stocks/vertex-pharmaceuticals-rated-buy-on-promising-vx-548-trial-results-and-safety-profile-1032905987,negative,0.9515447020530701
772,12/15/2023 2:34:40 PM,Vertex Receives CHMP Positive Opinion For The First CRISPR/Cas9 Gene-Edited Therapy CASGEVY ,RTTNews,/news/stocks/vertex-receives-chmp-positive-opinion-for-the-first-crispr-cas9-gene-edited-therapy-casgevy-1032904718,negative,0.8928442001342773
773,12/15/2023 10:04:19 PM,Pharma’s Frontline: 3 Stocks Driving Revolutionary Drug Development,InvestorPlace,/news/stocks/pharmas-frontline-3-stocks-driving-revolutionary-drug-development-1032906131,positive,0.8921711444854736
774,12/19/2023 9:50:13 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Merit Medical Systems (MMSI) and Masimo (MASI)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-vertex-pharmaceuticals-vrtx-merit-medical-systems-mmsi-and-masimo-masi-1032914153,neutral,0.8298758864402771
775,12/20/2023 1:21:27 PM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: CureVac (CVAC), Marinus (MRNS) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-curevac-cvac-marinus-mrns-and-vertex-pharmaceuticals-vrtx-1032917727,neutral,0.8315837979316711
776,12/20/2023 2:43:53 PM,CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief,InvestorPlace,/news/stocks/crsp-stock-alert-crispr-therapeutics-is-losing-its-medical-chief-1032916256,neutral,0.964610755443573
777,12/21/2023 4:23:17 PM,3 Biotech Stocks to Buy in the TradeSmith ‘Green Zone’,InvestorPlace,/news/stocks/3-biotech-stocks-to-buy-in-the-tradesmith-green-zone-1032920051,positive,0.6892320513725281
778,1/2/2024 6:34:26 PM,3 Biotech Stocks Set for Breakthroughs in 2024,InvestorPlace,/news/stocks/3-biotech-stocks-set-for-breakthroughs-in-2024-1032937787,positive,0.5988837480545044
779,1/3/2024 5:17:46 PM,3 Healthcare Stocks to Make You the Millionaire Next Door: 2024 Edition,InvestorPlace,/news/stocks/3-healthcare-stocks-to-make-you-the-millionaire-next-door-2024-edition-1032940863,positive,0.9251559376716614
780,1/4/2024 5:54:50 PM,Gen Z’s Top Picks for 2024: 7 Trending Stocks Among Young Investors,InvestorPlace,/news/stocks/gen-z-top-picks-for-2024-7-trending-stocks-among-young-investors-1032944152,positive,0.8243071436882019
781,1/6/2024 1:45:31 AM,RBC Capital Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/rbc-capital-sticks-to-its-hold-rating-for-vertex-pharmaceuticals-vrtx-1032947441,positive,0.7314440011978149
782,1/8/2024 12:01:04 PM,"Analysts Are Bullish on Top Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Intellia Therapeutics (NTLA)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-vertex-pharmaceuticals-vrtx-intellia-therapeutics-ntla-1032951826,negative,0.7289193272590637
783,1/8/2024 12:20:13 PM,"Analysts Are Bullish on These Healthcare Stocks: Intellia Therapeutics (NTLA), Exact Sciences (EXAS)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-intellia-therapeutics-ntla-exact-sciences-exas-1032951831,positive,0.6428828239440918
784,1/8/2024 12:30:21 PM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032951883,negative,0.5521676540374756
785,1/8/2024 10:30:12 PM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032952998,negative,0.5521676540374756
786,1/9/2024 5:58:34 AM,Vertex Pharmaceuticals: Expanding Market and Promising Pipeline Justify Buy Rating,TipRanks,/news/stocks/vertex-pharmaceuticals-expanding-market-and-promising-pipeline-justify-buy-rating-1032954761,negative,0.9190648198127747
787,1/9/2024 10:20:29 AM,"Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), Inspire Medical Systems (INSP) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-procept-biorobotics-prct-inspire-medical-systems-insp-and-vertex-pharmaceuticals-vrtx-1032955179,positive,0.8909645676612854
788,1/9/2024 9:00:58 PM,A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 16 Analysts,Benzinga,/news/stocks/a-glimpse-into-the-expert-outlook-on-vertex-pharmaceuticals-through-16-analysts-1032954924,positive,0.8648008704185486
789,1/10/2024 8:20:51 AM,"Analysts’ Top Healthcare Picks: Evolent Health (EVH), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-top-healthcare-picks-evolent-health-evh-vertex-pharmaceuticals-vrtx-1032956809,negative,0.7913600206375122
790,1/11/2024 9:38:39 PM,3 Stocks to Buy in the Booming Field of Gene Editing,InvestorPlace,/news/stocks/3-gene-editing-stocks-to-profit-from-the-coming-boom-1032962080,positive,0.7116246819496155
791,1/24/2024 1:18:31 PM,Netflix To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday,Benzinga,/news/stocks/netflix-to-rally-around-18-here-are-10-top-analyst-forecasts-for-wednesday-1032991920,positive,0.9167703986167908
792,1/24/2024 3:25:57 PM,"Canaccord cuts Vertex to sell, cites recent price run-up",Seeking Alpha,https://seekingalpha.com/news/4057927-canaccord-cuts-vertex-to-sell-cites-recent-price-run-up?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8479436039924622
793,1/24/2024 8:55:14 PM,"Slow Market Penetration For Biogen's Another Alzheimer's Drug: UBS Highlights Risks, Forecasts",Benzinga,/news/stocks/slow-market-penetration-for-biogen-s-another-alzheimer-s-drug-ubs-highlights-risks-forecasts-1032993934,neutral,0.8969920873641968
794,1/25/2024 1:32:27 PM,Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January,InvestorPlace,/news/stocks/biotech-stocks-are-on-fire-here-are-the-top-3-picks-for-january-1032996721,positive,0.9238400459289551
795,1/28/2024 5:00:53 PM,Big Pharma earnings season in spotlight amid positive sentiment,Seeking Alpha,https://seekingalpha.com/news/4059361-big-pharma-earnings-spotlight-positive-sentiment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8954368233680725
796,1/29/2024 3:04:30 PM,"AI, Biotech, Energy Sectors Expect M&A Revival For 2024",Benzinga,/news/stocks/ai-biotech-energy-sectors-expect-m-a-revival-for-2024-1033005691,negative,0.905494213104248
797,1/30/2024 11:57:24 AM,Vertex stock rises as non-opioid pain drug shows positive results in pivotal trials,Seeking Alpha,https://seekingalpha.com/news/4059926-vertex-stock-rises-as-non-opioid-pain-drug-shows-positive-results-in-pivotal-trials?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9345281720161438
798,1/30/2024 4:56:06 PM,Hold Rating on Vertex Pharmaceuticals’ VX-548 Amid Market Potential Concerns,TipRanks,/news/stocks/hold-rating-on-vertex-pharmaceuticals-vx-548-amid-market-potential-concerns-1033011567,neutral,0.9507059454917908
799,1/30/2024 8:10:54 PM,Analysts’ Opinions Are Mixed on These Healthcare Stocks: Canopy Growth (CGC) and Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-canopy-growth-cgc-and-vertex-pharmaceuticals-vrtx-1033012016,neutral,0.7439008951187134
800,1/30/2024 8:40:35 PM,Vertex Pharma hits 52-week high on addiction-free pain med,Seeking Alpha,https://seekingalpha.com/news/4060266-vertex-pharma-stock-gains-non-opioid-pain-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9148846864700317
801,1/30/2024 9:55:05 PM,Vertex's Experimental Pain Drug Meets Phase 3 Primary Goal ,RTTNews,/news/stocks/vertex-s-experimental-pain-drug-meets-phase-3-primary-goal-1033011642,negative,0.8602230548858643
802,1/30/2024 10:45:43 PM,Buy Rating for Vertex Pharmaceuticals Backed by Promising Phase III Results of VX-548,TipRanks,/news/stocks/buy-rating-for-vertex-pharmaceuticals-backed-by-promising-phase-iii-results-of-vx-548-1033012085,negative,0.9198741912841797
803,1/31/2024 10:09:45 AM,Analyst Issues Sell Rating on Vertex Pharmaceuticals Citing Overhyped Prospects for Pain Treatment VX-548,TipRanks,/news/stocks/analyst-issues-sell-rating-on-vertex-pharmaceuticals-citing-overhyped-prospects-for-pain-treatment-vx-548-1033014838,neutral,0.9188815951347351
804,1/31/2024 10:50:44 AM,"Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Vertex Pharmaceuticals (VRTX) and Neurocrine (NBIX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-stryker-syk-vertex-pharmaceuticals-vrtx-and-neurocrine-nbix-1033015049,positive,0.9025890827178955
805,1/31/2024 1:28:05 PM,Vertex Pharma downgraded at Baird on “modest efficacy” in pain med,Seeking Alpha,https://seekingalpha.com/news/4060597-vertex-pharma-stock-downgraded-at-baird?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9050453305244446
806,1/31/2024 5:00:28 PM,Key Takeaways From Vertex Pharmaceuticals Analyst Ratings,Benzinga,/news/stocks/key-takeaways-from-vertex-pharmaceuticals-analyst-ratings-1033016096,positive,0.9151307344436646
807,1/31/2024 9:25:11 PM,Buy Alert: 3 Stocks Sitting in the Sweet Spot,InvestorPlace,/news/stocks/buy-alert-3-stocks-sitting-in-the-sweet-spot-1033017091,positive,0.8871220946311951
808,2/1/2024 5:08:05 AM,Buy Rating Affirmed for Vertex Pharmaceuticals Amid Positive Prospects for Non-Opioid Pain Treatment,TipRanks,/news/stocks/buy-rating-affirmed-for-vertex-pharmaceuticals-amid-positive-prospects-for-non-opioid-pain-treatment-1033019010,negative,0.949979305267334
809,2/2/2024 2:10:07 AM,Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements,InvestorPlace,/news/stocks/top-stock-picks-2024-3-healthcare-stocks-leading-medical-advancements-1033022830,positive,0.6928355693817139
810,2/2/2024 8:41:39 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1033024513,negative,0.5521676540374756
811,2/2/2024 8:00:00 PM,"Catalyst watch: Alibaba earnings, World Defense Show, Fed speakers unleashed and Super Bowl buzz",Seeking Alpha,https://seekingalpha.com/news/4060879-catalyst-watch-alibaba-earnings-world-defense-show-fed-speakers-unleashed-and-super-bowl-buzz?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9349634647369385
812,2/2/2024 10:11:18 PM,CRISPR CMO who resigned after Casgevy approval lands at Takeda,Seeking Alpha,https://seekingalpha.com/news/4062354-crispr-cmo-who-resigned-after-casgevy-approval-lands-at-takeda?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6040295958518982
813,2/3/2024 5:51:07 PM,"Analysts Are Bullish on Top Healthcare Stocks: Cigna (CI), BridgeBio Pharma (BBIO)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-cigna-ci-bridgebio-pharma-bbio-1033026813,negative,0.46720802783966064
814,2/4/2024 1:45:00 PM,"Earnings week ahead: Alibaba, PepsiCo, Disney, Palantir, McDonalds, Ford and more",Seeking Alpha,https://seekingalpha.com/news/4062246-earnings-week-ahead-alibaba-pepsico-disney-palantir-mcdonalds-philip-morris-ford-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8989530205726624
815,2/4/2024 3:01:13 PM,Here's what Wall Street expects from Vertex Pharmaceuticals's earnings,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-q4-earnings-preview-stock-1033027290,positive,0.9302723407745361
816,2/4/2024 10:16:46 PM,Investors growing more bullish on SMID cap biotech stocks,Seeking Alpha,https://seekingalpha.com/news/4062396-investors-growing-more-bullish-on-smid-cap-biotech-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5847739577293396
817,2/4/2024 10:35:00 PM,Vertex Pharmaceuticals Q4 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4062299-vertex-pharmaceuticals-q4-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9087293744087219
818,2/4/2024 10:35:52 PM,Notable earnings after Monday's close,Seeking Alpha,https://seekingalpha.com/news/4062384-notable-earnings-after-mondays-close?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8940557837486267
819,2/5/2024 4:59:41 PM,Vertex Pharmaceuticals Gears Up For Q4 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call,Benzinga,/news/stocks/vertex-pharmaceuticals-gears-up-for-q4-print-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call-1033030983,positive,0.9256638884544373
820,2/5/2024 8:12:09 PM,"Stocks Fall As Traders Dial Back Rate Cut Bets; Dollar, Treasury Yields Rise: What's Driving Markets Monday?",Benzinga,/news/stocks/stocks-fall-as-traders-dial-back-rate-cut-bets-dollar-treasury-yields-rise-what-s-driving-markets-monday-1033031539,neutral,0.8780133724212646
821,2/5/2024 9:09:05 PM,"Vertex Pharmaceuticals Non-GAAP EPS of $4.20 beats by $0.11, revenue of $2.52B beats by $10M",Seeking Alpha,https://seekingalpha.com/news/4062845-vertex-pharmaceuticals-non-gaap-eps-of-4_20-beats-0_11-revenue-of-2_52b-beats-10m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.764359712600708
822,2/5/2024 9:42:11 PM,"Vertex to seek FDA, EMA approval for CF therapy by mid-2024",Seeking Alpha,https://seekingalpha.com/news/4062897-vertex-to-seek-fda-ema-approval-for-vanza-triple-therapy-for-cf?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5434912443161011
823,2/5/2024 10:11:28 PM,"Vertex Pharmaceuticals Inc. Q4 Profit Increases, beats estimates",RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q4-profit-increases-beats-estimates-1033031727,negative,0.9452891945838928
824,2/6/2024 4:20:10 AM,Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-and-vertex-pharmaceuticals-vrtx-1033033385,positive,0.9126845598220825
825,2/6/2024 10:27:18 AM,Buy Rating on Vertex Pharmaceuticals: Superior Clinical Data and Strong Growth Prospects,TipRanks,/news/stocks/buy-rating-on-vertex-pharmaceuticals-superior-clinical-data-and-strong-growth-prospects-1033034932,negative,0.9550708532333374
826,2/6/2024 10:51:03 AM,"Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Vaxcyte (PCVX) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-dexcom-dxcm-vaxcyte-pcvx-and-vertex-pharmaceuticals-vrtx-1033035081,positive,0.8835591673851013
827,2/6/2024 10:56:19 AM,Maintaining Hold on Vertex Pharmaceuticals Amid Steady Growth and Anticipated Drug Transition,TipRanks,/news/stocks/maintaining-hold-on-vertex-pharmaceuticals-amid-steady-growth-and-anticipated-drug-transition-1033035076,negative,0.880517840385437
828,2/6/2024 11:15:00 AM,The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024,InvestorPlace,/news/stocks/the-7-best-healthcare-stocks-to-invest-in-for-big-gains-in-2024-1033035941,negative,0.8954083323478699
829,2/6/2024 12:26:13 PM,Buy Rating on Vertex Pharmaceuticals Backed by Strong Sales and Promising Pipeline,TipRanks,/news/stocks/buy-rating-on-vertex-pharmaceuticals-backed-by-strong-sales-and-promising-pipeline-1033035957,negative,0.9487200975418091
830,2/6/2024 12:45:25 PM,Vertex Pharmaceuticals (VRTX) Gets a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-buy-from-cantor-fitzgerald-1033036048,positive,0.5678946375846863
831,2/6/2024 12:45:49 PM,Stifel Nicolaus Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/stifel-nicolaus-reaffirms-their-hold-rating-on-vertex-pharmaceuticals-vrtx-1033036047,positive,0.8062240481376648
832,2/6/2024 12:50:37 PM,"Analysts’ Top Healthcare Picks: Intuitive Surgical (ISRG), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-top-healthcare-picks-intuitive-surgical-isrg-vertex-pharmaceuticals-vrtx-1033036025,negative,0.8120447397232056
833,2/6/2024 1:54:09 PM,Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday,Benzinga,/news/stocks/uber-to-rally-around-15-here-are-10-top-analyst-forecasts-for-tuesday-1033034665,positive,0.9135574698448181
834,2/6/2024 5:06:51 PM,"Evercore downgrades Vertex; cites price, pain franchise headwinds",Seeking Alpha,https://seekingalpha.com/news/4063264-evercore-downgrades-vertex-cites-price-pain-franchise-headwinds?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9516206979751587
835,2/6/2024 8:55:20 PM,"Vertex's Next-Generation Cystic Fibrosis Program Shows Efficacy With Reduced Burden, Provides Growth Opportunity: Goldman Sachs",Benzinga,/news/stocks/vertex-s-next-generation-cystic-fibrosis-program-shows-efficacy-with-reduced-burden-provides-growth-opportunity-goldman-sachs-1033036640,negative,0.8632043600082397
836,2/7/2024 4:15:58 AM,Vertex Pharmaceuticals (VRTX) Gets a Buy from Wells Fargo,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-buy-from-wells-fargo-1033039020,negative,0.7378012537956238
837,2/7/2024 1:26:01 PM,Buy Rating Affirmed for Vertex Pharmaceuticals on Strong Clinical and Financial Performance,TipRanks,/news/stocks/buy-rating-affirmed-for-vertex-pharmaceuticals-on-strong-clinical-and-financial-performance-1033042013,negative,0.9516081809997559
838,2/7/2024 1:38:01 PM,Recommendation to Sell: Vertex Pharmaceuticals’ Lack of Market Expansion and Competitive Edge,TipRanks,/news/stocks/recommendation-to-sell-vertex-pharmaceuticals-lack-of-market-expansion-and-competitive-edge-1033042111,neutral,0.6750807762145996
839,2/7/2024 3:50:09 PM,Analysts Have Conflicting Sentiments on These Healthcare Companies: Vertex Pharmaceuticals (VRTX) and EyePoint Pharmaceuticals (EYPT),TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-vertex-pharmaceuticals-vrtx-and-eyepoint-pharmaceuticals-eypt-1033042568,neutral,0.9508217573165894
840,2/8/2024 6:00:38 AM,Analysts Offer Insights on Healthcare Companies: Cigna (CI) and Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-cigna-ci-and-vertex-pharmaceuticals-vrtx-1033045169,positive,0.9052340984344482
841,2/9/2024 11:25:00 AM,3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List,InvestorPlace,/news/stocks/3-strong-buy-healthcare-stocks-to-add-to-your-february-must-watch-list-1033050514,positive,0.842585027217865
842,2/11/2024 11:51:00 AM,3 Groundbreaking Healthcare Stocks to Buy for Robust Gains,InvestorPlace,/news/stocks/3-groundbreaking-healthcare-stocks-to-buy-for-robust-gains-1033053334,negative,0.8651124835014343
843,2/11/2024 5:17:08 PM,"After Meta debuts a dividend, Goldman does the math if big names follow suit",Seeking Alpha,https://seekingalpha.com/news/4065357-after-meta-debuts-a-dividend-goldman-does-the-math-if-big-names-follow-suit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.933788537979126
844,2/13/2024 8:26:17 AM,Vertex : EU Okays Casgevy For Sickle Cell Disease & Transfusion-Dependent Beta Thalassemia Treatment ,RTTNews,/news/stocks/vertex-eu-okays-casgevy-for-sickle-cell-disease-transfusion-dependent-beta-thalassemia-treatment-1033059710,positive,0.8890761137008667
845,2/13/2024 11:05:22 AM,"Vertex, CRISPR gene therapy approved in EU for sickle cell disease, beta-thalassemia",Seeking Alpha,https://seekingalpha.com/news/4065917-vertex-crispr-gene-therapy-approved-in-eu-for-sickle-cell-disease-beta-thalassemia?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6692454814910889
846,2/15/2024 6:01:01 PM,Is Crispr Therapeutics’ high short interest justifiable?,Seeking Alpha,https://seekingalpha.com/news/4067786-is-crispr-therapeutics-high-short-interest-justifiable?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.843755841255188
847,2/19/2024 5:24:46 PM,3 Revolutionary Biotech Stocks Poised for 10X Surge,InvestorPlace,/news/stocks/3-revolutionary-biotech-stocks-poised-for-10x-surge-1033080777,negative,0.5510572791099548
848,2/20/2024 9:00:33 PM,What Analysts Are Saying About Vertex Pharmaceuticals Stock,Benzinga,/news/stocks/what-analysts-are-saying-about-vertex-pharmaceuticals-stock-1033084741,positive,0.9365602135658264
849,2/21/2024 8:20:05 AM,"Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-johnson-johnson-jnj-vertex-pharmaceuticals-vrtx-1033087099,negative,0.5155614018440247
850,2/21/2024 12:13:01 PM,"Regeneron, Vertex Pharma join $100B club in biotech",Seeking Alpha,https://seekingalpha.com/news/4069456-regeneron-vertex-pharma-join-100b-club-biotech?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6630005836486816
851,2/21/2024 1:48:22 PM,CRISPR beats in Q4 as Casgevy approval boosts topline,Seeking Alpha,https://seekingalpha.com/news/4069525-crispr-stock-higher-after-q4-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.94022536277771
852,2/22/2024 8:02:51 PM,3 Secret Stocks to Double Your Money by 2028,InvestorPlace,/news/stocks/3-secret-stocks-to-double-your-money-by-2028-1033094711,positive,0.7226866483688354
853,2/22/2024 11:00:53 PM,"3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024",InvestorPlace,/news/stocks/3-biotech-stocks-to-turn-10000-into-1-million-february-2024-1033095198,positive,0.8369854688644409
854,2/23/2024 1:10:18 PM,Vertex gets EU backing for label expansion of Kalydeco in cystic fibrosis,Seeking Alpha,https://seekingalpha.com/news/4071023-vertex-gets-eu-backing-for-label-expansion-of-kalydeco-in-cystic-fibrosis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9170501232147217
855,2/23/2024 2:56:11 PM,Vertex's Kalydeco Gets CHMP Positive Opinion For Label Expansion To Cystic Fibrosis In Infants ,RTTNews,/news/stocks/vertex-s-kalydeco-gets-chmp-positive-opinion-for-label-expansion-to-cystic-fibrosis-in-infants-1033097464,negative,0.9396836757659912
856,2/27/2024 1:50:17 AM,Analysts Offer Insights on Healthcare Companies: Morphic Holding (MORF) and Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-morphic-holding-morf-and-vertex-pharmaceuticals-vrtx-1033104968,positive,0.9025435447692871
857,2/27/2024 5:00:57 PM,3 Biotech Stocks Bound to Blast Off By 2029,InvestorPlace,/news/stocks/3-biotech-stocks-bound-to-blast-off-by-2029-1033108802,positive,0.7029114961624146
858,2/28/2024 1:24:58 PM,Editas spikes as Vertex Pharma deal boosts Q4 topline,Seeking Alpha,https://seekingalpha.com/news/4072975-editas-stock-rises-vertex-deal-drives-q4-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9220036864280701
859,3/1/2024 4:39:59 PM,Apple Sinks After Wall Street Titan Pulls Magnificent 7 Stock From Conviction List,Benzinga,/news/stocks/apple-sinks-after-wall-street-titan-pulls-magnificent-7-stock-from-conviction-list-1033124291,neutral,0.9297418594360352
860,3/1/2024 5:29:42 PM,"Merck, Vertex cut from Goldman Sachs conviction list; Amgen added",Seeking Alpha,https://seekingalpha.com/news/4074740-merck-vertex-cut-goldman-sachs-conviction-list-amgen-added?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7583416104316711
861,3/4/2024 4:02:21 PM,ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential,InvestorPlace,/news/stocks/chatgpt-stock-predictions-3-biotech-companies-the-ai-bot-thinks-have-10x-potential-1033129435,positive,0.9215729832649231
862,3/4/2024 9:09:21 PM,Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits,InvestorPlace,/news/stocks/biotechs-on-the-rise-3-stocks-to-buy-for-a-shot-of-profits-1033130269,positive,0.7510855793952942
863,3/5/2024 11:28:00 AM,Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making,InvestorPlace,/news/stocks/game-changers-3-biotech-stocks-that-could-be-multibaggers-in-the-making-1033132285,positive,0.9068427085876465
864,3/5/2024 7:59:57 PM,"FENG, LUMN among major communication services gainers; MMV, ATUS among losers",Seeking Alpha,https://seekingalpha.com/news/4076217-feng-lumn-among-major-communication-services-gainers-mmv-atus-among-losers?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8607293367385864
865,3/6/2024 12:40:18 PM,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Alnylam Pharma (ALNY) and IO Biotech (IOBT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-alnylam-pharma-alny-and-io-biotech-iobt-1033138447,positive,0.8997399210929871
866,3/6/2024 7:45:00 PM,The Top 3 Biotech Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-top-3-biotech-stocks-to-buy-in-march-2024-1033139285,positive,0.9087775945663452
867,3/10/2024 9:31:38 PM,"Analysts Are Bullish on These Healthcare Stocks: MacroGenics (MGNX), Irhythm Technologies (IRTC)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-macrogenics-mgnx-irhythm-technologies-irtc-1033148747,negative,0.5846025943756104
868,3/13/2024 9:50:50 AM,"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Medtronic (MDT) and Caribou Biosciences (CRBU)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-medtronic-mdt-and-caribou-biosciences-crbu-1033159361,positive,0.8996384739875793
869,3/14/2024 11:20:30 AM,Biotech group backs anti-China bill; part ways with WuXi AppTec,Seeking Alpha,https://seekingalpha.com/news/4079392-biotech-group-backs-anti-china-bill-splits-wuxi-apptec?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5961117744445801
870,3/18/2024 3:02:46 PM,Bluebird secures up to $175M financing amid gene therapy launches,Seeking Alpha,https://seekingalpha.com/news/4080535-bluebird-secures-up-to-175m-financing-amid-gene-therapy-launches?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8673961162567139
871,3/19/2024 6:58:39 PM,From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires,InvestorPlace,/news/stocks/from-six-figures-to-seven-3-biotech-stocks-set-to-make-millionaires-1033177981,positive,0.8300082683563232
872,3/20/2024 5:49:51 PM,3 Biopharma Stocks Predicted to Soar in Q2 2024,InvestorPlace,/news/stocks/3-biopharma-stocks-predicted-to-soar-in-q2-2024-1033181880,negative,0.8191412687301636
873,3/21/2024 12:28:21 PM,Vertex expands kidney disease research as FDA clears clinical trial,Seeking Alpha,https://seekingalpha.com/news/4082015-vertex-pharma-stock-gains-fda-clears-trial?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7310681343078613
874,3/21/2024 1:45:14 PM,Vertex Gets FDA Nod Of IND For VX-407 For Autosomal Dominant Polycystic Kidney Disease ,RTTNews,/news/stocks/vertex-gets-fda-nod-of-ind-for-vx-407-for-autosomal-dominant-polycystic-kidney-disease-1033184530,negative,0.8443477749824524
875,3/22/2024 11:16:48 AM,Analyst Issues Sell Rating for Vertex Pharmaceuticals Amid Intensifying Drug Market Competition,TipRanks,/news/stocks/analyst-issues-sell-rating-for-vertex-pharmaceuticals-amid-intensifying-drug-market-competition-1033188893,neutral,0.5976814031600952
876,3/25/2024 7:00:00 PM,Wall Street’s Favorite Biotech Stocks? 3 Names That Could Make You Filthy Rich,InvestorPlace,/news/stocks/wall-streets-favorite-biotech-stocks-3-names-that-could-make-you-filthy-rich-1033194514,positive,0.9046082496643066
877,3/26/2024 10:44:00 AM,3 Biotech Stocks to Buy for the Next Bull Run: March 2024,InvestorPlace,/news/stocks/3-biotech-stocks-to-buy-for-the-next-bull-run-march-2024-1033196128,positive,0.9301541447639465
878,3/26/2024 3:43:00 PM,Biotech Roundtable: Is CRISPR all it's cracked up to be?,Seeking Alpha,https://seekingalpha.com/news/4083198-biotech-roundtable-is-crispr-all-its-cracked-up-to-be?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9258078336715698
879,4/1/2024 2:54:55 PM,Vertex Advances Inaxaplin Into Phase 2/3 Trial To Treat APOL1-Mediated Kidney Disease ,RTTNews,/news/stocks/vertex-advances-inaxaplin-into-phase-2-3-trial-to-treat-apol1-mediated-kidney-disease-1033210946,negative,0.7879554033279419
880,4/1/2024 3:32:33 PM,Vertex's NDS for its sickle cell disease and thalassemia treatment accepted for priority review by Health Canada,Seeking Alpha,https://seekingalpha.com/news/4085712-vertexs-nds-for-its-sickle-cell-disease-and-thalassemia-treatment-accepted-for-priority-review-by-health-canada?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.577877402305603
881,4/1/2024 5:49:22 PM,Vertex's NDS For Exagamglogene Autotemcel Gets Health Canada's Priority Review Acceptance ,RTTNews,/news/stocks/vertex-s-nds-for-exagamglogene-autotemcel-gets-health-canada-s-priority-review-acceptance-1033211814,positive,0.7619593143463135
882,4/2/2024 9:31:24 AM,"Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), Vertex Pharmaceuticals (VRTX) and Veeva Systems (VEEV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-cvs-health-cvs-vertex-pharmaceuticals-vrtx-and-veeva-systems-veev-1033214780,positive,0.905754804611206
883,4/2/2024 11:20:07 AM,"Analysts Offer Insights on Healthcare Companies: Smith & Nephew Snats (SNN), Ocuphire Pharma (OCUP) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-smith-nephew-snats-snn-ocuphire-pharma-ocup-and-vertex-pharmaceuticals-vrtx-1033215667,positive,0.9166666269302368
884,4/2/2024 11:25:29 AM,Truist Financial Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/truist-financial-sticks-to-their-buy-rating-for-vertex-pharmaceuticals-vrtx-1033215663,positive,0.6943008899688721
885,4/2/2024 3:36:00 PM,Biotech Roundtable: Who will bring the next CRISPR drug to market?,Seeking Alpha,https://seekingalpha.com/news/4083199-biotech-roundtable-who-will-bring-the-next-crispr-drug-to-market?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8740511536598206
886,4/9/2024 2:30:13 AM,"Analysts Offer Insights on Healthcare Companies: MannKind (MNKD), Vertex Pharmaceuticals (VRTX) and Korro Bio (KRRO)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-mannkind-mnkd-vertex-pharmaceuticals-vrtx-and-korro-bio-krro-1033231915,positive,0.8981100916862488
887,4/9/2024 11:00:00 AM,3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April,InvestorPlace,/news/stocks/3-high-growth-biotech-stocks-investors-shouldnt-sleep-on-in-april-1033232893,positive,0.8930463790893555
888,4/9/2024 3:10:29 PM,"Jim Cramer Was Upset At This Hostile Takeover, But 'They Fixed The Situation. Stock's Been A Horse'",Benzinga,/news/stocks/jim-cramer-was-upset-at-this-hostile-takeover-but-they-fixed-the-situation-stock-s-been-a-horse-1033233438,neutral,0.751442551612854
889,4/10/2024 8:10:49 PM,Vertex enters into agreement to acquire Alpine Immune Sciences,Seeking Alpha,https://seekingalpha.com/news/4088720-vertex-enters-into-agreement-to-acquire-alpine-immune-sciences?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6373068690299988
890,4/10/2024 10:46:10 PM,Vertex Pharmaceuticals To Buy Alpine Immune Sciences For $4.9 Bln ,RTTNews,/news/stocks/vertex-pharmaceuticals-to-buy-alpine-immune-sciences-for-4-9-bln-1033238877,positive,0.930499792098999
891,4/11/2024 1:10:29 AM,"Analysts’ Top Healthcare Picks: Humacyte (HUMA), Janux Therapeutics Inc (JANX)",TipRanks,/news/stocks/analysts-top-healthcare-picks-humacyte-huma-janux-therapeutics-inc-janx-1033239159,negative,0.553147554397583
892,4/11/2024 9:15:56 AM,Buy Rating Affirmed for Vertex Pharmaceuticals Post Alpine Therapeutics Acquisition,TipRanks,/news/stocks/buy-rating-affirmed-for-vertex-pharmaceuticals-post-alpine-therapeutics-acquisition-1033240796,positive,0.5020077228546143
893,4/11/2024 9:23:08 AM,Analysts Have Conflicting Sentiments on These Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Amylyx Pharmaceuticals Inc (AMLX),TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-vertex-pharmaceuticals-vrtx-and-amylyx-pharmaceuticals-inc-amlx-1033240789,neutral,0.9475722312927246
894,4/11/2024 9:57:57 AM,Strategic Acquisition and Pipeline Expansion Justify Buy Rating for Vertex Pharmaceuticals,TipRanks,/news/stocks/strategic-acquisition-and-pipeline-expansion-justify-buy-rating-for-vertex-pharmaceuticals-1033241100,negative,0.4965011179447174
895,4/11/2024 10:37:21 AM,Evercore ISI upgrades Vertex Pharmaceuticals (VRTX) to a Buy,TipRanks,/news/stocks/evercore-isi-upgrades-vertex-pharmaceuticals-vrtx-to-a-buy-1033241200,negative,0.8910960555076599
896,4/11/2024 10:56:15 AM,Buy Rating Justified by Vertex Pharmaceuticals’ Strategic Acquisitions and Promising Drug Pipeline,TipRanks,/news/stocks/buy-rating-justified-by-vertex-pharmaceuticals-strategic-acquisitions-and-promising-drug-pipeline-1033241259,negative,0.9415878653526306
897,4/11/2024 11:19:51 AM,Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-april-11th-1033240549,neutral,0.48035502433776855
898,4/11/2024 11:26:11 AM,Stifel Nicolaus Keeps Their Hold Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/stifel-nicolaus-keeps-their-hold-rating-on-vertex-pharmaceuticals-vrtx-1033241667,positive,0.9159100651741028
899,4/11/2024 11:26:32 AM,Vertex Pharmaceuticals (VRTX) Gets a Buy from Piper Sandler,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-buy-from-piper-sandler-1033241663,negative,0.6648930311203003
900,4/11/2024 12:36:33 PM,Vertex Pharma upgraded at Evercore on Alpine Immune deal,Seeking Alpha,https://seekingalpha.com/news/4088888-vertex-pharma-stock-upgraded--evercore-alpine-immune-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5769150853157043
901,4/11/2024 1:47:56 PM,The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today,InvestorPlace,/news/stocks/the-5-billion-reason-alpine-immune-sciences-alpn-stock-is-up-30-today-1033241236,negative,0.9471536874771118
902,4/11/2024 2:42:55 PM,Apple Spyware Warning: What to Know About ‘Mercenary Spyware Attack’ Alerts,InvestorPlace,/news/stocks/apple-spyware-warning-what-to-know-about-mercenary-spyware-attack-alerts-1033241816,positive,0.9143648147583008
903,4/11/2024 3:05:33 PM,Raymond James Just Raised Its Price Target on Nvidia (NVDA) Stock,InvestorPlace,/news/stocks/raymond-james-just-raised-its-price-target-on-nvidia-nvda-stock-1033241812,negative,0.5894102454185486
904,4/11/2024 5:10:22 PM,Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024,InvestorPlace,/news/stocks/wall-street-favorites-3-biotech-stocks-with-strong-buy-ratings-for-april-2024-1033242187,negative,0.8188539743423462
905,4/11/2024 8:13:19 PM,"Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What's Driving Markets Thursday?",Benzinga,/news/etf/stocks-bounce-back-with-tech-gold-gaining-after-modest-producer-inflation-data-what-s-driving-markets-thursday-1033242298,neutral,0.5139171481132507
906,4/11/2024 8:47:33 PM,Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact,Benzinga,/news/stocks/vertex-s-alpine-acquisition-unpacking-analyst-predictions-on-povetacicept-s-potential-impact-1033242338,positive,0.9312934279441833
907,4/12/2024 5:37:00 AM,Analyst Maintains ‘Sell’ Rating on Vertex Pharmaceuticals Amid Skepticism Over Alpine Acquisition and Early-Stage Data,TipRanks,/news/stocks/analyst-maintains-sell-rating-on-vertex-pharmaceuticals-amid-skepticism-over-alpine-acquisition-and-early-stage-data-1033243496,neutral,0.8513449430465698
908,4/12/2024 5:40:13 AM,Buy Rating Affirmed: Vertex Pharmaceuticals’ Strategic Acquisition and Market Positioning Promise Growth,TipRanks,/news/stocks/buy-rating-affirmed-vertex-pharmaceuticals-strategic-acquisition-and-market-positioning-promise-growth-1033243487,negative,0.9485771059989929
909,4/12/2024 5:41:03 AM,"Analysts Offer Insights on Healthcare Companies: Catalent (CTLT), Vertex Pharmaceuticals (VRTX) and Alkermes (ALKS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-catalent-ctlt-vertex-pharmaceuticals-vrtx-and-alkermes-alks-1033243485,positive,0.9036439657211304
910,4/12/2024 2:55:38 PM,Vertex Pharmaceuticals’ Hold Rating: Balancing Cystic Fibrosis Success with Uncertain Growth from New Acquisition,TipRanks,/news/stocks/vertex-pharmaceuticals-hold-rating-balancing-cystic-fibrosis-success-with-uncertain-growth-from-new-acquisition-1033245345,negative,0.6550270915031433
911,4/12/2024 7:01:10 PM,The Analyst Landscape: 16 Takes On Vertex Pharmaceuticals,Benzinga,/news/stocks/the-analyst-landscape-16-takes-on-vertex-pharmaceuticals-1033245262,positive,0.9333009719848633
912,4/15/2024 11:40:06 AM,"Analysts Offer Insights on Healthcare Companies: Pfizer (PFE), Vertex Pharmaceuticals (VRTX) and Amgen (AMGN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pfizer-pfe-vertex-pharmaceuticals-vrtx-and-amgen-amgn-1033249994,positive,0.9092313051223755
913,4/15/2024 8:46:49 PM,TD Cowen says sickle cell therapies may get higher CMS payments,Seeking Alpha,https://seekingalpha.com/news/4089805-td-cowen-says-sickle-cell-therapies-may-get-higher-cms-payments?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.622070848941803
914,4/18/2024 12:49:58 PM,Vertex starts rolling FDA submission for non-opioid pain therapy,Seeking Alpha,https://seekingalpha.com/news/4090968-vertex-rolling-submission-non-opioid-pain-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8378542065620422
915,4/18/2024 2:46:43 PM,Tesla To $123? Here Are 10 Top Analyst Forecasts For Thursday,Benzinga,/news/stocks/tesla-to-123-here-are-10-top-analyst-forecasts-for-thursday-1033262028,positive,0.8890991806983948
916,4/18/2024 4:15:08 PM,Guggenheim Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/guggenheim-sticks-to-their-buy-rating-for-vertex-pharmaceuticals-vrtx-1033263758,positive,0.8402799367904663
917,4/18/2024 10:45:17 PM,Buy Rating on Vertex Pharmaceuticals Fueled by Promising IgAN Therapy and Strategic Acquisition,TipRanks,/news/stocks/buy-rating-on-vertex-pharmaceuticals-fueled-by-promising-igan-therapy-and-strategic-acquisition-1033264152,negative,0.9523299336433411
918,4/19/2024 11:31:54 PM,"CRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intact",TipRanks,/news/stocks/crispr-therapeutics-stock-nasdaq-crsp-pushes-lower-but-fundamentals-are-intact-1033267516,neutral,0.5199550986289978
919,4/20/2024 10:15:00 AM,3 Biotech Stocks Set to Double by 2028,InvestorPlace,/news/stocks/3-biotech-stocks-set-to-double-by-2028-1033267557,negative,0.8461980223655701
920,4/22/2024 5:16:15 AM,Buy Rating on Vertex Pharmaceuticals: Risinger’s Confidence in VX-548’s Billion-Dollar Potential and FDA Progress,TipRanks,/news/stocks/buy-rating-on-vertex-pharmaceuticals-risinger-s-confidence-in-vx-548-s-billion-dollar-potential-and-fda-progress-1033269926,negative,0.8665100932121277
921,4/22/2024 12:30:28 PM,Vertex Pharmaceuticals (VRTX) Gets a Buy from Piper Sandler,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-buy-from-piper-sandler-1033271986,negative,0.6648930311203003
922,4/23/2024 7:00:35 AM,"Vertex Pharma Obtains Exclusive License To TreeFrog's Cell Manufacturing Technology, C-Stem ",RTTNews,/news/stocks/vertex-pharma-obtains-exclusive-license-to-treefrog-s-cell-manufacturing-technology-c-stem-1033274311,negative,0.7621669769287109
923,4/23/2024 1:12:16 PM,Vertex in-licenses cell therapy technology for diabetes candidates,Seeking Alpha,https://seekingalpha.com/news/4092480-vertex-in-licenses-cell-therapy-technology-diabetes-drugs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7838506102561951
924,4/23/2024 2:29:06 PM,Edgewise gets EU orphan drug status for muscular dystrophy drug,Seeking Alpha,https://seekingalpha.com/news/4092546-edgewise-gets-eu-orphan-drug-status-for-muscular-dystrophy-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6116942167282104
925,4/24/2024 11:30:45 AM,"Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), HealthStream (HSTM) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-neurocrine-nbix-healthstream-hstm-and-vertex-pharmaceuticals-vrtx-1033282907,positive,0.8885830640792847
926,4/25/2024 1:38:14 PM,Walgreens expands specialty pharmacy with unit dedicated to cell and gene therapies,Seeking Alpha,https://seekingalpha.com/news/4094138-walgreens-specialty-pharmacy-launches-gene-therapy-unit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.49810996651649475
927,4/28/2024 5:00:22 PM,"J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade",Seeking Alpha,https://seekingalpha.com/news/4095228-johnson-johnson-roche-astrazeneca-poised-have-highest-orphan-drug-sales-by-end-decade?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9317450523376465
928,4/30/2024 1:41:06 AM,"Analysts Offer Insights on Healthcare Companies: Accolade (ACCD), Vertex Pharmaceuticals (VRTX) and Zimmer Biomet Holdings (ZBH)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-accolade-accd-vertex-pharmaceuticals-vrtx-and-zimmer-biomet-holdings-zbh-1033303373,positive,0.9017207622528076
929,5/3/2024 10:15:00 AM,Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar,InvestorPlace,/news/stocks/shhh-3-secret-pharma-stocks-flying-below-wall-streets-radar-1033325813,positive,0.7317017316818237
930,5/3/2024 12:45:00 PM,3 Growth Stocks You’ll Kick Yourself for Not Buying Today,InvestorPlace,/news/stocks/three-growth-stocks-you-will-kick-yourself-for-not-buying-today-1033326475,positive,0.665041446685791
931,5/3/2024 6:18:13 PM,Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar,InvestorPlace,/news/stocks/shhh-3-secret-gene-editing-stocks-flying-below-wall-streets-radar-1033328196,positive,0.87724369764328
932,5/3/2024 7:00:00 PM,"Catalyst Watch: Disney earnings, Apple iPad event and Fed speakers back on the circuit",Seeking Alpha,https://seekingalpha.com/news/4098577-catalyst-watch-disney-earnings-apple-ipad-event-and-fed-speakers-back-on-the-circuit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9189660549163818
933,5/4/2024 4:00:00 PM,3 Biotech Stocks With the Potential to Make You an Overnight Millionaire,InvestorPlace,/news/stocks/3-biotech-stocks-with-the-potential-to-make-you-an-overnight-millionaire-1033328809,positive,0.8275285363197327
934,5/4/2024 8:47:00 PM,16 out of 24 health care companies beat topline numbers this week- Earnings scorecard,Seeking Alpha,https://seekingalpha.com/news/4099757-16-out-of-24-health-care-companies-beat-topline-numbers-this-week-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8876544833183289
935,5/5/2024 12:00:00 PM,"Earnings week ahead: Disney, Palantir, Shopify, Uber, Plug Power and more",Seeking Alpha,https://seekingalpha.com/news/4099576-earnings-week-ahead-disney-palantir-realty-income-shopify-uber-plug-power-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9203616976737976
936,5/5/2024 3:01:13 PM,Here's what to expect from Vertex Pharmaceuticals's earnings,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-q1-quarterly-earnings-preview-1033329562,positive,0.9407998323440552
937,5/5/2024 9:35:41 PM,Notable earnings after Monday's close,Seeking Alpha,https://seekingalpha.com/news/4100038-notable-earnings-after-mondays-close?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8940557837486267
938,5/6/2024 10:20:57 AM,"Analysts Offer Insights on Healthcare Companies: Owens & Minor (OMI), Vertex Pharmaceuticals (VRTX) and Aldeyra Therapeutics (ALDX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-owens-minor-omi-vertex-pharmaceuticals-vrtx-and-aldeyra-therapeutics-aldx-1033333459,positive,0.9101052284240723
939,5/6/2024 2:45:00 PM,Vertex Pharma hosts conference call for investors,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals_conference-1032227460,positive,0.9366990327835083
940,5/6/2024 4:44:19 PM,bluebird reports first commercial cell collection for Lyfgenia,Seeking Alpha,https://seekingalpha.com/news/4100542-bluebird-reports-first-commercial-cell-collection-for-lyfgenia?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7457677125930786
941,5/6/2024 6:30:17 PM,3 Biotech Stocks to Double Your Money in the Next 24 Months,InvestorPlace,/news/stocks/3-biotech-stocks-to-double-your-money-in-the-next-24-months-1033334986,negative,0.7702029347419739
942,5/6/2024 8:04:28 PM,"Vertex Pharmaceuticals Non-GAAP EPS of $4.76 beats by $0.70, revenue of $2.69B beats by $110M",Seeking Alpha,https://seekingalpha.com/news/4100681-vertex-pharmaceuticals-non-gaap-eps-of-4_76-beats-0_70-revenue-of-2_69b-beats-110m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5351995229721069
943,5/6/2024 9:21:48 PM,Vertex provides another EPS beat as net income rises 56% in Q1,Seeking Alpha,https://seekingalpha.com/news/4100817-vertex-provides-another-eps-beat-net-income-rises-56-q1?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9451617002487183
944,5/6/2024 10:12:54 PM,"Vertex Pharmaceuticals Inc. Q1 Profit Increases, beats estimates",RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q1-profit-increases-beats-estimates-1033335156,negative,0.9449380040168762
945,5/7/2024 12:56:10 AM,"VRTX Stock Earnings: Vertex Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024",InvestorPlace,/news/stocks/vrtx-stock-earnings-vertex-pharmaceuticals-for-q1-of-2024-1033335685,negative,0.8039406538009644
946,5/7/2024 8:25:29 AM,Buy Rating Affirmed for Vertex Pharmaceuticals on Strong Q1 Earnings and Expanding Market Presence,TipRanks,/news/stocks/buy-rating-affirmed-for-vertex-pharmaceuticals-on-strong-q1-earnings-and-expanding-market-presence-1033338629,negative,0.9552577137947083
947,5/7/2024 11:43:14 AM,Vertex Pharmaceuticals (VRTX) Receives a Buy from Barclays,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-buy-from-barclays-1033340539,negative,0.6518363952636719
948,5/7/2024 12:03:53 PM,Maintain Position on Vertex Pharmaceuticals: A Hold Rating Despite Strong Quarterly Performance,TipRanks,/news/stocks/maintain-position-on-vertex-pharmaceuticals-a-hold-rating-despite-strong-quarterly-performance-1033340731,negative,0.6792078614234924
949,5/7/2024 12:07:49 PM,Vertex Pharmaceuticals (VRTX) Gets a Hold from RBC Capital,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-hold-from-rbc-capital-1033340700,positive,0.9371644854545593
950,5/7/2024 12:08:25 PM,Piper Sandler Releases a Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/piper-sandler-releases-a-buy-rating-on-vertex-pharmaceuticals-vrtx-1033340693,positive,0.9108091592788696
951,5/7/2024 12:12:38 PM,Truist Financial Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/truist-financial-sticks-to-their-buy-rating-for-vertex-pharmaceuticals-vrtx-1033340644,positive,0.6943008899688721
952,5/7/2024 12:17:19 PM,Oppenheimer Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/oppenheimer-keeps-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1033340824,positive,0.9144737124443054
953,5/8/2024 4:35:18 AM,Sell Rating on Vertex Pharmaceuticals Amid Non-Recurring Gains and Overstated Sales,TipRanks,/news/stocks/sell-rating-on-vertex-pharmaceuticals-amid-non-recurring-gains-and-overstated-sales-1033345474,neutral,0.7120117545127869
954,5/8/2024 9:16:01 AM,Buy Rating for Vertex Pharmaceuticals Amid Strong CF Growth and Strategic Expansion,TipRanks,/news/stocks/buy-rating-for-vertex-pharmaceuticals-amid-strong-cf-growth-and-strategic-expansion-1033346961,negative,0.9522043466567993
955,5/8/2024 11:32:10 AM,Vertex Pharmaceuticals Sell Rating Maintained Amid Unsustainable Performance and Uncertain Pipeline Progress,TipRanks,/news/stocks/vertex-pharmaceuticals-sell-rating-maintained-amid-unsustainable-performance-and-uncertain-pipeline-progress-1033348768,neutral,0.9619438052177429
956,5/8/2024 2:48:13 PM,Balancing Act: Vertex Pharmaceuticals’ Growth Prospects and Valuation Concerns Justify a Hold Rating,TipRanks,/news/stocks/balancing-act-vertex-pharmaceuticals-growth-prospects-and-valuation-concerns-justify-a-hold-rating-1033349731,positive,0.5277759432792664
957,5/9/2024 2:07:28 AM,Stifel Nicolaus Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/stifel-nicolaus-reaffirms-their-hold-rating-on-vertex-pharmaceuticals-vrtx-1033354200,positive,0.8062240481376648
958,5/9/2024 6:10:33 PM,Bluebird bio spikes even as CRISPR leads in gene therapy rollout,Seeking Alpha,https://seekingalpha.com/news/4103984-bluebird-bio-stock-gains-q1-2024-results?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8199979066848755
959,5/9/2024 10:44:45 PM,HHS panel to vote in Nov. on DMD screening for newborns,Seeking Alpha,https://seekingalpha.com/news/4104342-hhs-panel-to-vote-in-nov-on-dmd-screening-for-newborns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8794383406639099
960,5/10/2024 4:44:07 PM,Alpine Immune ticks higher as HSR waiting period for Vertex Pharma deal expires,Seeking Alpha,https://seekingalpha.com/news/4104744-alpine-immune-ticks-higher-as-hsr-waiting-period-for-vertex-pharma-deal-expires?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.4135364294052124
961,5/12/2024 3:22:00 PM,8 out of 12 S&P 500 healthcare companies beat profit consensus this week: Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4104780-8-out-of-12-sp-500-healthcare-companies-beat-profit-consensus-this-week-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7937322854995728
962,5/14/2024 2:24:57 PM,3 Cheap Biotech Stocks to Buy Now: May 2024,InvestorPlace,/news/stocks/3-cheap-biotech-stocks-to-buy-now-may-2024-1033377438,positive,0.9149847030639648
963,5/18/2024 6:52:07 PM,"Novo Nordisk, J&J lead R&D rankings in big pharma: report",Seeking Alpha,https://seekingalpha.com/news/4108110-novo-nordisk-j-j-lead-rd-big-pharma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8400077223777771
964,5/20/2024 1:58:45 PM,PTC Therapeutics rallies 18% on EU authorization update for Translarna,Seeking Alpha,https://seekingalpha.com/news/4108342-ptc-therapeutics-rallies-on-eu-authorization-update-for-translarna?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9447431564331055
965,5/23/2024 11:10:00 AM,The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now,InvestorPlace,/news/stocks/the-2030-millionaires-club-3-biotech-stocks-to-buy-now-1033415459,positive,0.912845253944397
966,5/27/2024 12:30:30 PM,"Analysts Offer Insights on Healthcare Companies: Cooper Co (COO), Vertex Pharmaceuticals (VRTX) and Guardant Health (GH)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-cooper-co-coo-vertex-pharmaceuticals-vrtx-and-guardant-health-gh-1033424677,positive,0.9114394783973694
967,5/28/2024 10:46:26 AM,Wells Fargo Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/wells-fargo-keeps-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1033427230,positive,0.9048589468002319
968,5/30/2024 5:54:38 PM,BioLineRx stock jumps 14% on St. Jude clinical trial for mitoxafortide,Seeking Alpha,https://seekingalpha.com/news/4111673-biolinerx-stock-on-st-jude-clinical-trial-for-mitoxafortide?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9027496576309204
969,5/31/2024 5:01:19 PM,Analyst Expectations For Vertex Pharmaceuticals's Future,Benzinga,/news/stocks/analyst-expectations-for-vertex-pharmaceuticals-s-future-1033441748,negative,0.8458836078643799
970,6/4/2024 12:06:37 PM,RBC Capital Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/rbc-capital-sticks-to-their-hold-rating-for-vertex-pharmaceuticals-vrtx-1033450354,positive,0.7001856565475464
971,6/5/2024 8:05:36 AM,Buy Rating Affirmed for Vertex Pharmaceuticals on Strong CF Market Presence and Promising Pipeline,TipRanks,/news/stocks/buy-rating-affirmed-for-vertex-pharmaceuticals-on-strong-cf-market-presence-and-promising-pipeline-1033452947,negative,0.9545215964317322
972,6/7/2024 2:09:06 PM,"These Biotech Stocks Hit New Highs, Did You Reap The Rewards? ",RTTNews,/news/stocks/these-biotech-stocks-hit-new-highs-did-you-reap-the-rewards-1033460923,positive,0.5632970929145813
973,6/7/2024 8:44:44 PM,Arcturus' Inhaled mRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst,Benzinga,/news/stocks/arcturus-inhaled-mrna-therapeutic-in-cystic-fibrosis-study-highlights-potential-amid-competitive-landscape-analyst-1033462349,negative,0.9155243635177612
974,6/11/2024 10:55:37 AM,Vertex Pharmaceuticals (VRTX) Receives a Hold from RBC Capital,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-hold-from-rbc-capital-1033469172,positive,0.8737095594406128
975,6/11/2024 2:53:08 PM,Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday,Benzinga,/news/stocks/alphabet-to-rally-over-28-here-are-10-top-analyst-forecasts-for-tuesday-1033468838,positive,0.9073386192321777
976,6/11/2024 5:25:29 PM,"Wall Street’s most overbought stocks include NVDA, COST, LLY, and others",Seeking Alpha,https://seekingalpha.com/news/4114919-wall-streets-most-overbought-stocks-include-nvda-cost-lly-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7165610790252686
977,6/14/2024 6:52:15 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Dexcom (DXCM), R1 RCM (RCM) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-dexcom-dxcm-r1-rcm-rcm-and-vertex-pharmaceuticals-vrtx-1033479030,neutral,0.9397599101066589
978,6/14/2024 7:01:54 AM,Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX) and R1 RCM (RCM),TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-vertex-pharmaceuticals-vrtx-and-r1-rcm-rcm-1033479078,neutral,0.8102372288703918
979,6/17/2024 8:00:17 PM,13 Analysts Have This To Say About Vertex Pharmaceuticals,Benzinga,/news/stocks/13-analysts-have-this-to-say-about-vertex-pharmaceuticals-1033484906,positive,0.9308427572250366
980,6/20/2024 7:38:41 PM,Vertex inks a long-term coverage deal for cystic fibrosis drugs in England,Seeking Alpha,https://seekingalpha.com/news/4117696-vertex-wins-nhs-coverage-cystic-fibrosis-drugs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9223702549934387
981,6/21/2024 8:53:53 PM,Vertex releases positive phase 1/2 results on VX-880 for type 1 diabetes,Seeking Alpha,https://seekingalpha.com/news/4118043-vertex-releases-positive-phase-12-results-vx-880-type-1-diabetes?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9327454566955566
982,6/22/2024 1:36:39 PM,Buy Rating on Vertex Pharmaceuticals’ VX-880 Backed by Breakthrough Efficacy in Type 1 Diabetes,TipRanks,/news/stocks/buy-rating-on-vertex-pharmaceuticals-vx-880-backed-by-breakthrough-efficacy-in-type-1-diabetes-1033497577,negative,0.8918390870094299
983,6/22/2024 1:50:11 PM,Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-and-vertex-pharmaceuticals-vrtx-1033497585,positive,0.9126845598220825
984,6/22/2024 2:00:36 PM,"Analysts Are Bullish on Top Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Eli Lilly & Co (LLY)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-vertex-pharmaceuticals-vrtx-eli-lilly-co-lly-1033497592,positive,0.5018159747123718
985,6/22/2024 2:05:16 PM,"Vertex Pharmaceuticals’ VX-880 Shows Promising Durability and Efficacy in T1D Therapy, Merits Buy Rating",TipRanks,/news/stocks/vertex-pharmaceuticals-vx-880-shows-promising-durability-and-efficacy-in-t1d-therapy-merits-buy-rating-1033497591,negative,0.9061175584793091
986,6/24/2024 8:45:25 AM,Buy Rating Affirmed: Vertex Pharmaceuticals’ VX-880 Shows Promising Diabetes Treatment Outcomes,TipRanks,/news/stocks/buy-rating-affirmed-vertex-pharmaceuticals-vx-880-shows-promising-diabetes-treatment-outcomes-1033499603,negative,0.9417328834533691
987,6/24/2024 10:19:06 AM,Vertex Pharmaceuticals’ Promising T1D Therapy and Diversified Pipeline Merit a Buy Rating,TipRanks,/news/stocks/vertex-pharmaceuticals-promising-t1d-therapy-and-diversified-pipeline-merit-a-buy-rating-1033500009,negative,0.9444254636764526
988,6/24/2024 4:06:59 PM,"Tandem Diabetes, DexCom see weakness following ADA conference",Seeking Alpha,https://seekingalpha.com/news/4118441-tandem-diabetes-dexcom-see-weakness-following-ada-conference?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7187515497207642
989,6/25/2024 7:55:15 PM,Maintaining Hold on Vertex Pharmaceuticals Amid Promising Yet Early VX-880 Data and Premium Valuation Concerns,TipRanks,/news/stocks/maintaining-hold-on-vertex-pharmaceuticals-amid-promising-yet-early-vx-880-data-and-premium-valuation-concerns-1033505522,negative,0.7615753412246704
990,6/27/2024 1:16:01 AM,Vertex Pharmaceuticals’ VX-880 Shows Promise in T1D Treatment Amid Regulatory Discussions,TipRanks,/news/stocks/vertex-pharmaceuticals-vx-880-shows-promise-in-t1d-treatment-amid-regulatory-discussions-1033509719,negative,0.9528489708900452
991,6/27/2024 7:56:14 AM,Vertex Pharmaceuticals (VRTX) Receives a Buy from Evercore ISI,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-buy-from-evercore-isi-1033510816,negative,0.5977699160575867
992,6/27/2024 10:40:00 AM,3 Biotech Stocks That Could Make Your Grandchildren Rich,InvestorPlace,/news/stocks/3-biotech-stocks-that-could-make-your-grandchildren-rich-1033510910,positive,0.9181333780288696
993,6/27/2024 2:41:41 PM,This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday,Benzinga,/news/stocks/this-vertex-pharmaceuticals-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-thursday-1033511259,positive,0.9211711287498474
994,6/27/2024 6:21:43 PM,You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.,InvestorPlace,/news/stocks/youve-been-warned-3-biotech-stocks-to-buy-now-or-regret-forever-1033512850,positive,0.8179779648780823
995,6/29/2024 3:35:00 PM,Insulet tops S&P 500 growth chart for Q2 as it gains market share in the diabetes space,Seeking Alpha,https://seekingalpha.com/news/4120025-insulet-tops-sp-500-growth-chart-for-q2-as-it-gains-market-share-in-the-diabetes-space?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9450204372406006
996,7/1/2024 2:02:13 PM,3 Breakout Biotech Stocks on Track to Double by 2032,InvestorPlace,/news/stocks/3-breakout-biotech-stocks-on-track-to-double-by-2032-1033520178,negative,0.9260048866271973
997,7/2/2024 10:24:00 AM,3 Under-the-Radar Biotech Stocks With Blockbuster Potential,InvestorPlace,/news/stocks/3-under-the-radar-biotech-stocks-with-blockbuster-potential-1033522419,positive,0.6027738451957703
998,7/2/2024 12:58:53 PM,Vertex’s cystic fibrosis drug gets FDA priority review,Seeking Alpha,https://seekingalpha.com/news/4121626-vertexs-cystic-fibrosis-drug-gets-fda-priority-review?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6901664137840271
999,7/2/2024 3:39:53 PM,Vertex Pharma: Vanza Triple Granted Priority Review - Quick Facts ,RTTNews,/news/stocks/vertex-pharma-vanza-triple-granted-priority-review-quick-facts-1033523117,positive,0.6552686095237732
1000,7/3/2024 7:11:58 PM,3 Top-Rated Gene Editing Stocks Actually Making Money,InvestorPlace,/news/stocks/3-top-rated-gene-editing-stocks-actually-making-money-1033527834,negative,0.49673932790756226
1001,7/5/2024 6:14:56 PM,The 3 Best Biotech Stocks to Buy in July 2024,InvestorPlace,/news/stocks/the-3-best-biotech-stocks-to-buy-in-july-2024-1033532887,positive,0.8355516791343689
1002,7/8/2024 10:00:00 AM,3 Pharma Stocks Already Ushering in the Next Biotech Boom,InvestorPlace,/news/stocks/3-pharma-stocks-already-ushering-in-the-next-biotech-boom-1033535178,negative,0.6573389172554016
1003,7/9/2024 11:00:00 AM,The 3 Most Undervalued Gene Editing Stocks to Buy in July 2024,InvestorPlace,/news/stocks/3-undervalued-gene-editing-stocks-for-patient-investors-1033538875,positive,0.7962018847465515
1004,7/11/2024 9:00:58 PM,Forecasting The Future: 13 Analyst Projections For Vertex Pharmaceuticals,Benzinga,/news/stocks/forecasting-the-future-13-analyst-projections-for-vertex-pharmaceuticals-1033548408,positive,0.9407670497894287
1005,7/13/2024 6:03:47 PM,"Morgan Stanley sees $180B patent cliff, $380B deal capacity fueling biopharma M&A",Seeking Alpha,https://seekingalpha.com/news/4124109-morgan-stanley-sees-180b-patent-cliff-380b-deal-capacity-fueling-biopharma-ma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8902468085289001
1006,7/15/2024 3:21:13 PM,Vertex Pharma Announces Expanded Approval Of TRIKAFTA By Health Canada - Quick Facts ,RTTNews,/news/stocks/vertex-pharma-announces-expanded-approval-of-trikafta-by-health-canada-quick-facts-1033555374,positive,0.5580022931098938
1007,7/17/2024 5:30:34 PM,3 Gene Editing Stocks That Could Grow Your Wealth,InvestorPlace,/news/stocks/3-gene-editing-stocks-that-could-grow-your-wealth-1033565080,positive,0.8814128637313843
1008,7/19/2024 10:16:06 AM,Strong Buy Rating for Vertex Pharmaceuticals as Casgevy Shows Promise in Sickle Cell Treatment Landscape,TipRanks,/news/stocks/strong-buy-rating-for-vertex-pharmaceuticals-as-casgevy-shows-promise-in-sickle-cell-treatment-landscape-1033572372,negative,0.9543628692626953
1009,7/19/2024 11:00:00 AM,The 3 Best Neuroscience Biotech Stocks to Buy Now,InvestorPlace,/news/stocks/the-3-best-neuroscience-biotech-stocks-to-buy-now-1033571923,positive,0.8533231019973755
1010,7/22/2024 8:45:00 PM,3 Gene Editing Stocks Shaping the Future of Medicine,InvestorPlace,/news/stocks/3-gene-editing-stocks-shaping-the-future-of-medicine-1033579415,positive,0.8735917210578918
1011,7/23/2024 9:01:21 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: IQVIA Holdings (IQV), Vertex Pharmaceuticals (VRTX) and Gilead Sciences (GILD)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-iqvia-holdings-iqv-vertex-pharmaceuticals-vrtx-and-gilead-sciences-gild-1033582182,neutral,0.7335153222084045
1012,7/23/2024 10:40:32 AM,Piper Sandler Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/piper-sandler-reaffirms-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1033582767,positive,0.8110734820365906
1013,7/23/2024 10:47:24 AM,Buy Rating Affirmed for Vertex Pharmaceuticals Amid Strategic Acquisition and Strong CF Franchise Outlook,TipRanks,/news/stocks/buy-rating-affirmed-for-vertex-pharmaceuticals-amid-strategic-acquisition-and-strong-cf-franchise-outlook-1033582842,negative,0.9525081515312195
1014,7/23/2024 6:57:01 PM,7 Biotech Stocks to Keep on Your Clinical Radar,InvestorPlace,/news/stocks/7-biotech-stocks-to-keep-on-your-clinical-radar-1033584230,positive,0.8920463919639587
1015,7/25/2024 2:29:32 PM,Actinium wins FDA nod to conduct clinical trial for radiotherapy,Seeking Alpha,https://seekingalpha.com/news/4128402-actinium-stock-gains-fda-nod-clinical-trial?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8815839290618896
1016,7/27/2024 12:35:29 AM,Needham Remains a Hold on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/needham-remains-a-hold-on-vertex-pharmaceuticals-vrtx-1033601889,positive,0.8774190545082092
1017,7/29/2024 8:00:00 PM,The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024,InvestorPlace,/news/stocks/the-top-3-cathie-wood-stocks-to-buy-now-summer-2024-1033607866,positive,0.9389747381210327
1018,7/30/2024 5:55:52 AM,Buy Rating Affirmed for Vertex Pharmaceuticals Amid Promising Pain Management and Cystic Fibrosis Developments,TipRanks,/news/stocks/buy-rating-affirmed-for-vertex-pharmaceuticals-amid-promising-pain-management-and-cystic-fibrosis-developments-1033610607,negative,0.9464957118034363
1019,7/30/2024 5:28:48 PM,Vertex NDA for suzetrigine for acute pain accepted by FDA,Seeking Alpha,https://seekingalpha.com/news/4130407-vertex-nda-suzetrigine-acute-pain-accepted-fda?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7098693251609802
1020,7/30/2024 11:37:14 PM,PepGen stock tumbles 25% following release of DMD drug data,Seeking Alpha,https://seekingalpha.com/news/4130739-pepgen-stock-tumbles-following-release-of-dmd-drug-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9665219187736511
1021,7/31/2024 3:01:13 PM,Here's what Wall Street expects from Vertex Pharmaceuticals's earnings report,Markets Insider Automation,/news/stocks/vertex_pharmaceuticals-q2-quarterly-earnings-preview-stock-1033618270,positive,0.9002076983451843
1022,7/31/2024 8:30:00 PM,The Top 3 Biotech Stocks to Buy Now Summer 2024,InvestorPlace,/news/stocks/the-top-3-biotech-stocks-to-buy-now-summer-2024-1033620880,positive,0.9336078763008118
1023,7/31/2024 9:20:44 PM,Vertex Pharmaceuticals Q2 2024 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4131243-vertex-pharmaceuticals-q2-2024-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.898004949092865
1024,8/1/2024 3:34:49 PM,REGENXBIO releases new data on DMD drug ahead of earnings,Seeking Alpha,https://seekingalpha.com/news/4132398-regenxbio-releases-new-data-on-dmd-drug-ahead-of-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9292389750480652
1025,8/1/2024 8:02:32 PM,"Vertex Pharmaceuticals Non-GAAP EPS of -$12.83 misses by $1.08, revenue of $2.65B misses by $10M",Seeking Alpha,https://seekingalpha.com/news/4132524-vertex-pharmaceuticals-non-gaap-eps-of-12_83-misses-1_08-revenue-of-2_65b-misses-10m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6801150441169739
1026,8/1/2024 11:59:15 PM,Vertex Pharmaceuticals Inc. Q2 Earnings Summary ,RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q2-earnings-summary-1033629268,positive,0.7024490237236023
1027,8/2/2024 2:35:21 AM,Vertex Pharmaceuticals: A Strong Buy on Robust CF Franchise and Promising Pipeline Growth,TipRanks,/news/stocks/vertex-pharmaceuticals-a-strong-buy-on-robust-cf-franchise-and-promising-pipeline-growth-1033630267,negative,0.9522677063941956
1028,8/2/2024 8:25:26 AM,Buy Rating Affirmed for Vertex Pharmaceuticals Amid Strong Financials and Promising CF Treatments,TipRanks,/news/stocks/buy-rating-affirmed-for-vertex-pharmaceuticals-amid-strong-financials-and-promising-cf-treatments-1033631426,negative,0.9536446928977966
1029,8/2/2024 10:25:33 AM,Vertex Pharmaceuticals’ VX-880: A Strong Buy on Impressive Efficacy and Revenue Growth Potential,TipRanks,/news/stocks/vertex-pharmaceuticals-vx-880-a-strong-buy-on-impressive-efficacy-and-revenue-growth-potential-1033632055,negative,0.9535393714904785
1030,8/2/2024 10:43:33 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: uniQure (QURE), Aurinia Pharmaceuticals (AUPH) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-uniqure-qure-aurinia-pharmaceuticals-auph-and-vertex-pharmaceuticals-vrtx-1033632289,neutral,0.9367904663085938
1031,8/2/2024 10:47:01 AM,Buy Rating for Vertex Pharmaceuticals Based on LSR Treatment Prospects and Market Expansion Opportunities,TipRanks,/news/stocks/buy-rating-for-vertex-pharmaceuticals-based-on-lsr-treatment-prospects-and-market-expansion-opportunities-1033632264,negative,0.5720837712287903
1032,8/2/2024 10:57:13 AM,Vertex Pharmaceuticals: Solid Performance but Uncertain Expansion Justifies Hold Rating,TipRanks,/news/stocks/vertex-pharmaceuticals-solid-performance-but-uncertain-expansion-justifies-hold-rating-1033632213,negative,0.7502848505973816
1033,8/2/2024 11:02:47 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1033632690,negative,0.5521676540374756
1034,8/2/2024 11:03:06 AM,Vertex Pharmaceuticals (VRTX) Receives a Buy from Piper Sandler,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-buy-from-piper-sandler-1033632687,negative,0.6595693826675415
1035,8/2/2024 12:51:05 PM,Evercore ISI Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/evercore-isi-sticks-to-their-buy-rating-for-vertex-pharmaceuticals-vrtx-1033633381,positive,0.7159746289253235
1036,8/2/2024 12:54:08 PM,Morgan Stanley Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/morgan-stanley-sticks-to-their-hold-rating-for-vertex-pharmaceuticals-vrtx-1033633354,positive,0.849822998046875
1037,8/2/2024 3:24:17 PM,Vertex boosts revenue forecast on back of cystic fibrosis franchise growth,Seeking Alpha,https://seekingalpha.com/news/4133388-vertex-boosts-revenue-forecast-back-cystic-fibrosis-franchise-growth?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9504014253616333
1038,8/2/2024 5:54:56 PM,3 Biotech Stocks That Could Have Investors Grinning Soon,InvestorPlace,/news/stocks/3-biotech-stocks-that-could-have-investors-grinning-soon-1033633904,positive,0.8883239030838013
1039,8/4/2024 11:00:05 AM,"Weekly Biotech Buzz: FGEN Cuts Jobs, FDA OKs ADAP's Groundbreaking Cell Therapy, ME Rebuffs CEO Bid ",RTTNews,/news/stocks/weekly-biotech-buzz-fgen-cuts-jobs-fda-oks-adap-s-groundbreaking-cell-therapy-me-rebuffs-ceo-bid-1033634796,positive,0.5439757108688354
1040,8/4/2024 2:19:10 PM,Buy Rating Reaffirmed for Vertex Pharmaceuticals Amid Strong Performance and Promising Pipeline,TipRanks,/news/stocks/buy-rating-reaffirmed-for-vertex-pharmaceuticals-amid-strong-performance-and-promising-pipeline-1033635280,negative,0.9535961747169495
1041,8/4/2024 5:33:39 PM,3 Biotech Stocks on Track for 50% Returns (or More) by 2028,InvestorPlace,/news/stocks/3-biotech-stocks-on-track-for-50-returns-or-more-by-2028-1033635294,negative,0.8791724443435669
1042,8/5/2024 6:16:57 AM,Buy Rating on Vertex Pharmaceuticals: Uncovering the Market Potential of Novel Pain Treatments,TipRanks,/news/stocks/buy-rating-on-vertex-pharmaceuticals-uncovering-the-market-potential-of-novel-pain-treatments-1033637870,positive,0.673617959022522
1043,8/5/2024 6:29:07 AM,Analyst Issues Sell Rating on Vertex Pharmaceuticals Amid Maturing CF Products and Overvalued Pain Franchise,TipRanks,/news/stocks/analyst-issues-sell-rating-on-vertex-pharmaceuticals-amid-maturing-cf-products-and-overvalued-pain-franchise-1033637941,neutral,0.5367138981819153
1044,8/5/2024 7:50:47 AM,"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Adaptimmune Therapeutics (ADAP), Lantheus (LNTH) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-adaptimmune-therapeutics-adap-lantheus-lnth-and-vertex-pharmaceuticals-vrtx-1033638248,neutral,0.8011959195137024
1045,8/5/2024 10:22:39 AM,Buy Rating on Vertex Pharmaceuticals: Strong Q2 Performance and Promising Pipeline Catalysts,TipRanks,/news/stocks/buy-rating-on-vertex-pharmaceuticals-strong-q2-performance-and-promising-pipeline-catalysts-1033639271,negative,0.9523228406906128
1046,8/5/2024 10:22:43 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1033639270,negative,0.5521676540374756
1047,8/5/2024 11:17:20 AM,Vertex Pharmaceuticals (VRTX) Gets a Buy from Truist Financial,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-buy-from-truist-financial-1033639868,positive,0.6158863306045532
1048,8/5/2024 11:47:00 AM,Vertex Pharmaceuticals (VRTX) Gets a Buy from Oppenheimer,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-buy-from-oppenheimer-1033639955,positive,0.5161256790161133
1049,8/5/2024 4:34:56 PM,Vertex downgraded at Barclays due to valuation,Seeking Alpha,https://seekingalpha.com/news/4134180-vertex-downgraded-barclays-due-valuation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6489418745040894
1050,8/8/2024 10:30:00 AM,The 3 Best Biotech Stocks to Buy in August 2024,InvestorPlace,/news/stocks/the-3-best-biotech-stocks-to-buy-in-august-2024-1033659856,positive,0.8261002898216248
1051,8/8/2024 6:03:23 PM,"BofA upgrades Editas to buy, cites reni-cel progress",Seeking Alpha,https://seekingalpha.com/news/4137447-bofa-upgrades-editas-to-buy-cites-reni-cel-progress?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8580940365791321
1052,8/15/2024 10:00:00 AM,3 Biotech Stocks to Buy on the Dip: August 2024,InvestorPlace,/news/stocks/3-biotech-stocks-to-buy-on-the-dip-august-2024-1033694134,positive,0.899672269821167
1053,8/20/2024 7:35:37 PM,Vertex Pharmaceuticals: A Cautious Hold Amidst Mixed Financial Signals and Pipeline Uncertainty,TipRanks,/news/stocks/vertex-pharmaceuticals-a-cautious-hold-amidst-mixed-financial-signals-and-pipeline-uncertainty-1033708779,neutral,0.9237489700317383
1054,8/28/2024 12:18:14 PM,Evercore ISI Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/evercore-isi-reaffirms-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1033729659,positive,0.8241257667541504
1055,9/3/2024 8:48:57 PM,"Dyne stock tumbles 31% amid drug updates, management changes",Seeking Alpha,https://seekingalpha.com/news/4146464-dyne-stock-tumbles-amid-drug-updates-management-changes?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9654690027236938
1056,9/19/2024 10:46:51 AM,Vertex Pharmaceuticals (VRTX) Gets a Hold from RBC Capital,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-hold-from-rbc-capital-1033783546,positive,0.9371644854545593
1057,9/25/2024 10:08:43 PM,Pfizer withdraws sickle cell drug Oxbryta over safety concerns,Seeking Alpha,https://seekingalpha.com/news/4153485-pfizer-withdraws-sickle-cell-drug-oxbryta-over-safety-concerns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9518337845802307
1058,9/26/2024 4:41:35 AM,"Health Canada Oks Vertex's CASGEVY, First CRISPR/Cas9 Gene-Edited Therapy For Sickle Cell Disease ",RTTNews,/news/stocks/health-canada-oks-vertex-s-casgevy-first-crispr-cas9-gene-edited-therapy-for-sickle-cell-disease-1033798594,positive,0.525793731212616
1059,9/26/2024 3:21:59 PM,Vertex Says Health Canada Accepts NDS For Triple Combination To Treat Cystic Fibrosis ,RTTNews,/news/stocks/vertex-says-health-canada-accepts-nds-for-triple-combination-to-treat-cystic-fibrosis-1033800748,negative,0.7566721439361572
1060,9/30/2024 1:06:13 PM,Evercore ISI Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/evercore-isi-sticks-to-their-buy-rating-for-vertex-pharmaceuticals-vrtx-1033808630,positive,0.7159746289253235
1061,10/1/2024 9:47:57 AM,Maintaining Hold Rating on Vertex Pharmaceuticals Amidst LSR Trial Uncertainties,TipRanks,/news/stocks/maintaining-hold-rating-on-vertex-pharmaceuticals-amidst-lsr-trial-uncertainties-1033811132,neutral,0.5058957934379578
1062,10/3/2024 9:57:26 AM,Vertex Pharmaceuticals Hold Rating: Cautious Optimism and Risk-Reward Analysis Amidst LSR Trial Anticipation,TipRanks,/news/stocks/vertex-pharmaceuticals-hold-rating-cautious-optimism-and-risk-reward-analysis-amidst-lsr-trial-anticipation-1033818178,negative,0.5288307070732117
1063,10/3/2024 5:13:50 PM,Avidity gets FDA partial clinical hold lifted on DM1 drug candidate,Seeking Alpha,https://seekingalpha.com/news/4156185-avidity-gets-fda-partial-clinical-hold-lifted-on-dm1-drug-candidate?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8628494143486023
1064,10/4/2024 9:31:10 AM,Vertex Pharmaceuticals: Balancing Robust CF Market Presence with Regulatory Risks and Pipeline Uncertainties,TipRanks,/news/stocks/vertex-pharmaceuticals-balancing-robust-cf-market-presence-with-regulatory-risks-and-pipeline-uncertainties-1033821128,negative,0.9230695962905884
1065,10/4/2024 9:32:03 AM,"Analysts Conflicted on These Healthcare Names: TransMedics Group (TMDX), Vertex Pharmaceuticals (VRTX) and Edwards Lifesciences (EW)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-transmedics-group-tmdx-vertex-pharmaceuticals-vrtx-and-edwards-lifesciences-ew-1033821124,neutral,0.6997402906417847
1066,10/4/2024 5:33:57 PM,Capricor stock rallies 20% on DMD data presentation update,Seeking Alpha,https://seekingalpha.com/news/4156526-capricor-stock-rallies-on-dmd-data-presentation-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.913978099822998
1067,10/8/2024 7:35:34 AM,Buy Rating Affirmed for Vertex Pharmaceuticals on Promising Pain Management Drug Prospects,TipRanks,/news/stocks/buy-rating-affirmed-for-vertex-pharmaceuticals-on-promising-pain-management-drug-prospects-1033827430,negative,0.9229528903961182
1068,10/8/2024 8:10:30 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Vertex Pharmaceuticals (VRTX), AnaptysBio (ANAB) and Edgewise Therapeutics (EWTX)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-vertex-pharmaceuticals-vrtx-anaptysbio-anab-and-edgewise-therapeutics-ewtx-1033827516,neutral,0.9393119215965271
1069,10/8/2024 12:05:15 PM,Cantor Fitzgerald Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/cantor-fitzgerald-keeps-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1033828797,positive,0.9179483652114868
1070,10/9/2024 10:40:21 AM,"Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Brookdale Senior Living (BKD) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-teladoc-tdoc-brookdale-senior-living-bkd-and-vertex-pharmaceuticals-vrtx-1033831821,positive,0.9046057462692261
1071,10/10/2024 8:56:59 PM,7 children given bluebird's Skysona developed blood cancer: study,Seeking Alpha,https://seekingalpha.com/news/4157751-7-children-given-bluebirds-skysona-developed-blood-cancer-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8228806853294373
1072,10/11/2024 12:37:36 PM,Vertex Pharmaceuticals (VRTX) Receives a Hold from Morgan Stanley,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-hold-from-morgan-stanley-1033839260,positive,0.8456210494041443
1073,10/11/2024 4:41:56 PM,Capricor reports positive long-term data for DMD drug deramiocel,Seeking Alpha,https://seekingalpha.com/news/4157959-capricor-reports-positive-long-term-data-for-dmd-drug-deramiocel?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9516777396202087
1074,10/17/2024 6:09:36 PM,Vertex coverage resumed by UBS at buy on growth potential,Seeking Alpha,https://seekingalpha.com/news/4171747-vertex-coverage-resumed-by-ubs-at-buy-on-growth-potential?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.4868282675743103
1075,10/21/2024 9:17:06 AM,Barclays Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/barclays-reaffirms-their-hold-rating-on-vertex-pharmaceuticals-vrtx-1033864151,positive,0.8009685277938843
1076,10/21/2024 10:18:19 AM,Vertex Pharmaceuticals: Strategic Growth and Promising Drug Development Drive Buy Rating,TipRanks,/news/stocks/vertex-pharmaceuticals-strategic-growth-and-promising-drug-development-drive-buy-rating-1033864600,negative,0.8666284680366516
1077,10/21/2024 10:25:22 AM,Cautious Hold on Vertex Pharmaceuticals Amidst Limited New Insights and Awaited Data,TipRanks,/news/stocks/cautious-hold-on-vertex-pharmaceuticals-amidst-limited-new-insights-and-awaited-data-1033864571,neutral,0.9461895227432251
1078,10/21/2024 10:31:40 AM,"Analysts Are Neutral on These Healthcare Stocks: CVS Health (CVS), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-are-neutral-on-these-healthcare-stocks-cvs-health-cvs-vertex-pharmaceuticals-vrtx-1033864750,positive,0.627683162689209
1079,10/21/2024 10:50:10 AM,"Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), Korro Bio (KRRO) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-exelixis-exel-korro-bio-krro-and-vertex-pharmaceuticals-vrtx-1033864831,positive,0.877122163772583
1080,10/21/2024 10:55:45 AM,Vertex Pharmaceuticals’ Suzetrigine: A Promising Non-Opioid Solution to Acute Pain Management,TipRanks,/news/stocks/vertex-pharmaceuticals-suzetrigine-a-promising-non-opioid-solution-to-acute-pain-management-1033864803,negative,0.9013933539390564
1081,10/21/2024 11:38:55 AM,Vertex Pharmaceuticals’ Promising Developments and Strategic Market Positioning Reinforce Buy Rating,TipRanks,/news/stocks/vertex-pharmaceuticals-promising-developments-and-strategic-market-positioning-reinforce-buy-rating-1033865117,negative,0.9385514855384827
1082,10/21/2024 11:46:02 AM,TD Cowen Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/td-cowen-sticks-to-their-buy-rating-for-vertex-pharmaceuticals-vrtx-1033865212,positive,0.8322702050209045
1083,10/21/2024 11:55:57 AM,Stifel Nicolaus Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/stifel-nicolaus-reaffirms-their-hold-rating-on-vertex-pharmaceuticals-vrtx-1033865184,positive,0.8062240481376648
1084,10/21/2024 11:56:28 AM,Evercore ISI Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/evercore-isi-sticks-to-their-buy-rating-for-vertex-pharmaceuticals-vrtx-1033865177,positive,0.7159746289253235
1085,10/21/2024 12:27:34 PM,Optimistic Buy Rating for Vertex Pharmaceuticals Amid Promising VX-548 Developments,TipRanks,/news/stocks/optimistic-buy-rating-for-vertex-pharmaceuticals-amid-promising-vx-548-developments-1033865589,negative,0.9511232972145081
1086,10/22/2024 9:37:04 AM,Vertex Pharmaceuticals’ Promising Market Position and Opioid-Sparing Solution Drive Buy Rating,TipRanks,/news/stocks/vertex-pharmaceuticals-promising-market-position-and-opioid-sparing-solution-drive-buy-rating-1033870526,negative,0.9360434412956238
1087,10/23/2024 11:39:45 AM,Piper Sandler Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/piper-sandler-reaffirms-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1033879427,positive,0.8110734820365906
1088,10/24/2024 12:27:18 PM,Vertex Pharmaceuticals (VRTX) Gets a Buy from Evercore ISI,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-buy-from-evercore-isi-1033887722,negative,0.7322961688041687
1089,10/26/2024 3:56:13 PM,Vertex Pharmaceuticals: Hold Rating Amid Promising Developments and Pending Long-Term Validation,TipRanks,/news/stocks/vertex-pharmaceuticals-hold-rating-amid-promising-developments-and-pending-long-term-validation-1033896019,neutral,0.9451306462287903
1090,10/28/2024 11:17:18 AM,Vertex Pharmaceuticals (VRTX) Gets a Buy from Truist Financial,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-buy-from-truist-financial-1033902073,positive,0.6158863306045532
1091,10/28/2024 11:37:19 AM,Vertex Pharmaceuticals (VRTX) Receives a Hold from Scotiabank,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-hold-from-scotiabank-1033902149,positive,0.8503953218460083
1092,10/29/2024 10:45:55 AM,Cautious Sell Recommendation on Vertex Pharmaceuticals Amid IgAN Therapy Uncertainties,TipRanks,/news/stocks/cautious-sell-recommendation-on-vertex-pharmaceuticals-amid-igan-therapy-uncertainties-1033909421,neutral,0.9262742400169373
1093,10/29/2024 10:18:51 PM,Vertex Pharmaceuticals’ Strategic Approach to LSR Pain Trial Justifies Buy Rating,TipRanks,/news/stocks/vertex-pharmaceuticals-strategic-approach-to-lsr-pain-trial-justifies-buy-rating-1033912578,positive,0.6002911925315857
1094,10/30/2024 11:51:19 AM,Oppenheimer Remains a Buy on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/oppenheimer-remains-a-buy-on-vertex-pharmaceuticals-vrtx-1033918529,positive,0.9471307396888733
1095,11/3/2024 10:35:00 PM,Vertex Pharmaceuticals Q3 2024 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/4234526-vertex-pharmaceuticals-q3-2024-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8937596082687378
1096,11/4/2024 5:47:51 AM,"Earnings week ahead: O, PLTR, QCOM, SQ, AMC, PARA, LCID, RIVN, WBD, and more",Seeking Alpha,https://seekingalpha.com/news/4234003-earnings-week-ahead-o-pltr-qcom-sq-amc-para-lcid-rivn-wbd-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9318290948867798
1097,11/4/2024 6:40:28 PM,Notable companies reporting after market close,TipRanks,/news/stocks/notable-companies-reporting-after-market-close-1033946951,positive,0.8840794563293457
1098,11/4/2024 7:16:34 PM,Editas downgraded to market perform by Raymond James,Seeking Alpha,https://seekingalpha.com/news/4244508-editas-downgraded-to-market-perform-by-raymond-james?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6861405968666077
1099,11/4/2024 9:03:41 PM,"Vertex Pharmaceuticals Non-GAAP EPS of $4.38 beats by $0.25, revenue of $2.77B beats by $80M",Seeking Alpha,https://seekingalpha.com/news/4245205-vertex-pharmaceuticals-non-gaap-eps-of-4_38-beats-0_25-revenue-of-2_77b-beats-80m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6670129299163818
1100,11/4/2024 9:05:52 PM,"Vertex Pharmaceuticals reports Q3 adjusted EPS $4.38, consensus $4.14",TipRanks,/news/stocks/vertex-pharmaceuticals-reports-q3-adjusted-eps-4-38-consensus-4-14-1033947336,positive,0.6834831237792969
1101,11/4/2024 9:14:18 PM,"Vertex raises FY24 product revenue view to $10.8B-$10.9B, consensus $10.75B",TipRanks,/news/stocks/vertex-raises-fy24-product-revenue-view-to-10-8b--10-9b-consensus-10-75b-1033947422,negative,0.9052911400794983
1102,11/4/2024 9:48:04 PM,Vertex raises 2024 product revenue outlook following Q3 beats,Seeking Alpha,https://seekingalpha.com/news/4245265-vertex-raises-2024-product-revenue-outlook-following-q-3-beats?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7214460372924805
1103,11/4/2024 10:35:14 PM,"Earnings Snapshot: Vertex Pharmaceuticals top Q3 estimates, raises FY revenue guidance",Seeking Alpha,https://seekingalpha.com/news/4244504-earnings-snapshot-vertex-pharmaceuticals?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9143358469009399
1104,11/4/2024 10:41:37 PM,"Vertex Pharmaceuticals Inc. Q3 Profit Increases, Beats Estimates ",RTTNews,/news/stocks/vertex-pharmaceuticals-inc-q3-profit-increases-beats-estimates-1033946962,negative,0.9452749490737915
1105,11/4/2024 11:15:25 PM,Closing Bell Movers: Palantir jumps 13% after results,TipRanks,/news/stocks/closing-bell-movers-palantir-jumps-13-after-results-1033947813,negative,0.9209824800491333
1106,11/5/2024 3:35:14 AM,Vertex Pharmaceuticals: Strong Financial Performance and Promising Future Prospects Justify Buy Rating,TipRanks,/news/stocks/vertex-pharmaceuticals-strong-financial-performance-and-promising-future-prospects-justify-buy-rating-1033949490,negative,0.892438530921936
1107,11/5/2024 3:59:00 AM,Vertex Pharmaceuticals Reports Strong Q3 2024 Growth,TipRanks,/news/stocks/vertex-pharmaceuticals-reports-strong-q3-2024-growth-1033949672,negative,0.9518449902534485
1108,11/5/2024 9:27:27 AM,Barclays Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/barclays-sticks-to-their-hold-rating-for-vertex-pharmaceuticals-vrtx-1033951360,positive,0.868051290512085
1109,11/5/2024 11:03:27 AM,Analysts Offer Insights on Healthcare Companies: Glaukos (GKOS) and Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-glaukos-gkos-and-vertex-pharmaceuticals-vrtx-1033951955,positive,0.890390157699585
1110,11/5/2024 11:09:01 AM,Vertex Pharmaceuticals: Promising Q3 Performance Amid Clinical and Regulatory Uncertainties,TipRanks,/news/stocks/vertex-pharmaceuticals-promising-q3-performance-amid-clinical-and-regulatory-uncertainties-1033951923,negative,0.9501442909240723
1111,11/5/2024 11:28:10 AM,Cautious Hold Rating on Vertex Pharmaceuticals Amid Strong Performance and Limited Upside,TipRanks,/news/stocks/cautious-hold-rating-on-vertex-pharmaceuticals-amid-strong-performance-and-limited-upside-1033952225,neutral,0.4925256371498108
1112,11/5/2024 11:28:20 AM,Vertex Pharmaceuticals’ Suzetrigine: Promising Pain-Reduction with Minimal Side Effects Justifies Buy Rating,TipRanks,/news/stocks/vertex-pharmaceuticals-suzetrigine-promising-pain-reduction-with-minimal-side-effects-justifies-buy-rating-1033952224,negative,0.8234602808952332
1113,11/5/2024 12:06:57 PM,Vertex Pharmaceuticals price target raised to $476 from $473 at Morgan Stanley,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-raised-to-476-from-473-at-morgan-stanley-1033952788,negative,0.9446931481361389
1114,11/5/2024 12:09:14 PM,Vertex Pharmaceuticals (VRTX) Receives a Buy from Truist Financial,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-buy-from-truist-financial-1033952758,positive,0.5419458150863647
1115,11/5/2024 12:23:59 PM,RBC Capital Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/rbc-capital-reaffirms-their-hold-rating-on-vertex-pharmaceuticals-vrtx-1033952869,positive,0.7816005945205688
1116,11/5/2024 12:45:21 PM,Cantor Fitzgerald Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-their-buy-rating-for-vertex-pharmaceuticals-vrtx-1033953166,positive,0.8566361665725708
1117,11/5/2024 12:46:08 PM,Vertex Pharmaceuticals price target raised to $560 from $502 at Bernstein,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-raised-to-560-from-502-at-bernstein-1033953155,negative,0.9440960884094238
1118,11/5/2024 1:09:54 PM,Vertex Pharmaceuticals (VRTX) Gets a Buy from Evercore ISI,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-buy-from-evercore-isi-1033953268,negative,0.7322961688041687
1119,11/5/2024 1:10:49 PM,Stifel Nicolaus Keeps Their Hold Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/stifel-nicolaus-keeps-their-hold-rating-on-vertex-pharmaceuticals-vrtx-1033953248,positive,0.9159100651741028
1120,11/5/2024 1:57:30 PM,Scotiabank Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/scotiabank-reaffirms-their-hold-rating-on-vertex-pharmaceuticals-vrtx-1033953840,positive,0.8099977374076843
1121,11/5/2024 2:35:10 PM,Vertex Pharmaceuticals price target raised to $486 from $480 at Scotiabank,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-raised-to-486-from-480-at-scotiabank-1033954010,negative,0.9470259547233582
1122,11/5/2024 2:40:34 PM,Vertex Pharmaceuticals price target raised to $451 from $437 at RBC Capital,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-raised-to-451-from-437-at-rbc-capital-1033953986,negative,0.9449598789215088
1123,11/6/2024 12:24:36 PM,J.P. Morgan Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/j-p-morgan-sticks-to-its-buy-rating-for-vertex-pharmaceuticals-vrtx-1033962165,positive,0.6284043192863464
1124,11/6/2024 12:40:36 PM,Vertex Pharmaceuticals price target raised to $408 from $361 at Canaccord,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-raised-to-408-from-361-at-canaccord-1033962312,negative,0.9468576908111572
1125,11/7/2024 6:01:56 AM,Vertex Pharmaceuticals Faces Integration Challenges in Alpine Acquisition,TipRanks,/news/stocks/vertex-pharmaceuticals-faces-integration-challenges-in-alpine-acquisition-1033968266,neutral,0.8153140544891357
1126,11/13/2024 9:16:09 PM,Vertex Pharmaceuticals initiated with a Buy at Citi,TipRanks,/news/stocks/vertex-pharmaceuticals-initiated-with-a-buy-at-citi-1034011804,positive,0.7288206219673157
1127,11/14/2024 2:45:32 PM,"American upgraded, Regeneron initiated: Wall Street’s top analyst calls",TipRanks,/news/stocks/american-upgraded-regeneron-initiated-wall-street-s-top-analyst-calls-1034019984,positive,0.8680362105369568
1128,11/14/2024 7:26:46 PM,"Gilead, Vertex initiated as new big biotech buys at Citi",Seeking Alpha,https://seekingalpha.com/news/4291773-gilead-vertex-initiated-new-big-biotech-buys-citi?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.738814651966095
1129,11/15/2024 7:30:36 PM,"Large pharmas, biotechs down as industries grapple with RFK Jr. at HHS",Seeking Alpha,https://seekingalpha.com/news/4296140-large-pharmas-biotechs-down-industries-grapple-with-rfk-jr-hhs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9230126738548279
1130,11/20/2024 1:26:43 PM,Vertex Pharmaceuticals (VRTX) Receives a Hold from Stifel Nicolaus,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-hold-from-stifel-nicolaus-1034043492,positive,0.8448398113250732
1131,11/21/2024 11:36:20 AM,Vertex Pharmaceuticals: Promising Growth with Suzetrigine Potential and Strategic Diversification,TipRanks,/news/stocks/vertex-pharmaceuticals-promising-growth-with-suzetrigine-potential-and-strategic-diversification-1034048939,negative,0.9209057688713074
1132,11/21/2024 1:05:57 PM,Vertex Pharmaceuticals (VRTX) Receives a Hold from Scotiabank,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-hold-from-scotiabank-1034050092,positive,0.8503953218460083
1133,11/25/2024 8:10:16 PM,Vertex leads J.P. Morgan's top biotech picks list for 2025,Seeking Alpha,https://seekingalpha.com/news/4331812-vertex-leads-jp-morgans-top-biotech-picks-list-for-2025?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8817193508148193
1134,11/26/2024 6:03:03 PM,"Dyne, Avidity initiated at outperform by RBC on DM1 drugs",Seeking Alpha,https://seekingalpha.com/news/4336451-dyne-avidity-initiated-at-outperform-by-rbc-on-dm1-drugs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.796779215335846
1135,11/28/2024 1:47:35 AM,RBC Capital Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/rbc-capital-sticks-to-their-hold-rating-for-vertex-pharmaceuticals-vrtx-1034073998,positive,0.7001856565475464
1136,12/2/2024 9:45:06 AM,Bernstein Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/bernstein-reaffirms-their-hold-rating-on-vertex-pharmaceuticals-vrtx-1034085547,positive,0.8594037890434265
1137,12/4/2024 5:40:44 PM,"CMS rolls out new payment model for Vertex, bluebird gene therapies",Seeking Alpha,https://seekingalpha.com/news/4362665-cms-rolls-out-new-payment-model-for-vertex-bluebird-gene-therapies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5130112171173096
1138,12/5/2024 2:45:25 PM,"CMS to work with Vertex, blubird to improve access to therapies, Reuters reports",TipRanks,/news/stocks/cms-to-work-with-vertex-blubird-to-improve-access-to-therapies-reuters-reports-1034103438,negative,0.790289580821991
1139,12/5/2024 3:19:25 PM,Evercore ISI Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/evercore-isi-reaffirms-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1034103594,positive,0.8241257667541504
1140,12/8/2024 9:50:20 PM,Vertex Pharmaceuticals presents long-term data on CASGEVY at ASH,TipRanks,/news/stocks/vertex-pharmaceuticals-presents-long-term-data-on-casgevy-at-ash-1034111204,positive,0.9036392569541931
1141,12/9/2024 10:25:13 AM,Vertex Pharmaceuticals upgraded to Buy from Hold at Jefferies,TipRanks,/news/stocks/vertex-pharmaceuticals-upgraded-to-buy-from-hold-at-jefferies-1034113488,negative,0.6112523078918457
1142,12/9/2024 10:35:47 AM,Vertex Pharmaceuticals: Promising Growth and Robust Pipeline Highlighted in Buy Rating,TipRanks,/news/stocks/vertex-pharmaceuticals-promising-growth-and-robust-pipeline-highlighted-in-buy-rating-1034113587,negative,0.9258835911750793
1143,12/9/2024 5:17:36 PM,Vertex reports positive long-term data for Casgevy,Seeking Alpha,https://seekingalpha.com/news/4378866-vertex-reports-positive-long-term-data-for-casgevy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.955946147441864
1144,12/9/2024 8:47:47 PM,"Vertex upgraded to buy by Jefferies on fundamentals, pipeline",Seeking Alpha,https://seekingalpha.com/news/4379754-vertex-upgraded-to-buy-by-jefferies-on-fundamentals-pipeline?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7425395846366882
1145,12/12/2024 10:45:36 AM,TD Cowen Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/td-cowen-keeps-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1034129701,positive,0.907618522644043
1146,12/16/2024 12:20:11 PM,Vertex Pharmaceuticals price target raised to $494 from $490 at Stifel,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-raised-to-494-from-490-at-stifel-1034141311,negative,0.9475244283676147
1147,12/16/2024 5:41:40 PM,PepGen stock down 22% on FDA clinical hold (update),Seeking Alpha,https://seekingalpha.com/news/4386774-pepgen-stock-craters-on-fda-clinical-hold?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.964131772518158
1148,12/19/2024 11:10:39 AM,Vertex Pharma’s suzetrigine meets Phase 2 primary endpoint in radiculopathy,TipRanks,/news/stocks/vertex-pharma-s-suzetrigine-meets-phase-2-primary-endpoint-in-radiculopathy-1034156154,negative,0.8111017346382141
1149,12/19/2024 11:46:14 AM,Vertex’s non-opioid drug succeeds in back pain trial,Seeking Alpha,https://seekingalpha.com/news/4388000-vertexs-non-opioid-drug-succeeds-in-back-pain-trial?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7884029150009155
1150,12/19/2024 2:00:03 PM,Vertex Stock Falls After Release Of Phase 2 Results For Suzetrigine Study ,RTTNews,/news/stocks/vertex-stock-falls-after-release-of-phase-2-results-for-suzetrigine-study-1034155559,neutral,0.9445183277130127
1151,12/19/2024 2:41:28 PM,"Biggest stock movers Thursday: ACN, MU, MESO, and more",Seeking Alpha,https://seekingalpha.com/news/4387979-biggest-stock-movers-thursday-mu-meso-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9108431935310364
1152,12/19/2024 4:50:32 PM,Vertex Pharmaceuticals price target lowered to $522 from $545 at BofA,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-lowered-to-522-from-545-at-bofa-1034158297,neutral,0.799045205116272
1153,12/19/2024 5:00:26 PM,Vertex Pharmaceuticals price target lowered to $400 from $451 at RBC Capital,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-lowered-to-400-from-451-at-rbc-capital-1034158384,neutral,0.7742589712142944
1154,12/19/2024 6:25:23 PM,Vertex Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer,TipRanks,/news/stocks/vertex-pharmaceuticals-downgraded-to-perform-from-outperform-at-oppenheimer-1034158608,neutral,0.8780192136764526
1155,12/19/2024 6:30:14 PM,Oppenheimer downgrades Vertex after lumbosacral radiculopathy study,TipRanks,/news/stocks/oppenheimer-downgrades-vertex-after-lumbosacral-radiculopathy-study-1034158697,neutral,0.731670618057251
1156,12/19/2024 7:16:58 PM,Vertex downgraded to perform by Oppenheimer,Seeking Alpha,https://seekingalpha.com/news/4388439-vertex-downgraded-to-perform-by-oppenheimer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.626722514629364
1157,12/20/2024 10:50:13 AM,Vertex Pharmaceuticals price target lowered to $418 from $509 at Barclays,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-lowered-to-418-from-509-at-barclays-1034161597,neutral,0.8794950842857361
1158,12/20/2024 11:20:49 AM,Vertex price target lowered to $535 from $600 at H.C. Wainwright,TipRanks,/news/stocks/vertex-price-target-lowered-to-535-from-600-at-h-c-wainwright-1034161828,neutral,0.6578006148338318
1159,12/20/2024 11:40:11 AM,"Vertex could be down 10% due to LSR disappointment, says Wells Fargo",TipRanks,/news/stocks/vertex-could-be-down-10-due-to-lsr-disappointment-says-wells-fargo-1034161899,neutral,0.9729647040367126
1160,12/20/2024 12:30:25 PM,Vertex Pharmaceuticals price target lowered to $441 from $506 at Bernstein,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-lowered-to-441-from-506-at-bernstein-1034162522,neutral,0.7297595739364624
1161,12/20/2024 2:01:11 PM,Vertex Pharmaceuticals price target lowered to $520 from $566 at BMO Capital,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-lowered-to-520-from-566-at-bmo-capital-1034163049,neutral,0.7592471241950989
1162,12/20/2024 2:16:08 PM,"Channel Therapeutics highlights difference between NaV1.7, NaV1.8",TipRanks,/news/stocks/channel-therapeutics-highlights-difference-between-nav1-7-nav1-8-1034163115,negative,0.7681363224983215
1163,12/20/2024 4:30:27 PM,J.P. Morgan’s top Healthcare stocks for 2025,Seeking Alpha,https://seekingalpha.com/news/4389333-jp-morgans-top-healthcare-stocks-for-2025?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9314796924591064
1164,12/20/2024 5:49:22 PM,Vertex Pharmaceuticals Faces Uncertainty with Mixed Phase 2 Trial Results,TipRanks,/news/stocks/vertex-pharmaceuticals-faces-uncertainty-with-mixed-phase-2-trial-results-1034163763,neutral,0.9593304395675659
1165,12/20/2024 6:09:34 PM,"Vertex Pharmaceuticals: Buy Rating Despite LSR Trial Setback, Future Prospects Remain Strong",TipRanks,/news/stocks/vertex-pharmaceuticals-buy-rating-despite-lsr-trial-setback-future-prospects-remain-strong-1034163834,negative,0.9540454745292664
1166,12/20/2024 6:12:20 PM,Cautious Outlook on Vertex Pharmaceuticals Due to Suzetrigine’s Uncertain Efficacy in DPN Trials,TipRanks,/news/stocks/cautious-outlook-on-vertex-pharmaceuticals-due-to-suzetrigine-s-uncertain-efficacy-in-dpn-trials-1034163815,neutral,0.9537561535835266
1167,12/20/2024 6:19:31 PM,Barclays Keeps Their Hold Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/barclays-keeps-their-hold-rating-on-vertex-pharmaceuticals-vrtx-1034164016,positive,0.9186518788337708
1168,12/20/2024 6:23:16 PM,Cautious Optimism for Vertex Pharmaceuticals: Suzetrigene’s Potential Amidst Placebo Challenges,TipRanks,/news/stocks/cautious-optimism-for-vertex-pharmaceuticals-suzetrigene-s-potential-amidst-placebo-challenges-1034163973,negative,0.8951089978218079
1169,12/20/2024 8:40:14 PM,Vertex announces FDA exands approval for Trikafta,TipRanks,/news/stocks/vertex-announces-fda-exands-approval-for-trikafta-1034164285,positive,0.7772435545921326
1170,12/20/2024 8:50:14 PM,Vertex announces FDA approval of Alyftrek,TipRanks,/news/stocks/vertex-announces-fda-approval-of-alyftrek-1034164323,positive,0.8033536076545715
1171,12/20/2024 9:17:32 PM,Vertex Pharmaceuticals Gains FDA Approval for Cystic Fibrosis Drug,TipRanks,/news/stocks/vertex-pharmaceuticals-gains-fda-approval-for-cystic-fibrosis-drug-1034164362,negative,0.9445990324020386
1172,12/20/2024 10:38:48 PM,Vertex's Cystic Fibrosis Drug Alyftrek Gets FDA Approval ,RTTNews,/news/stocks/vertex-s-cystic-fibrosis-drug-alyftrek-gets-fda-approval-1034164077,negative,0.8798971772193909
1173,12/20/2024 10:42:21 PM,Vertex' Trikafta  Gets Expanded FDA Approval For Cystic Fibrosis Treatment ,RTTNews,/news/stocks/vertex-trikafta-gets-expanded-fda-approval-for-cystic-fibrosis-treatment-1034164186,negative,0.9324318170547485
1174,12/20/2024 11:04:29 PM,Vertex wins approval of new cystic fibrosis therapy Alyftrek,Seeking Alpha,https://seekingalpha.com/news/4389495-vertex-wins-approval-of-new-cystic-fibrosis-therapy-alyftrek?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9273200631141663
1175,12/21/2024 3:58:23 PM,Trending stocks in bearish pre-holiday week for U.S. stock market,Seeking Alpha,https://seekingalpha.com/news/4389543-trending-stocks-in-bearish-pre-holiday-week-for-us-stock-market?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8949296474456787
1176,12/22/2024 9:12:14 PM,SA Asks: Which Big Pharmas are likely to announce big M&A deals?,Seeking Alpha,https://seekingalpha.com/news/4389614-sa-asks-which-big-pharmas-are-likely-to-announce-big-m-deals?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9418226480484009
1177,12/23/2024 12:10:57 PM,"Analysts Conflicted on These Healthcare Names: Neurocrine (NBIX), Vertex Pharmaceuticals (VRTX) and Jasper Therapeutics (JSPR)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-neurocrine-nbix-vertex-pharmaceuticals-vrtx-and-jasper-therapeutics-jspr-1034168118,neutral,0.7097612023353577
1178,12/23/2024 12:50:14 PM,Vertex Pharmaceuticals price target lowered to $500 from $503 at JPMorgan,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-lowered-to-500-from-503-at-jpmorgan-1034168418,neutral,0.7701568007469177
1179,12/23/2024 1:05:58 PM,"Vertex black box warning for Alyftrek ‘somewhat a surprise,’ says Barclays",TipRanks,/news/stocks/vertex-black-box-warning-for-alyftrek-somewhat-a-surprise-says-barclays-1034168526,negative,0.6547467112541199
1180,12/23/2024 1:41:07 PM,"Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Vertex Pharmaceuticals (VRTX) and Ascendis Pharma (ASND)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-biontech-se-bntx-vertex-pharmaceuticals-vrtx-and-ascendis-pharma-asnd-1034168660,positive,0.8944296836853027
1181,12/23/2024 2:00:23 PM,Vertex Pharmaceuticals price target raised to $430 from $426 at Scotiabank,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-raised-to-430-from-426-at-scotiabank-1034168892,negative,0.9472814202308655
1182,12/23/2024 2:25:21 PM,TD Cowen Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/td-cowen-reaffirms-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1034168956,positive,0.7801474928855896
1183,12/23/2024 2:25:26 PM,Vertex Pharmaceuticals (VRTX) Receives a Buy from Bank of America Securities,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-buy-from-bank-of-america-securities-1034168954,negative,0.5815661549568176
1184,12/23/2024 2:50:32 PM,Vertex Pharmaceuticals price target lowered to $460 from $550 at Truist,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-lowered-to-460-from-550-at-truist-1034169086,neutral,0.5415940284729004
1185,12/23/2024 3:55:11 PM,RBC Capital Keeps Their Hold Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/rbc-capital-keeps-their-hold-rating-on-vertex-pharmaceuticals-vrtx-1034169243,positive,0.913004457950592
1186,12/25/2024 12:01:28 PM,"Analysts Are Bullish on Top Healthcare Stocks: Oruka Therapeutics (ORKA), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-oruka-therapeutics-orka-vertex-pharmaceuticals-vrtx-1034172922,negative,0.6580787301063538
1187,12/31/2024 2:35:22 PM,"Yum, Ralph Lauren upgraded: Wall Street’s top analyst calls",TipRanks,/news/stocks/yum-ralph-lauren-upgraded-wall-street-s-top-analyst-calls-1034183432,positive,0.8483331799507141
1188,1/2/2025 3:40:30 AM,Biotech Stocks Facing FDA Decision In January 2025 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-january-2025-1034184979,positive,0.9066577553749084
1189,1/7/2025 8:27:47 AM,Bernstein Remains a Hold on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/bernstein-remains-a-hold-on-vertex-pharmaceuticals-vrtx-1034199027,positive,0.8724948763847351
1190,1/7/2025 12:06:15 PM,"Vertex Pharmaceuticals, Orna Therapeutics announce research collaboration",TipRanks,/news/stocks/vertex-pharmaceuticals-orna-therapeutics-announce-research-collaboration-1034200707,positive,0.8488023281097412
1191,1/7/2025 1:11:55 PM,Orna Therapeutics collaborates with Vertex Pharmaceuticals to develop approaches for sickle cell disease,Seeking Alpha,https://seekingalpha.com/news/4392988-orna-therapeutics-collaborates-with-vertex-pharmaceuticals-to-develop-approaches-for-sickle-cell-disease?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.500582218170166
1192,1/7/2025 1:16:02 PM,"Orna Therapeutics, Vertex Pharma Enter Three-year Research Collaboration - Quick Facts ",RTTNews,/news/stocks/orna-therapeutics-vertex-pharma-enter-three-year-research-collaboration-quick-facts-1034199155,negative,0.5424730777740479
1193,1/9/2025 8:36:08 PM,Pharma companies welcome new year with 583 drug price hikes so far,Seeking Alpha,https://seekingalpha.com/news/4393873-2025-start-583-drug-price-hikes?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9193293452262878
1194,1/10/2025 11:36:33 AM,Vertex Pharmaceuticals: Hold Rating Amid Mixed Results for Suzetrigine in LSR and Optimistic Prospects in Acute Pain,TipRanks,/news/stocks/vertex-pharmaceuticals-hold-rating-amid-mixed-results-for-suzetrigine-in-lsr-and-optimistic-prospects-in-acute-pain-1034214509,neutral,0.9574377536773682
1195,1/10/2025 11:40:33 AM,Wells Fargo Issues a Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/wells-fargo-issues-a-buy-rating-on-vertex-pharmaceuticals-vrtx-1034214457,positive,0.8692298531532288
1196,1/10/2025 12:41:21 PM,"Zai Lab, Vertex Pharmaceuticals announce povetacicept license agreement",TipRanks,/news/stocks/zai-lab-vertex-pharmaceuticals-announce-povetacicept-license-agreement-1034215200,positive,0.7360185384750366
1197,1/10/2025 2:15:55 PM,Vertex Pharmaceuticals price target lowered to $456 from $476 at Morgan Stanley,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-lowered-to-456-from-476-at-morgan-stanley-1034215890,neutral,0.8401978015899658
1198,1/11/2025 8:06:44 PM,Can 2025 J.P. Morgan Healthcare Conference spark biotech M&A?,Seeking Alpha,https://seekingalpha.com/news/4394318-can-2025-jp-morgan-healthcare-conference-spark-biotech-ma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8774529099464417
1199,1/13/2025 10:35:55 AM,Citi Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/citi-sticks-to-its-buy-rating-for-vertex-pharmaceuticals-vrtx-1034220265,positive,0.6344321370124817
1200,1/13/2025 11:50:06 AM,Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL) and Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-exelixis-exel-and-vertex-pharmaceuticals-vrtx-1034220820,positive,0.8898999691009521
1201,1/13/2025 12:36:47 PM,Truist Financial Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/truist-financial-keeps-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1034221429,positive,0.8827792406082153
1202,1/13/2025 1:05:57 PM,Vertex Pharmaceuticals: Strong Future Potential with Key Drug Launches and Underappreciated Opportunities,TipRanks,/news/stocks/vertex-pharmaceuticals-strong-future-potential-with-key-drug-launches-and-underappreciated-opportunities-1034221664,negative,0.5956606268882751
1203,1/13/2025 1:57:45 PM,Piper Sandler Sticks to Their Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/piper-sandler-sticks-to-their-buy-rating-for-vertex-pharmaceuticals-vrtx-1034222156,positive,0.8629418015480042
1204,1/13/2025 7:57:08 PM,Vertex Pharmaceuticals: Strong Pipeline and Strategic Growth Propel ‘Buy’ Rating,TipRanks,/news/stocks/vertex-pharmaceuticals-strong-pipeline-and-strategic-growth-propel-buy-rating-1034222947,negative,0.8678542375564575
1205,1/13/2025 8:00:49 PM,"Vertex a ‘core large-cap biotech holding,’ says JPMorgan",TipRanks,/news/stocks/vertex-a-core-large-cap-biotech-holding-says-jpmorgan-1034223041,positive,0.5628551244735718
1206,1/14/2025 10:45:26 AM,Vertex Pharmaceuticals: Balancing Growth Prospects and Uncertainties with a Hold Rating,TipRanks,/news/stocks/vertex-pharmaceuticals-balancing-growth-prospects-and-uncertainties-with-a-hold-rating-1034225280,positive,0.7824845314025879
1207,1/14/2025 10:57:49 AM,Barclays Reaffirms Their Hold Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/barclays-reaffirms-their-hold-rating-on-vertex-pharmaceuticals-vrtx-1034225251,positive,0.8009685277938843
1208,1/14/2025 10:58:25 AM,Bernstein Sticks to Its Hold Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/bernstein-sticks-to-its-hold-rating-for-vertex-pharmaceuticals-vrtx-1034225391,positive,0.8252479434013367
1209,1/14/2025 12:45:45 PM,Vertex Pharmaceuticals: Strategic Advancements and Promising Pipeline Drive Buy Rating,TipRanks,/news/stocks/vertex-pharmaceuticals-strategic-advancements-and-promising-pipeline-drive-buy-rating-1034226397,negative,0.9212255477905273
1210,1/15/2025 9:00:44 PM,"McKesson, Vertex Pharmaceuticals among top healthcare Quant picks before Q4 earnings",Seeking Alpha,https://seekingalpha.com/news/4395424-mckesson-vertex-pharmaceuticals-among-top-healthcare-quant-picks-before-q4-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7037222981452942
1211,1/16/2025 12:35:27 PM,Bank of America Securities Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/bank-of-america-securities-reaffirms-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1034236337,positive,0.7993835806846619
1212,1/23/2025 1:58:12 AM,Vertex Pharmaceuticals (VRTX) Receives a Hold from RBC Capital,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-hold-from-rbc-capital-1034257427,positive,0.8737095594406128
1213,1/24/2025 1:08:00 PM,Vertex Pharmaceuticals (VRTX) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-buy-from-cantor-fitzgerald-1034266890,positive,0.5509439706802368
1214,1/27/2025 11:01:08 AM,Vertex Pharmaceuticals price target lowered to $450 from $456 at Morgan Stanley,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-lowered-to-450-from-456-at-morgan-stanley-1034271745,neutral,0.7589074969291687
1215,1/27/2025 12:01:47 PM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1034272479,negative,0.5521676540374756
1216,1/27/2025 1:50:23 PM,Vertex Pharmaceuticals price target lowered to $533 from $535 at Piper Sandler,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-lowered-to-533-from-535-at-piper-sandler-1034273096,neutral,0.85462486743927
1217,1/28/2025 7:27:14 AM,Vertex Pharmaceuticals’ Suzetrigine: A Promising Opioid Alternative in Pain Management,TipRanks,/news/stocks/vertex-pharmaceuticals-suzetrigine-a-promising-opioid-alternative-in-pain-management-1034275974,negative,0.8981238603591919
1218,1/30/2025 10:15:45 AM,Vertex downgraded to Equal Weight from Overweight at Wells Fargo,TipRanks,/news/stocks/vertex-downgraded-to-equal-weight-from-overweight-at-wells-fargo-1034288015,neutral,0.6101205945014954
1219,1/30/2025 10:20:18 AM,Wells downgrades Vertex to Equal Weight on lack of catalysts,TipRanks,/news/stocks/wells-downgrades-vertex-to-equal-weight-on-lack-of-catalysts-1034287994,neutral,0.8586761355400085
1220,1/30/2025 2:40:42 PM,"Meta Platforms, CVS Health upgraded: Wall Street’s top analyst calls",TipRanks,/news/stocks/meta-platforms-cvs-health-upgraded-wall-street-s-top-analyst-calls-1034290084,positive,0.8524630665779114
1221,1/30/2025 3:03:05 PM,Vertex downgraded at Wells Fargo on limited near-term upside,Seeking Alpha,https://seekingalpha.com/news/4400720-vertex-downgraded-wells-fargo-limited-near-term-upside?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7720373272895813
1222,1/30/2025 10:55:15 PM,Vertex Pharmaceuticals’ non-opioid Journavx approved for pain by FDA,TipRanks,/news/stocks/vertex-pharmaceuticals-non-opioid-journavx-approved-for-pain-by-fda-1034292069,negative,0.8458096385002136
1223,1/30/2025 10:55:35 PM,"Vertex Pharmaceuticals’ non-opioid painkiller approved by FDA, Bloomberg says",TipRanks,/news/stocks/vertex-pharmaceuticals-non-opioid-painkiller-approved-by-fda-bloomberg-says-1034292066,negative,0.747399091720581
1224,1/30/2025 11:00:26 PM,Vertex Pharmaceuticals up 2% at $448 after FDA Journavx approval,TipRanks,/news/stocks/vertex-pharmaceuticals-up-2-at-448-after-fda-journavx-approval-1034292119,negative,0.9172881841659546
1225,1/30/2025 11:30:22 PM,Vertex Pharmaceuticals announces FDA approval of Journavx,TipRanks,/news/stocks/vertex-pharmaceuticals-announces-fda-approval-of-journavx-1034292104,positive,0.5580954551696777
1226,1/30/2025 11:37:36 PM,Vertex gets FDA approval for non-opioid pain reliever,Seeking Alpha,https://seekingalpha.com/news/4401178-vertex-gets-fda-approval-for-non-opioid-pain-reliever?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9287413954734802
1227,1/31/2025 12:45:20 AM,"Closing Bell Movers: Atlassian up 19%, Apple gains 3% after results",TipRanks,/news/stocks/closing-bell-movers-atlassian-up-19-apple-gains-3-after-results-1034292187,negative,0.9112798571586609
1228,1/31/2025 5:19:22 AM,FDA Approves Vertex Pharma's JOURNAVX As The First Drug In A New Class Of Non-Opioid Pain Medicines ,RTTNews,/news/stocks/fda-approves-vertex-pharma-s-journavx-as-the-first-drug-in-a-new-class-of-non-opioid-pain-medicines-1034292410,negative,0.803962767124176
1229,1/31/2025 7:04:35 AM,Vertex (VRTX) Secures FDA Approval for Highly-Awaited Non-Opioid Painkiller,TipRanks,/news/stocks/vertex-vrtx-secures-fda-approval-for-highly-awaited-non-opioid-painkiller-1034293618,negative,0.9476019144058228
1230,1/31/2025 8:11:34 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Cigna (CI), Vertex Pharmaceuticals (VRTX) and Arcus Biosciences (RCUS)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-cigna-ci-vertex-pharmaceuticals-vrtx-and-arcus-biosciences-rcus-1034293769,neutral,0.9341903328895569
1231,1/31/2025 8:35:55 AM,Vertex In CASGEVY Reimbursement Deal With NHS England For Sickle Cell Disease Patients ,RTTNews,/news/stocks/vertex-in-casgevy-reimbursement-deal-with-nhs-england-for-sickle-cell-disease-patients-1034293683,negative,0.7415130138397217
1232,1/31/2025 10:10:23 AM,Vertex Pharmaceuticals announces Casgevy reimbursement pact with NHS England,TipRanks,/news/stocks/vertex-pharmaceuticals-announces-casgevy-reimbursement-pact-with-nhs-england-1034294343,negative,0.5793247222900391
1233,1/31/2025 11:00:15 AM,Vertex Pharmaceuticals price target raised to $435 from $418 at Barclays,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-raised-to-435-from-418-at-barclays-1034294595,negative,0.945584774017334
1234,1/31/2025 11:27:54 AM,Cautious Outlook on Vertex Pharmaceuticals Amid Journavx Approval and Pricing Concerns,TipRanks,/news/stocks/cautious-outlook-on-vertex-pharmaceuticals-amid-journavx-approval-and-pricing-concerns-1034294663,neutral,0.8789645433425903
1235,1/31/2025 11:33:08 AM,Vertex Pharmaceuticals’ JOURNA VX: Navigating Market Challenges Despite Promising Financial Outlook,TipRanks,/news/stocks/vertex-pharmaceuticals-journa-vx-navigating-market-challenges-despite-promising-financial-outlook-1034294846,negative,0.8239627480506897
1236,1/31/2025 11:47:03 AM,Vertex wins reimbursement deal for CRISPR-partnered sickle cell therapy in England,Seeking Alpha,https://seekingalpha.com/news/4401294-vertex-wins-reimbursement-deal-for-crispr-partnered-sickle-cell-therapy-in-england?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9478329420089722
1237,1/31/2025 12:06:21 PM,Vertex Pharmaceuticals (VRTX) Receives a Hold from Scotiabank,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-receives-a-hold-from-scotiabank-1034295074,positive,0.8503953218460083
1238,1/31/2025 12:19:09 PM,Truist Financial Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/truist-financial-sticks-to-its-buy-rating-for-vertex-pharmaceuticals-vrtx-1034295249,negative,0.6346495151519775
1239,1/31/2025 12:36:27 PM,Vertex Pharmaceuticals price target lowered to $320 from $325 at Baird,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-lowered-to-320-from-325-at-baird-1034295361,neutral,0.7154892683029175
1240,1/31/2025 12:46:00 PM,TD Cowen Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/td-cowen-reaffirms-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1034295512,positive,0.7801474928855896
1241,1/31/2025 1:11:37 PM,Vertex Pharmaceuticals price target raised to $550 from $535 at H.C. Wainwright,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-raised-to-550-from-535-at-h-c-wainwright-1034295613,negative,0.9494593143463135
1242,1/31/2025 1:16:04 PM,Buy Rating for Vertex Pharmaceuticals: FDA Approval of Journavx Boosts Market Potential and Stock Price Target,TipRanks,/news/stocks/buy-rating-for-vertex-pharmaceuticals-fda-approval-of-journavx-boosts-market-potential-and-stock-price-target-1034295770,negative,0.955671489238739
1243,1/31/2025 1:17:43 PM,Vertex Pharmaceuticals (VRTX) Initiated with a Buy at Cantor Fitzgerald,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-initiated-with-a-buy-at-cantor-fitzgerald-1034295748,positive,0.8666924834251404
1244,1/31/2025 1:57:30 PM,"Optimistic Outlook for Vertex Pharmaceuticals: Strong Performance, New Approvals, and Promising Pipeline Drive Buy Rating",TipRanks,/news/stocks/optimistic-outlook-for-vertex-pharmaceuticals-strong-performance-new-approvals-and-promising-pipeline-drive-buy-rating-1034295936,negative,0.9510549306869507
1245,1/31/2025 1:58:49 PM,Vertex Pharmaceuticals (VRTX) Gets a Buy from Bank of America Securities,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-buy-from-bank-of-america-securities-1034296100,negative,0.5508448481559753
1246,1/31/2025 2:05:21 PM,Vertex Pharmaceuticals price target raised to $433 from $430 at Scotiabank,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-raised-to-433-from-430-at-scotiabank-1034296090,negative,0.9482825398445129
1247,1/31/2025 2:55:14 PM,Early notable gainers among liquid option names on January 31st,TipRanks,/news/stocks/early-notable-gainers-among-liquid-option-names-on-january-31st-1034296301,negative,0.9077146053314209
1248,1/31/2025 3:40:26 PM,Vertex Pharmaceuticals price target raised to $545 from $520 at BMO Capital,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-raised-to-545-from-520-at-bmo-capital-1034296736,negative,0.9478808641433716
1249,1/31/2025 5:00:56 PM,"Apple, Intel little changed near noon following earnings: Morning Buzz",TipRanks,/news/stocks/apple-intel-little-changed-near-noon-following-earnings-morning-buzz-1034297283,positive,0.8414871692657471
1250,2/3/2025 6:27:36 AM,Evercore ISI Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/evercore-isi-keeps-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1034301418,positive,0.9134822487831116
1251,2/3/2025 6:35:52 AM,Vertex Pharmaceuticals: Strong Buy Rating Driven by Suzetrigine Approval and Promising Market Prospects,TipRanks,/news/stocks/vertex-pharmaceuticals-strong-buy-rating-driven-by-suzetrigine-approval-and-promising-market-prospects-1034301478,negative,0.9509260058403015
1252,2/3/2025 7:05:23 AM,Vertex Pharmaceuticals: Strong Buy Rating Driven by Journavx Approval and Market Expansion Opportunities,TipRanks,/news/stocks/vertex-pharmaceuticals-strong-buy-rating-driven-by-journavx-approval-and-market-expansion-opportunities-1034301582,negative,0.9489714503288269
1253,2/3/2025 9:29:02 AM,Vertex Pharmaceuticals (VRTX) Set for Painless Gains After FDA Approval,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-set-for-painless-gains-after-fda-approval-1034302225,negative,0.7414191961288452
1254,2/3/2025 4:00:32 PM,Biotech Alert: Searches spiking for these stocks today,TipRanks,/news/stocks/biotech-alert-searches-spiking-for-these-stocks-today-1034304720,positive,0.7777097821235657
1255,2/4/2025 11:21:28 AM,Bank of America Securities Keeps Their Buy Rating on Vertex Pharmaceuticals (VRTX),TipRanks,/news/stocks/bank-of-america-securities-keeps-their-buy-rating-on-vertex-pharmaceuticals-vrtx-1034308253,positive,0.9166613221168518
1256,2/4/2025 12:38:19 PM,Vertex Pharmaceuticals price target raised to $540 from $522 at BofA,TipRanks,/news/stocks/vertex-pharmaceuticals-price-target-raised-to-540-from-522-at-bofa-1034308879,negative,0.948602557182312
1257,2/7/2025 7:01:24 PM,Cystic fibrosis drug developer Sionna rises on trading debut,Seeking Alpha,https://seekingalpha.com/news/4405260-sionna-stock-rises-trading-debut?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.4273597300052643
1258,2/7/2025 8:00:52 PM,"Catalyst Watch: Tariff countdown, McDonald's earnings, Sailpoint IPO, Powell goes to DC, and Super Bowl aftershocks",Seeking Alpha,https://seekingalpha.com/news/4405190-catalyst-watch-tariff-countdown-mcdonalds-earnings-sailpoint-ipo-powell-goes-to-dc-and-super-bowl-aftershocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9343588352203369
1259,2/8/2025 12:07:08 PM,Vertex Pharmaceuticals (VRTX) Gets a Buy from J.P. Morgan,TipRanks,/news/stocks/vertex-pharmaceuticals-vrtx-gets-a-buy-from-j-p-morgan-1034329653,negative,0.6875255107879639
1260,2/8/2025 6:46:00 PM,Another strong earnings week as over 75% of companies deliver EPS wins-Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4405204-another-strong-earnings-week-as-over-75-of-companies-deliver-eps-wins-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9524391889572144
